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Abstract
This study describes the molecular characteristics of STEC isolated from the pas-
toralist community of Nyabushozi in Southwestern Uganda. Faecal samples or rectal
swabs of children with diarrhoea obtained in phases 1 and 2 were investigated for
the presence of STEC by PCR detection of stx genes. During phase 1, cattle reared
on range which were associated with households of sick children were investigated in
parallel to the children for STEC excretion. STEC was isolated from E. coli in 7 of
80 (8.8%) children and in 15 of 216 (6.9%) bovines in phase 1. Similarly, STEC was
isolated from 11 of 142 (7.7%) E. coli carrying children and 3 of 45 (6.7%) water
samples in phase 2.
Molecular characterization further ascertained the genetic relatedness of STEC.
PFGE profiles of up to 10 colonies obtained from an individual source (child, bovine
or water) and in total 185 STEC colonies were analysed. Nine profiles from 43
colonies (phase 1) and 15 profiles from 38 colonies (phase 2) obtained from chil-
dren were not or were distally related, indicating the genetic diversity of clinical
STEC. The intra-host analysis of STEC profiles revealed that strains from 11 of the
13 children exhibited multiple clonal subgroups. The 101 colonies from 15 bovines
clustered in 18 different profiles. Clonal subgroups were observed in multiple STEC
colonies from 11 of 12 bovines. Closely related profiles indicated that STEC isolated
from two children (Hh2 and Hh4) was acquired from bovines or their environment.
While none of the clinical or bovine STEC were related to 5 genetically diverse water
strains.
A single isolate of STEC representing each PFGE profile in association with stx gene
content was serotyped for the O antigen. Twenty four bovine STEC were typed into
10 O serogroups including O8, O76, O111 and O113, which were also identified
among the clinical STEC. The 25 clinical STEC belonged to 15 serogroups of which
O29, O149 and O176 are being reported for the first time as clinical STEC. STEC
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Abstract
O166 was isolated from a child and water during the same sampling, indicating the
potential health hazard of drinking STEC-contaminated water. The production of
Shiga toxin (Stx) investigated using Duopath Verotoxin detection kits showed that
a majority of STEC from different sources produced Stx1 or Stx2 or both Stx.
Using PCR or PCR-RFLP assays, stx2 and eae gene types were analysed. Variant
stx2−vhc was most prevalent and closely associated with stx2d−2 in clinical and bovine
STEC. The frequency of eae-positive STEC among clinical and bovine STEC was
15 of 25 (60%) and 14 of 24, (58.3%), respectively. eae-γ2/θ was predominant
among the bovine STEC, eae-κ/δ in clinical STEC, while eae-β1 was associated with
STEC from different sources including water. Previously undescribed eae-positive
serogroups O28ac, O113, O142 and O158 were identified.
Studies of the genetic background showed that both clinical and bovine STEC
obtained in phase 1 predominantly belonged to phylogenetic group A and B1,
while phase 2 clinical and water STEC belonged to group D and A, respectively.
Seropathotype classification of clinical STEC, separated most strains (20 of 24
strains) into seropathotype D. These STEC belonged to phylogenetic groups A,
B1 and D.
Thus, the characterised genetic attributes of STEC from Nyabushozi suggests that
the pathogens have the potential to cause a wide spectrum of childhood illnesses
ranging from mild to bloody diarrhoea and haemolytic uraemic syndrome.
xxii
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Chapter 1
General Introduction
1.1 Aims of this work: background
1.1.1 Geographic, demographic and climate characteristics
of the cattle corridor in Uganda
Uganda is located in the great lakes region of East Africa. The country is bordered
by Kenya in the East, Tanzania and Rwanda in the South, the Democratic Republic
of Congo in the West and Sudan in the North (Figure 1.1). The landmass covers an
area of about 241,500 sq. km, of which 15.3% is open water, 3.0% permanent wet-
lands and 9.4% seasonal wetlands (National Environmental Management Authority,
2002). More than two-thirds of the country, located on a plateau, 1000-2500m above
sea level is available as agricultural arable land (Kamanyire, 2000; National Envi-
ronmental Management Authority, 2002). Over 87% of the 28.4 million inhabitants
are rural based (United Nations Population Fund, 2007), engaged in livestock and
crop agricultural activities (Kamanyire, 2000).
Stretching across the country is the cattle corridor, a typical savannah grassland,
which extends from the border with Rwanda in the south-west to the Sudan and
Kenya borders in the North-east, dividing the country into two distinct crop and
cattle keeping regions (Asiimwe, 2000; Kamanyire, 2000). The region covers 43%
of the country (National Environmental Management Authority, 2002), receives er-
ratic rainfall (500-1000mm annually), has prolonged droughts, poor soil and scarce
1
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Figure 1.1: Cattle corridor region in Uganda.
permanent surface reservoirs (Kisamba-Mugerwa and Nuwagaba, 1996). The pas-
toral and agro-pastoral communities in the cattle corridor rangelands support more
than 95% of the national cattle population (Kisamba-Mugerwa, 2001; Oloya, 2006),
and produce most (85%) of the beef and milk in the country (Kisamba-Mugerwa,
2001). The longhorn Ankole cattle, an indigenous dual purpose animal, dominate
the cattle corridors of central and western Uganda. As the area is beset by severe
water shortage, which in turn affects the availability of green pasture, large herds
of cattle are reared under pastoralism where resources are utilised commonly by the
pastoralists (Kisamba-Mugerwa and Nuwagaba, 1996).
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1.1.2 Pastoral livestock system in Mbarara subregion
Mbarara subregion in south-western Uganda (Figure 1.1) is composed of 4 districts;
Ibanda, Isingiro, Kiruhura and Mbarara that form part of the corridor. The region
has approximately 1 million inhabitants and boasts the highest cattle population
in the country; almost every adult owns cattle (Uganda Bureau of Statistics, 2007).
The region is commonly referred to as the “land where milk and honey flows along the
paths” because of abundant milk supply to the country (Kamanyire, 2000). Over
92% of its population is rural and less than 5% of the population have access to
clean potable water (Uganda Bureau of Statistics, 2007). The drier eastern district
of Kiruhura is predominantly under pastoralism (Mwambutsya, 1991). Valley dams,
constructed in the region provide permanent water reservoirs for humans and their
livestock.
For centuries, a dominant Bahima ethnic group in Mbarara subregion have kept
longhorn Ankole cattle and practised pastoralism (Mwambutsya, 1991), their ani-
mals sharing both grass and water (Mugasi et al. 1999). Cattle form the central
focus of their cultural, spiritual and economic existence (Kisamba-Mugerwa and
Nuwagaba, 1996). Tradition dictates that the number of cattle owned by an in-
dividual is a measure of wealth and a symbol of social status in the community
(Mugasi et al. 1999). Pastoralism is further promoted by a tradition that regards
modern livestock management systems as imprisonment of the animal (Aveling et
al. 1998). In pastoral communities of Uganda, including the Bahima, consumption
of raw milk and milk products is a strong tradition (Oloya, 2006).
1.1.3 Cattle: the source of one of the pathogenic groups of
Escherichia coli
Escherichia coli (E. coli) is part of the normal gut flora of man and animals (Donnen-
berg and Whittam, 2001). Certain strains possess virulence factors enabling them
to cause gastrointestinal diseases, or infections at other sites (Kaper et al. 2004).
E. coli strains that cause diarrhoeal diseases have been categorised into pathogenic
groups [1.2] based on their virulence properties (Nataro and Kaper, 1998; Kaper
et al. 2004). One of these groups, enterohaemorrhagic E. coli (EHEC), is defined
3
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by the presence of Shiga-toxin genes (Nataro and Kaper, 1998). Such strains are
frequently termed Shiga toxin-producing E. coli (STEC), of which some, are highly
pathogenic for humans, particularly children (Nataro and Kaper, 1998; Paton and
Paton, 1998b; Kaper et al. 2004; Thorpe, 2004; Tarr et al. 2005; Gyles et al. 1998).
Figure 1.2: Reservoirs and transmission routes of STEC.
STEC is a food and water-borne pathogen acquired orally. Cattle are the primary
source of STEC, shed in faeces to contaminate the carcass. Other domestic rumi-
nants also shed STEC. Undercooked ground beef is the main source of infection.
Water and fresh vegetables contaminated with bovine faeces are additional sources.
Direct human-to-human transmission occurs but human to cattle transmission has
not been reported.
The gastrointestinal tracts of ruminants, particularly cattle are the major reservoirs
of STEC, which is shed in faeces of healthy animals (Nataro and Kaper, 1998; Gyles
et al. 2007; Armstrong et al. 1996; Caprioli et al. 2005; Hussein and Sakma, 2005;
Hussein, 2007; Mora et al. 2007). STEC is the only true pathogenic group of E. coli
with a zoonotic origin (Blanco et al. 2005).
From cattle, the primary host, STEC is transmitted to humans via several routes
as shown in Figure 1.2. First the carcasses may be contaminated at slaughter;
4
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the subsequent beef grinding processes distribute the organisms throughout the beef
(Boyce et al. 1995). Undercooked ground beef is a primary source of STEC infection
(Riley et al. 1983; Griffin and Tauxe, 1991; Armstrong et al. 1996; Caprioli et al.
2005). Additionally, milk, especially unpasteurized milk and milk products (Hussein
and Sakuma, 2005; Hussein, 2007), are sources of STEC. Other foods, such as salami,
sausages, contaminated vegetables and fruits have also been associated with similar
infections (CDC, 1995,2006a; Michino et al. 1999; Breuer et al. 2001; Caprioli et al.
2005). Person-to-person transmission of STEC occurs, promoted by close contact
or poor hygienic conditions (Gouveia et al. 1998; Parry and Salmon, 1998). More
frequently, STEC infections are associated with human-cattle contact or contact with
the environment of cattle (Crampin et al. 1999; O’Brien et al. 2001), especially in
rural farming communities (Strachan et al. 2001). Children are at particular risk
of infection from the farm environment contaminated with cattle faeces (Crump et
al. 2002; Grif et al. 2005). Surface drinking water supplies, contaminated with
manure-containing STEC, have also been implicated in STEC infection (Olsen et al.
2002; Yatsuyanagi et al. 2002).
There is abundant information on the epidemiology of STEC in developed nations;
however, very little is known about the epidemiology of this organism in sub-Saharan
Africa. STEC infection is considered a health hazard in developed nations where it is
associated with fast-food restaurants (Karmali et al. 1983; Grimm et al. 1995 Arm-
strong et al. 1996; CDC, 1995,2006a) and intensive livestock systems (Fegan et al.
2004; Vali et al. 2005; Sanderson et al. 2006). Although foodborne STEC infections
are relatively frequent in North America and Japan, (Michino et al. 1999; Breuer et
al. 2001; Kassenborg et al. 2004; CDC, 2006b), in rural communities contamination
of the environment with high-density cattle population, water in particular, has be-
come a major source of infection (Strachan et al. 2001; Olsen et al. 2002). The few
studies on the epidemiology of STEC in sub-Saharan Africa did not consider human
populations in close contact with cattle (Kaddu-Mulindwa et al. 2001; Gascon et
al. 2000; Rappelli et al. 2005). One study of STEC in cattle from a farm in central
Uganda identified STEC, of diverse serotypes, in 42 of 159 cattle. Interestingly,
some of the serotypes, such as O74:H42 and O76:H2, were isolated for the first time,
(Kaddu-Mulindwa et al. 2001; http://www.microbionet.com.au/vtectable.htm),
which could suggest that cattle in Uganda harbour distinct serotypes of STEC.
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As part of the study by (Kaddu-Mulindwa et al. 2001), diarrhoeal children from
Mulago referral hospital in Kampala were investigated for STEC infection. The chil-
dren had not had contact with cattle included in the study and were not part of the
pastoralist community. STEC was not isolated from the children (Kaddu-Mulindwa
et al. 2001).
Nothing is known about the occurrence of STEC in cattle in the pastoralist commu-
nity of the cattle corridor of Uganda. Further, the extent of transmission of STEC
from cattle, or their environment, to children, who live in close contact with cattle
is unknown. Thus, the aims of my study were to investigate and characterise STEC
from cattle and water sources in Mbarara region (Figure 1.1). Additionally, these
organisms were sought in diarrhoegenic-children in the pastoralist community of this
region.
1.2 E. coli associated with gastrointestinal infec-
tions
Initially, all diarrhoea-associated E. coli were termed enteropathogenic E. coli (Neter
et al. 1955). An increase in knowledge of pathogenicity led to the designation of
six specific groups: Enteropathogenic E. coli (EPEC), enterohaemorrhagic E. coli
(EHEC), enteroinvasive E. coli (EIEC), enterotoxigenic E. coli (ETEC), enteroag-
gregative E. coli (EAEC) and diffusely adherent E. coli (Nataro and Kaper, 1998;
Clarke, 2001; Donnenberg and Whittam, 2001; Huang and DuPont, 2004; Kaper et
al. 2004; Nguyen et al. 2005).
1.2.1 Enteropathogenic E. coli
Since it was first recognised more than 6 decades ago (Bray, 1945), EPEC remains
a major pathogen of children in developing countries (Nataro and Kaper, 1998;
Clarke, 2001; Naylor et al. 2005). It is associated with poor hygienic conditions and
a major cause of high childhood mortality (Chen and Frankel, 2005). EPEC is the
prototype of the locus of enterocyte effacement (LEE) carrying E. coli pathogens,
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which intimately attach to the intestinal epithelial cells causing attaching and ef-
facing (A/E) lesions (Jerse et al. 1990; McDaniel et al. 1995; Jores et al. 2004).
The subsequent pathophysiological changes cause electrolyte imbalance and impaired
absorption from, and increased secretion into, the intestinal lumen cells leading to
diarrhoea (Field, 2003).
1.2.2 Enteroinvasive E. coli
Enteroinvasive E. coli is the only group of E. coli known to cause diarrhoea by
invasion of epithelial cells (Nataro and Kaper, 1998). It causes watery diarrhoea
and dysentery which are clinically similar to the corresponding illness caused by
Shigella (Nataro and Kaper, 1998; Lan et al. 2004).
As EIEC and Shigella organisms have the same phenotypic characteristics (Lan et
al. 2004), they are believed to have evolved from the same lineage but diverged into
distinct pathovars (Pupo et al. 1997; Lan et al. 2004).
1.2.3 Enterotoxigenic E. coli
Enterotoxigenic E. coli (ETEC) produce plasmid-encoded heat labile toxins (LT)
and heat stable-toxins (Nataro and Kaper, 1998). ETEC is the major cause of
weaning diarrhoea, a watery type of diarrhoea among infants in developing countries
(Wenner˚as and Erling, 2004). The disease is usually self limiting but fatal cases
have been reported in infants, however, the organisms are frequently isolated from
healthy people (Nataro and Kaper, 1998). Since individuals in developed nations lack
immunity to ETEC, they frequently develop diarrhoea following their first exposure
to ETEC infection referred to as travelers’ diarrhoea (Sack, 1990; Lima, 2001).
1.2.4 Enteroaggregative E. coli
Enteroaggregative Escherichia coli is the major cause of a persistent diarrhoea (14
days) in children and adults worldwide (Huang and DuPont, 2004; Weintraub,
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2007). The water- and food-borne pathogen is promoted by poor sanitary con-
ditions (Adachi et al. 2002). In recent times, EAEC has become a major cause of
diarrhoea in patients infected with human immunodeficiency virus (HIV) (Durrer
et al. 2000). The pathogens derived their name from the characteristic aggregative
adherent pattern they form on human epithelial (HEp-2) cells (Durrer et al. 2000;
Huang and DuPont, 2004). They posses an adhesive pili, (Salyers and Whitt, 1994)
which enable EAEC to colonise the intestinal epithelial cells (Czeczulin, et al. 1997;
Huang and DuPont, 2004). The organism initiates mucus secretion by the entero-
cytes (Hicks et al. 1996) as well as inflammation leading to diarrhoea (Huang and
DuPont, 2004).
1.2.5 Diffusely adherent E. coli
Diffusely adherent Escherichia coli (DAEC) causes diarrhoeal disease in humans of
all age groups, worldwide (Jallat et al. 1993). Characteristically this pathogen forms
a diffuse adherence (DA) pattern on cultured epithelial cells (Nataro and Kaper,
1998; Scaletsky et al. 2002). It is the surface fimbriae proteins that are major
adherence factors responsible for the DA phenotype (Bilge et al. 1996), encoded by
genes located on a conjugative plasmid or in the chromosome (Czeczulin et al. 1997;
Lopes et al. 2005).
1.2.6 Enterohaemorrhagic E. coli
Enterohaemorrhagic E. coli (EHEC) is a subgroup of Shiga toxin (Stx)-producing E.
coli (STEC) that causes a range of diseases from mild watery diarrhoea, to bloody
diarrhoea (haemorrhagic colitis) and haemolytic-uraemic syndrome (Levine, 1987;
Levine et al. 1987; Tarr et al. 1996,2005 ; Nataro and Kaper, 1998; Thorpe, 2004).
The genes encoding Shiga toxins (stx1 and stx2) are phage mediated and strains may
contain one or both of the genes (O’brien and Holmes, 1987). Since these toxins have
activity on Vero cells, they are also called Verotoxins (Konowalchuk et al. 1977).
As this group is the subject of my research, a more detailed description of EHEC is
presented [1.3].
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1.3 Shiga toxin containing E. coli
1.3.1 Biology
STEC are non-spore forming Gram negative rods which produce catalase and indole,
but lack oxidase. They are non-fastidious organisms which grow readily on peptone,
meat extract, blood and MacConkey agar media (Ryan, 1990). The majority of
strains are motile (Ryan, 1990); a notable exception is STEC O157:NM which lost
its flagellae during evolution (Feng et al. 1998; Karch and Bielaszewska, 2001).
A feature of STEC O157:H7 strains is that they lack the ability to ferment sorbitol
(March and Ratnam, 1986). As STEC belonging to this serogroup is most frequently
associated with haemorrhagic colitis (HC) and haemolytic uraemic syndrome (HUS),
most diagnostic laboratories use sorbitol MacConkey agar (SMAC) to distinguish
STEC O157:H7 from non-O157:H7 strains (March and Ratnam et al. 1986; Mead,
and Griffin, 1998; Bielaszewska and Karch, 2000). Clinically important sorbitol
fermenting non-O157 STEC serotypes such as O111, O113, O26 and as well as
O157:NM are frequently undetected in diagnostic laboratories (Tarr et al. 2005).
For this reason, the extent of non-O157:H7 STEC in human illness is not known.
As such, clinical infections with non-157:H7 STEC are likely to be misdiagnosed
and under reported (Mead and Griffin, 1998; Thorpe, 2004; Thompson et al. 2005;
CDC, 2007; Gilmour et al. 2007a).
1.3.2 Serotypes
Serotyping of STEC is based on the expression of the somatic (O) lipopolysaccha-
ride, capsular (K) and flagellar (H) antigens according to Kauffmann (1947) classi-
fication. Presently, 472 STEC serotypes have been identified (Blanco et al. 2004c;
http://www.lugo.usc.es/ecoli). Apart from STEC O157:H7 and NM, other serotypes
of public health importance are O26:H-, O26:H11, O91:H-, O103:H2, O111:H-,
O113:H21, O118:H16, O128:H2, O145:H-, O145:H28 and O146:H21 (Beutin et al.
2004; Karch et al. 2005).
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1.3.3 Virulence factors of Shiga toxin-producing E. coli
1.3.3.1 Shiga toxin: Structure and biological properties
Shiga toxins belong to a family of closely related toxins, the AB5 hexameric type
of molecules (Merritt and Hol 1995; Sandvig, 2001; Fraser et al. 2004). The family
includes Shiga elaborated by Shigella dysenteriae type1 and Stx from STEC (Fraser
et al. 1994). In addition, other pathogens, Citrobacter rodentium, Aeromonas ceviae
and Enterobacter cloacae contain Stx (Nataro and Kaper, 1998).
The hexameric molecule (Figure 1.3), consists of five B-subunits (7.7kDa) each linked
to a single 32kDa A-subunit via a disulphide bond (O’brien and Holmes, 1987;
Donnenberg and Whittam, 2001; Sandvig, 2001). The enzymatic A-subunit has an
internal disulphide bond which is proteolytically cleaved to form the A1 and A2
fragments (Sandvig, 2001; Fraser et al. 2004). It is the B-pentamer that recognises
and binds to the host cells in the target organs (Merritt and Hol, 1995).
Figure 1.3: The crystal structure of Shiga toxin.
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The biological activities of Shiga toxin have been well characterised. Purified Shiga
toxin is unequivocally enterotoxigenic to the small intestine of rabbits and lethal
to mice (O′Brien et al. 1982). Further, its cytotoxicity to African-Green monkey
kidney (Vero) cells (Konowalchuk et al. 1977), Hela cells and partial toxicity to baby
hamster cells are well established (O′Brien et al. 1983; O′Brien and LaVeck, 1983).
One or both λ-like bacteriophage mediated Shiga toxins (Stx1 and Stx2) and their
variants are the main virulence factors of STEC (O’Brien and Holmes, 1987). It has
been shown using epidemiological and experimental studies that the potency of Stx2
is higher (400 times) than Stx1 (Tesh et al. 1993). Also, STEC containing Stx2 is
associated more with severe human illness than STEC containing Stx1 or Stx1 and
Stx2 (Tesh et al. 1993; Boerlin et al. 1999). Since the amino acid sequence identity
between Stx1 and Stx2 is only 50% (Tesh et al. 1993; Fraser et al. 2004), they differ
in their immunological properties (O’Brien and Holmes, 1987).
A study by Strockbine et al. (1986) showed Stx1 is immunologically similar to
Shiga from S. dysenteriae type 1. Further, they have identical amino acid sequences
in the B-subunits and 98% identity in the A-subunit (O′Brien et al. 1982). Less
heterogeneity has been observed in Stx1 than in Stx2 (Paton et al. 1993; Nataro
and Kaper, 1998). Three variants encoded by stx1−OX3 (Koch et al. 2001), stx1c
(Zhang et al. 2002a; Brett et al. 2003b) and stx1d (Girardeau et al. 2005) have been
described.
In contrast, greater amino acid sequence variation is exhibited by Stx2 (Schmitt et
al. 1991; De Baets et al. 2004; Zhang et al. 2005). Presently, 15 distinct stx2
variants (Table 1.1) have been identified (Melton-Celsa et al. 1996; Pierard et al.
1998; Bertin et al. 2001; Schmidt et al. 2000; Eklund et al. 2002; Brett et al.
2003a; Gobius et al. 2003; Leung et al. 2003; Zhang et al. 2005). Following the
chronological order suggested by Scheutz et al. (2001), the variants are designated:
stx2, stx2c, stx2d, stx2e, stx2f and stx2g (Calderwood et al. 1996; Acheson, 1998).
STEC may contain more than one stx2 variant (Bertin et al. 2001; Scheutz et al.
2001; Eklund et al. 2002). Stx-EDL993, Stx2e and Stx2d have distinct antigenic and
biological characteristics (Caprioli et al. 2005); however, other Stx2 variants which
share greater amino acid identity have similar biological and immunologic properties
(Melton-Celsa et al. 1996).
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Table 1.1: Variants of stx2
Variant Associated disease in man
stx2−EDL933 HUS
stx2c HUS
stx2−O48 HUS
stx2−OX3a sudden infant death
stx2−OX3b sudden infant death
stx2−O111 HUS
stx2−O118/stx2d abdominal cramps
stx2−NV 206 none
stx2−vhc none
stx2d−1/stx2−vha mild diarrhoea/ HUS
stx2d−2/stx2−vhb mild diarrhoea/ HUS
stx2e asymptomatic infection/mild
diarrhoea
stx2ev none
stx2f none
stx2g none
Source: Bertin et al. (2001); Leung et al. (2003)
and De Baets et al. (2004)
Variants of stx2d encode the activatable group of toxins (Melton-Celsa et al.
1996,2002) because the protease elastase in the intestinal mucus increases their cy-
totoxicity (Kokai-Kun et al. 2000). Stx2, a prototype toxin from O157:H7 EDL933
and Sakai strains and the presence of Stx2c variants are closely related with se-
vere human illness (Friedrich et al. 2002). Conversely, proteins encoded by stx1,
stx2−O118 (non activatable stx2d) and stx2e cause no illness or mild watery diarrhoea
in humans (Friedrich et al. 2002; Jenkins et al. 2003b; Cleary, 2004). Currently,
stx2f (Schmidt et al. 2000) and stx2g (Leung et al. 2003), which were recently
identified among feral parrots and healthy cattle, respectively, have not been linked
to human illness.
Studies have shown that the distribution of Stx glycolipid receptors, globotrioa-
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sylceramide (Gb3) in the various tissues and organs determines the toxic effects
(Lingwood, 1996). The Gb3-rich endothelial cells of the kidney and brain are prone
to severe cytopathic effects (Lingwood, 1996; Kaper et al. 2004; Noris and Remuzzi,
2005). Stx2e, preferentially binds to globotetrasylceramide (Gb4) than to Gb3 (De-
Grandis et al. 1989; Boyd et al. 1993; Paton and Paton, 1998b; Sonntag et al.
2005).
1.3.3.2 Systemic uptake of Shiga toxin
Subsequent to colonizing the intestinal mucosa, EHEC releases Shiga toxins into
the gut lumen (Paton and Paton, 1998b). Although it is evident that Stx translo-
cates across the epithelial cell barrier without causing cellular damage (Acheson et
al. 1996; Paton and Paton, 1998b), it alters the integrity of the epithelial tight
junctions (Sears, 2000) and underlying endothelial cells (Noris and Remuzzi, 2005).
The presence of STEC as well as its toxin evokes a local cellular immune response
mediated by tumour necrosis factor alpha (α) and interleukin-8 (IL-8) (Hurley et al.
2001). This is preceded by increased neutrophils which traverse the compromised
tight junctions into the intestinal lumen (Parkos et al. 1991; Hurley et al. 2001).
Concurrently, Stx transmigrate in the opposite direction into the microvascular cir-
culation (Hurley et al. 2001). Besides the tight junction, Stx1 crosses the epithelial
cells by intracellular receptor-mediated endocytosis (Hurley et al. 1999,2001).
Recent studies have clearly shown that Stx is transported in the blood stream bound
to polymorphonuclear leukocytes (PMNs) (te-Loo et al. 2000). Although erythro-
cytes (Bitzan et al. 1994) and platelets (Cooling et al. 1998) were initially thought
to transport Stx, recent findings down play their role (te-Loo et al. 2000). The role
of PMN in the transport of Stx has been unequivocally shown by the increased blood
count of Stx-neutrophil bound cells in patients with HUS (te-Loo et al. 2000). Fur-
ther evidence shows that the Gb3 expressed by glomerular endothelial cells of target
organs has 100-fold higher affinity for Stx than the non-Gb3 Stx-receptor on PMNs
(Ruggenent et al. 2001). As such, Stx is transferred to the capillary endothelial
cells of glomerular of renal tubules and central nervous system (Kaper et al. 2004;
Noris and Remuzzi, 2005). Once the toxin has been internalised by the cell and
transported to the Golgi apparatus (Tesh and O’Brien, 1991; Kaper et al. 2004),
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the A-subunit is proteolytically nicked into two fragments, A1 and A2 (O
′Brien and
Holmes, 1987; Sandvig, 2001; Robert et al. 2006). The enzymatic portion, A1, inac-
tivates the ribosome by enzymatically depurinating a single adenine base from the
28S eukaryotic rRNA of the 60S ribosome, to inhibit protein synthesis and eventual
cell death (O′Brien and Holmes, 1987; Nataro et al. 2004; Noris and Remuzzi, 2005).
It has been reported that intestinal mucosa epithelial cells express Gb3 receptors
with higher affinity for Stx1 than Stx2 (Tesh et al. 1993; Jacewizc et al. 1999).
Consequently, the systemic translocation of Stx1 is minimised and its cytopathic
effects are localised to the intestinal areas which manifest as bloody diarrhoea (Tesh
et al. 1993). However, Stx2 is known to cross the intestinal epithelial cell into the
blood (Jacewizc et al. 1999) and preferentially bind to the Gb3-rich cells of kidney
and brain tissues (Tesh et al. 1993).
1.3.3.3 Role of Shiga toxin in the induction of watery diarrhoea
It was noted that the presence of STEC in the intestinal areas stimulates inflamma-
tion of the mucosa (Kandel et al. 1989), which interferes with electrolyte balance
(Field, 2003). Accordingly, the reduced water and sodium ion intake, as well as
increased chloride ion secretion into the intestinal lumen, lead to watery diarrhoea
(Li et al. 1993; O′loughlin and Robins-Browne, 2001; Field, 2003). Earlier work-
ers, Keusch et al. (1972) demonstrated that purified Shiga toxin elicited diarrhoea
through fluid accumulation in a segment of a ligated rabbit ileal loop. However, there
are contrasting results with recent findings. STEC-negative mutants were able to
induce watery but not bloody diarrhoea in rabbits (Fontaine et al. 1998; O′loughlin
and Robins-Browne, 2001). Thus, Stx plays a major role in inducing bloody diar-
rhoea (Fontaine et al. 1998; Schmidt et al. 1999; O′loughlin and Robins-Browne,
2001; Kaper et al. 2004; Karmali, 2004).
1.3.3.4 Role of Shiga toxin in the induction of haemorrhagic colitis in
humans
Although EHEC infection may be asymptomatic or self-limiting watery diarrhoea
with abdominal cramps (Proulx et al. 2001; Karch et al. 2005), in 30-70% of pa-
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tients, infection may progress to HC (Mead and Griffin, 1998; Banatvala et al. 2001;
Andreoli et al. 2002; Noris and Remuzzi, 2005). The presence of STEC and Stx elicit
a colonic inflammatory response (Thorpe, 2004), a major factor in the induction of
localised intestinal capillary endothelial damage (King et al. 2002). A number of
studies have shown Stx induces a chemokine response from human intestinal epithe-
lial cells, characterised by interleukin-8 (IL-8) and tumour necrosis factor and PMNs
activation (Thorpe et al. 2001; Harrison et al. 2004). The activated PMNs causes
endothelial cell injury (Bitzan et al. 1998). Recent studies have demonstrated fur-
ther that Stx interferes with production of endothelial-derived vasoactive mediators,
endothelin and nitric oxide, which in turn promote oxidant microvascular injury seen
in cases of HC and HUS (Li et al. 1993; Andreoli et al. 2002; Vareille et al. 2007).
Additionally, Stx causes selective apoptosis of Gb3 receptor-rich villi (Kandel et al.
1989). This results in increased exudation and decreased absorption by the intesti-
nal epithelial cells (Field, 2003). Essentially, the toxin causes marked angiopathy of
the microvasculature in the mesentery (Sakiri et al. 1998; Tarr et al. 2005), mucosal
and submucosal areas of the colon resulting in haemorrhage, necrosis and sloughing
of the cells into the lumen (Sakiri et al. 1998).
1.3.3.5 Role of Shiga toxin in the pathogenesis of haemolytic uraemic
syndrome
It is apparent that the direct effects of Stx as well as the host immune response
to the toxin are responsible for the clinical manifestations in HUS patients (Paton
and Paton, 1998b; Banatvala et al. 2001; Proulx et al. 2001; Andreoli et al. 2002;
Karpman, 2002). Inflammation of renal parenchymal cells and release of nitric oxide
(Vareille et al. 2007) are evident. The toxin is associated with upward regulation of
proinflammatory cytokines, TNF (Sakiri et al. 1998; Ruggenent et al. 2001). The
latter increases the expression of Gb3 receptors, binding and uptake of Stx by the
glomerular endothelial cells (Tesh et al. 1993). The overall effect is severe renal
damage in patients (Tesh et al. 1993; Noris and Remuzzi, 2005). Additionally, renal
endothelial injury is a result of activated neutrophils, which damage endothelial
cell fibronectin (Forsyth et al. 1989). Further, Stx2-neutrophil-bound cells exhibit
delayed spontaneous apoptosis, which is thought to aggravate further neutrophil-
mediated tissue damage (Liu et al. 1999).
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The direct cytotoxicity caused by Stx appears as glomerular endothelial and tubular
cell death (Sears and Kaper, 1996; Taguchi et al. 1998; Schuller et al. 2004). There
is obstruction to capillary blood flow and renal insufficiency (Noris and Remuzzi,
2005). Stx-induced renal cellular damage involves the renal endothelial, glomerular,
mesangial, proximal and distal renal tubular epithelial cells (Hughes et al. 1998;
Kevin and Kaplan, 2000; Karpman, 2002). The extensive tissue damage is due
to higher expression of Gb3 and higher affinity for Stx2 (Kevin and Kaplan, 2000).
Essentially, Stx-induced HUS is marked by thrombotic microangiopathic haemolytic
anaemia, thrombocytopenia, and renal failure (Ruggenent et al. 2001; Andreoli et al.
2002). Histopathologically, the glomerular endothelial cells are swollen and detached
from underlying basement membranes (Sakiri et al. 1998; Ruggenent et al. 2001;
Karpman, 2002) and thrombotic occlusion of capillary lumens (Thorpe, 2004; Noris
and Remuzzi, 2005).
Similarly, postdiarrhoeal central nervous signs in STEC infection results from Stx
stimulated production of tissue necrosis factor-α by endothelial cells (Harrison et al.
2004), resulting in cell damage in the brain (Andreoli, 1999; Andreoli et al. 2002).
Histopathologically, brain lesions are characterised by haemorrhagic brain infarcts,
and cerebral oedema, the main cause of death in Stx HUS (Andreoli et al. 2002).
Based on recent epidemiological studies, 3-20% of STEC infected patients, mainly
children under 5 years, develop postdiarrhoeal HUS (Fitzpatrick, 1999; Karch et al.
2005; Noris and Remuzzi, 2005). Fifty percent of all patients experience a life long
noticeable degree of renal impairment (Thorpe, 2004). Further, 10% develop life
long renal complications or die (Thorpe, 2004).
1.3.3.6 The effect of age on the pathogenesis of haemolytic uraemic syn-
drome
Children under 5 years are three times more likely to develop HUS and HUS-related
renal failure than adults (Paton and Paton, 1998; Noris and Remuzzi, 2005; Tarr et
al. 2005). An explanation is due to the increased expression of Gb3 and selective
Stx-binding in the renal glomeruli and juxtaglomerular capillaries in children (Paton
and Paton, 1998).
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1.3.3.7 Locus of enterocyte effacement: functional analysis
The locus of enterocyte effacement (LEE), which supports the intimin gene (eae),
enhances the ability of STEC to elude the local cellular protective mechanisms and
colonise the intestinal epithelial cells (Nataro and Kaper, 1998). Localised destruc-
tion of microvilli and intimin-mediated intimate attachment of STEC to the intesti-
nal epithelial cells (Moon et al. 1983; Jerse et al. 1990) is followed by delivery of the
Shiga toxins (Kaper et al. 2004). Several proteins including transcriptional regula-
tors, type III secretion system (TTSS) proteins, translocators, type III-specific chap-
erons, secreted effectors, intimin and translocator secretion control proteins (Dean
et al. 2005; Ogino et al. 2006) are involved in signal pathways of LEE (Nataro and
Kaper, 1998).
Sufficient evidence shows that the LEE-containing intimin was inserted adjacent to
either selC, pheU, or pheV tRNA loci depending on the lineage of the ancestral
clones (Whittam et al. 1993; Feng et al. 1998; Zhang et al. 2002b). Genomic
studies have revealed that LEE is composed of 41 core genes conserved in STEC,
EPEC and Citrobacter rodentium (Knutton et al. 1998; Donnenberg and Whittam,
20012001). However, 13 additional genes located in a P4 family prophage are present
in the LEE of EHEC (Hacker and Kaper, 2000; Schmidt and Hensel, 2004). These
genes are thought to have been acquired by E. coli O157:H7 after the acquisition of
LEE by this organism (Donnenberg and Whittam, 2001).
Functionally, five polycistronic operons, LEE1, LEE2, LEE3, LEE4 and LEE5 en-
code the core genes (Clarke et al. 2003; Hao-Jie and Wan-Jr, 2005). Located at the
5’-end of LEE (Figure 1.4) are LEE1, LEE2 and LEE3 which encode TTSS, (Mellies
et al. 1999; Gal-Mor and Finlay, 2006). TTSS spans the bacterial cell membrane,
translocates and injects the bacterial effector proteins into the host cells (Hacker
and Kaper, 2000; Donnenberg and Whittam, 2001; Caprioli et al. 2005; Gal-Mor
and Finlay, 2006). These functions are mediated by its needle complex (NC) struc-
ture composed of a basal body, a central long needle (Sekiya et al. 2001) and an
expandable sheath-like EspA (Ogino et al. 2006). TTSS is assembled from at least
20 known proteins which are encoded by three categories of genes; namely, E. coli
secretion genes (esc), secretion of E. coli protein genes (sep) and E. coli secreted
protein genes (esp) as well as the chaperone for E. coli secretion (ces) (Creasey et al.
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Figure 1.4: Structure of the conserved 41 open reading frames in the LEE.
2003). The recently described esc genes encode conserved proteins in TTSS (Hacker
and Kaper, 2000; Clarke et al. 2003) which include escC, escD, escF, escJ, escN,
escR escS, escT, escU, and escV (Hacker and Kaper, 2000; Clarke et al. 2003).
Further studies have shown the EscF protein polymerises to form the thin needle
core of the NC (Ogino et al. 2006). The EscC and EscJ constitute the outer ring
and inner ring proteins of the basal body respectively (Gauthier et al. 2003; Ogino
et al. 2006).
The secreted effector proteins (Sep), EspA, EspB and EspD are encoded by the 4th
operon located at the 3’-end of the LEE (Deng et al. 2004; Dean et al. 2005).
Studies have shown EspA, a 25kDa protein forms a syringe-like filament component
which associates with TTSS to deliver EspB and EspD into the host cell (Knutton
et al. 1998; Clarke et al. 2003; Ogino et al. 2006). In addition, EspA plays a role in
attaching EHEC to the host cells (Cleary et al. 2004). Similarly, the 37kDa EspB
protein modulates the filamentous EspA activity during bacteria-host cell interaction
and changes its function from adherence to translocating effector proteins (Deng et
al.2004). Moreover, it is thought to initiate A/E histopathology by interfering with
the cytoskeleton arrangement (Clarke et al. 2003; Shaw et al. 2005). EspD is
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involved in pore formation in the host cells (Knutton et al. 1998).
The central portion of LEE, LEE5 operon encodes intimin, an outer membrane
adhesin protein (Jerse et al. 1990), the translocator intimin receptor (Tir) (Kenny
et al. 1997; Caprioli et al. 2005) and the chaperone, CesT (Schmidt and Hensel,
2004). Intimin mediates intimate attachment of STEC to the enterocytes (Jerse et
al. 1990; Frankel et al. 2001). Tir is inserted into the host cell with the intimin
biding site exposed and accessible for the interaction with this protein (Kenny et
al. 1997; Clarke et al. 2003), which may also interact with receptors other than
Tir (Hartland et al. 1999; Sinclair and O’Brien, 2002). It has been suggested that
CesT is crucial in stabilising Tir (Schmidt and Hensel, 2004). Apart from binding
intimin, Tir plays a role in the signal transduction process leading to A/E lesions
(Dean et al. 2005). It has been shown that intimin-Tir binding initiates pedestal-like
cytoskeleton changes in the intestinal epithelial cells (Clarke et al. 2003).
Additional effector proteins involved in signal transduction pathways include EspB,
Map, EspF, EspH, EspG and EspZ (Shaw et al. 2005; Gal-Mor and Finlay, 2006),
but they do not seem to play a role in the formation of A/E lesions (Ritchie and Wal-
dor, 2005). EspF causes cell death and disrupts intestinal epithelial tight junctions
(Donnenberg and Whittam, 2001; Guttman et al. 2006). Recent studies demon-
strated that EspF plays an additional role in the inhibition of tissue inflammation
and suppression of the PMN response, which enhance STEC colonisation of the
small intestine (Ritchie and Waldor, 2005). Map (mitochondrial-associated protein)
promotes mitochondrial death, stimulates filopodia formation (Dean et al. 2005)
and together with EspG initiates colonisation of the small intestine as well (Ritchie
and Waldor, 2005).
Non-LEE-encoded A (NleA) effector protein, which is encoded in three pathogenic-
ity islands outside of LEE, was recently characterised, and together with effector
proteins from LEE, mediate the A/E lesions (Deng et al. 2004; Garmendia et al.
2005).
The regulation of LEE is more complex than was originally thought, both global and
specific regulation are involved (Deng et al. 2004). The global regulatory proteins,
GrLA and GrLR activate and repress the activity of LEE, respectively (Deng et al.
2004; Gal-Mor and Finlay, 2006). Regulation involves also the plasmid-encoded reg-
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ulator (Per) (Mellies et al. 1999), DNA biding protein H-NS, integration host factor
(IHF) and quorum sensing (QS) (Clarke et al. 2003), and a LEE-encoded positive
regulator (Ler) (Elliot et al. 1998), localised in LEE1 (Castillo et al. 2005). Per
concurrently regulates intimin and activates Ler; the latter regulates the four LEE
(LEE2-LEE5) cistron (Schmidt and Hensel, 2004). Further, transcription of LEE2
and LEE3 are regulated by QS (Sperandio et al. 1999) and QS E. coli regulator,
(Qse)A (Clarke et al. 2003).
1.3.3.8 Locus of enterocyte effacement and its role in diarrhoea
LEE carrying pathogens such as EHEC, Citrobacter rodentium, rabbit diarrhoegenic
E. coli1 (RDEC-1) and EPEC (Kaper and Nataro, 1998) have been associated with
diarrhoea for many years (Frankel et al. 1996a; Hacker and Kaper, 2000; Clarke et
al. 2003). The organisms colonise the enterocytes and enhance their virulence by
localised destruction of microvilli and adhering intimately to the intestinal epithe-
lial cells (Sherman et al. 1988; Jerse et al. 1990; Nataro and Kaper, 1998). Within
the cellular matrix, cytoskeletal modification occurs characterised by increased poly-
merisation of actin-rich pedestal and formation of pseudopod-like extensions (Hacker
and Kaper, 2000), histopathological changes referred to as A/E lesions (Moon et al.
1983; Kresse et al. 1998; China et al. 1999; Kaper et al. 2004).
Besides the A/E lesions, LEE triggers diarrhoea by other mechanisms (Guttman et
al. 2006). Effacement of microvilli leads to an electrolyte imbalance associated with
reduced sodium ion uptake resulting in net secretion of fluids in the intestinal lumen
(Field, 2003). Secondly, there is impaired digestion and absorption of nutrients
(Kenny et al. 1997; Kenny, 2002). Further, the disruption of intestinal epithelial
tight junctions increases exposure of the underlying tissues to materials from the
intestinal lumen which cause inflammation and secretion of fluid (Guttman et al.
2006).
1.3.3.9 Variants and characteristics of intimin
The outer membrane adhesin protein, intimin, was first described in EPEC eigh-
teen years ago (Jerse et al. 1990). Two years later a similar protein was identified
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in EHEC O157:H7 (Yu and Kaper, 1992). Structurally, intimin has a mosaic-like
appearance (McGraw et al. 1999; Frankel et al. 2001) and is heterogenous (Ra-
machandran et al. 2003; Blanco et al. 2004c; Mora et al 2007). Its N’terminal
is highly conserved across the variants, whereas the C′ terminal is heterogenous
(Phillips and Frankel, 2000; Frankel et al. 2001; Oswald et al. 2000; Zhang et
al. 2002b). The C’ terminal of intimin, referred to as the 280-amino-acid sequence
(Int280) is the cell binding region (Adu-Bobie et al. 1998b; Frankel et al. 2001),
exhibiting specific host tissue cell tropism (Philips et al. 2000; Chong et al. 2007).
To date, 18 distinct variants have been described namely; α1, α2, β1, β2, ξ or β2B,
δ(κ,β2O), γ1, γ2(θ), ε1, ε2(νR), ζ, ι1, ι2(µR), λ, µB, νB, ξB and ρ (Adu-Bobie
et al. 1998a; Oswald et al. 2000; Tarr and Whittam, 2002; Zhang et al. 2002b;
Jenkins et al. 2003a; Ramachandran et al. 2003; Blanco et al. 2004b; Mora et
al. 2007; Cookson et al. 2007). The nomenclature, using the Greek alphabet, for
the assignation of intimin variants was proposed by Zhang et al. (2002b). Any
intimin gene with a nucleotide sequence of less than 95% homology to the current
intimin gene types is classified as a new variant (Zhang et al. 2002b). On the other
hand, intimin genes with more than 95% nucleotide sequence identities are given
the subtype name of the corresponding almost identical intimin type (Zhang et al.
2002b). It appears that the diversity of intimin genes is due to the acquisition and
recombination of foreign bacterial DNA (McGraw et al. 1999).
1.3.3.10 Phylogenetic diversity of intimin
It is believed that eae entered the genome of the ancestral E. coli O55 before stx
(Feng et al. 1998). Rather than being random, eae type distribution among the
serotypes of STEC has an evolutionary basis (Tzipori at al. 1995; Oswald et al.
2000; Reid et al. 2000). eae-β1 appears to be widely distributed among diverse
serotypes of STEC (McGraw et al. 1999; Oswald et al. 2000; Ramachandran et al.
2003; Blanco et al. 2004a,2004b; Mora et al. 2007). On the other hand, eae-γ1 is
associated with EHEC O157:H7 and eae-γ2 with STEC O111 (Oswald et al. 2000),
the two serogroups belong to EHEC1 and EHEC2 respectively (Donnenberg and
Whittam, 2001). eae-α is more restricted to EPEC O55:H6 than STEC (Oswald et
al. 2000). It has also been shown that O157:H7 containing eae-γ1 has a specific cell
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tropism, binding to the follicle-associated epithelium of Peyers patches, other than
colonising the entire small intestinal epithelium (Phillips et al. 2000; Fitzhenry et
al. 2002).
The variant eae- is commonly detected in STEC strains of serogroups O8, O11,
O45, O103, O121, O136, O163 and O165 (Oswald et al. 2000; Blanco et al. 2004c);
while eae-ξ is associated with O84 and eae-ζ with serogroups O84, O138, O150 and
O156 (Blanco et al. 2004c). Like O157:H7, eae- positive O103 strains has selective
tropism for Peyer’s patches (Fitzhenry et al. 2002).
1.4 Evolution of enterohaemorrhagic E. coli
Escherichia coli and Salmonella typhimurium, two important members of Enter-
obacteriaceae family, are believed to have diverged from a common lineage between
120 and 160 million years ago (Ochman and Wilson, 1987). Subsequently, along the
evolutionary path, about 10-15 million years ago, commensal and pathogenic E. coli
strains evolved and eventually diverged from a common ancestor (Whittam et al.
1993; Feng et al. 1998; Donnenberg and Whittam, 2001).
The evolutionary studies of pathogenic E. coli, particularly STEC gives insights on
the possible origins of the virulence markers present in diverse pathovars of E.coli
(Baumler, 1997). The recently sequenced E. coli genomes, (Blattner et al. 1997;
Hayashi et al. 2001; Perna et al. 2001), undeniably revealed a highly dynamic
E. coli genome (Donnenberg and Whittam, 2001) characterized by gains, losses and
rearrangements of DNA regions (Whittam et al. 1993; Ochman et al. 2000; Johansen
et al. 2001; Perna et al. 2001; Welch et al. 2002; Caprioli et al. 2005; Dobrindt,
2005), giving rise to diverse strains and pathotypes of E. coli seen today (Lawrence
and Ochman, 1998; Donnenberg and Whittam, 2001; Schmidt and Hensel, 2004;
Caprioli et al. 2005).
Plausible evolutionary theories delineate a stepwise evolutionary ladder for the emer-
gence of STEC (Feng et al. 1998; Donnenberg and Whittam, 2001; Wick et al.
2005). Soon, after diverging from Shigella flexnori (Ochman et al. 2000), the SF+,
β-glucuronidase positive (GUD+) ancestor E. coli (A2) evolved into a O55:H7-like
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ancestral E. coli (A3) (Whittam et al. 1993; Feng et al. 1998) as depicted in Figure
1.5. Approximately 5 million years ago (Armstrong et al. 1996), a LEE carrying
eae-γ1 (Donnenberg and Whittam, 2001) was inserted at the selC site of the genome
of O55:H7-like ancestor (Wieler et al. 1997).
Figure 1.5: A model for the evolution of EHEC.
Thereafter, it is thought that a bacteriophage containing stx2 entered the LEE-
containing O55:H7-like ancestor (A4) (Wick et al. 2005; Zhang et al. 2006). This
was a major evolutionary landmark in the emergence of EHEC (A4-A5) and di-
verging from EPEC (A4-iv) (Reid et al. 2000). Furthermore, the stx2-carrying
O55:H7-like progenitor (A5) gained a virulence plasmid (pO157) and simultaneous
antigenic drift (A5-A6) resulted in O157-like E. coli (Feng et al. 1998; Donnenberg
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and Whittam, 2001; Wick et al. 2005). At about the same time, a prophage P4
containing 13 genes was integrated into the LEE of EHEC progenitor (Ochman et
al. 2000; Johansen et al. 2001; Perna et al. 2001).
At this evolutionary step (A6), two parallel evolutionary pathways occurred; one lin-
eage lost the flagellae but retained the ability to ferment sorbitol and β-glucuronidase
to become (SF+, GUD+) O157:NM lineage (B), referred to as the German clone
(Feng et al. 1998; Wick et al. 2005). The other lineage lost the ability to ferment
sorbitol but gained urease gene cluster (C) (Friedrich et al. 2005) and stx1 to give
rise to O157:H7-like clone (C1) (Wick et al. 2005). Eventually the clone lost its
GUD activity and emerged as the SF−, GUD− EHEC O157:H7 (C2) which carries
stx1 and stx2 (Whittam et al. 1993; Feng et al. 1998; Donnenberg and Whittam,
2001; Monday et al. 2001, Wick et al. 2005; Zhang et al. 2006). Recent evidence
showed that EHEC O157:H7, O157:NM and EPEC O55:H7 belonged to same clonal
group (EHEC 1) (Donnenberg and Whittam, 2001).
Besides EHEC O157:H7, the evolution of other STEC, especially non O157:H7
EHEC, is not clearly understood. Although non-O157:H7 STEC posses stx and
eae, two genes associated with HC and HUS infections in humans (Karmali, 1989;
Paton and Paton, 1998b, Nataro and Kaper, 1998, Law, 2000; Karmali, 2004; Beutin
et al. 2004, Caprioli et al. 2005), they are only distantly related to EHEC O157:H7
(Whittam et al. 1993; Feng et al. 1998; Donnenberg and Whittam, 2001; Wick
et al. 2005). It is thought they emerged when their SF+, GUD+ ancestral E. coli
(A3), (Figure 1.5) acquired LEE containing eae-(β) at the phe site and thereafter
evolved to O26:H11-like (D) ancestor (Donnenberg and Whittam, 2001; Wick et al.
2005). A stx1-containing bacteriophage entered the genome of O26-like E. coli (D1),
followed by a plasmid, pO157, giving rise to O26:H11 (D2) (Donnenberg and Whit-
tam, 2001; Wick et al. 2005). Subsequent antigenic shifts ensued (D2-D3), leading
to the emergence of serotypes such as O26:H-, O111:H8, O111:H- and other EHEC
(Donnenberg and Whittam, 2001; Wick et al. 2005). These non-O157:H7 EHEC,
with LEE inserted at the phe (Sperandio et al. 1998), form the EHEC 2 cluster
(Donnenberg and Whittam, 2001). It is probable that the bacteriophage-containing
stx2 and the urease gene cluster entered the genome at the time of antigenic shift
(D2-D3).
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Although the evolution of the majority of STEC is still unknown, it could be hypoth-
esized that they also emerged by horizontal gene transfer, as described for EHEC.
These STEC are distantly related to each other and to EHEC 1 and EHEC 2 clusters
(Whittam et al. 1993).
It is clear now that O157:H7 and other STEC evolved and adapted to the gastroin-
testinal tract (GIT) of ruminants, particularly the bovine (Schmidt et al. 2000).
The bovine GIT is the single most important gene pool (Gilmour et al. 2006) with a
complex microbiome of genetically diverse bacterial species (Kaper and Sperandio,
2005) typified by horizontal transfers of virulence genes (Ochman et al. 2000; Don-
nenberg and Whittam, 2001; Feil and Spratt, 2001). It is not surprising, therefore,
that most of the 470 STEC serotypes identified today are normal microbiota of the
gut of healthy cattle (http://www.lugo.usc.es/ecoli). For this reason, cattle have
attracted worldwide public health attention because they excrete STEC and human
infections with this zoonose (Mead and Griffin, 1998; Hacker and Kaper, 2000) may
be characterised by fatal sequelae in children and the elderly (Proulx et al. 2001).
1.5 Epidemiology of Shiga toxin-producing E. coli
1.5.1 Emergence of enterohaemorrhagic E. coli
In 1982 investigations of outbreaks of diarrhoeal illness in Oregon and Michigan, USA
identified O157:H7 as the causative organism of the illness (Riley et al. 1983). In
both outbreaks, hamburgers from fast-foods restaurants were suspected, and EHEC
O157:H7 was isolated from hamburgers (Riley et al. 1983; Wells et al. 1983).
Further studies identified a Shiga-like toxin elaborated by O157:H7 (O′Brien et al.
(1983). Interestingly, these workers had previously characterised a similar toxin
from an E. coli of unknown serotype, associated with bloody diarrhoea (O′Brien et
al. 1982). As the toxin was immunologically identical to Shiga toxin produced by
Shigella dysenteriae type 1 (O′Brien et al. 1982, 1983), it was named Shiga-like
toxin (SLT) or Shiga toxin (O’Brien and LaVeck, 1983).
Concurrent investigations of an outbreak of bloody diarrhoea and HUS in Canada,
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unequivocally linked E. coli to the outbreak (Karmali et al. 1983). Further, the
E. coli elaborated toxins that were cytotoxic to African Green monkey kidney cells
(Vero cells) (Karmali et al. 1983). The name Verocytotoxin (VT), suggested by
Konowalchuk et al. (1977), who observed and described similar activity of E. coli
toxins on Vero cells was given. Later, it was confirmed that Verocytotoxins (Karmali
et al. 1983) and Shiga toxins (O’Brien and LaVeck, 1983) were identical; neverthe-
less, parallel nomenclature continues to be used interchangeably in literature today.
It is strongly believed that O157:H7 emerged as a human pathogen in the last half
of the 20th century (Armstrong et al. 1996; Mead and Griffin, 1998). Retrospective
investigations on the prevalence of O157:H7 among diarrhoegenic patients between
1975 and 1982 in the USA and United Kingdom, detected only one O157:H7 isolate
from each of the countries (Riley et al. 1983; Day et al. 1983). Moreover, the recent
past has seen an advent of STEC serogroups such as O26, O91, O103, O111, O118,
O145 and O166, which may cause severe human illness, similar to O157:H7 (Levine,
1987; Beutin et al. 2004; Kaper et al. 2004; Caprioli et al. 2005).
1.5.2 Worldwide occurrence of Shiga toxin-producing E.
coli
Since its first recognition as a food-borne pathogen 25 years ago (Riley et al. 1983),
outbreaks of EHEC O157:H7 have occurred on a global scale, reported in Latin
America, (Vaz et al. 2006), Africa (Eﬄer et al. 2001), Europe, including Germany
(Zhang et al. 2002b; Beutin et al. 2004), France (Pradel et al. 2000) and the United
Kingdom (Fitzpatrick, 1999), Asia, in Japan (Izumiya et al. 1997; Michino et al.
1999), Australia (Paton et al. 1996; Elliot et al. 2001; Bettelheim et al. 2002) and
North America (Karmali et al. 1983; Thorpe, 2004). Several studies have shown that
STEC serotypes have different geographical distributions, O157:H7 predominantly
causes human infections in USA (Slutsker et al. 1997), Canada (Thorpe, 2004),
Japan (Izumiya et al. 1997; Michino et al. 1999), United Kingdom (Vali et al.
2004) and Argentina (Parma et al. 2000). Annual infections rates of 1-30 cases per
100 000 investigations have been reported. It is children that are most at risk of the
consequences of infection with EHEC (Fitzpatrick, 1999).
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Prevalence of O157:H7 over other STEC serotypes is probably related to the fact
that most diagnostic laboratories screen only for O157:H7 strains (Tarr et al. 2005;
Thompson at al. 2005; CDC, 2007). However, recent studies using molecular tech-
niques show increased prevalence of non-O157:H7 STEC-bloody diarrhoea related
illnesses in Europe (Beutin et al. 1998,2004) and Australia (Elliot et al. 2001);
caused by O26, O121, O103, O111, O113 and O145 serogroups (Bettelheim, 2003;
Beutin et al; 2004; Karch et al. 2005; Vanselow et al. 2005).
1.5.3 Shiga toxin producing E. coli in sub-Sahara Africa
Notwithstanding the paucity of information on STEC in cattle and the role of these
organisms in diarrhoea from sub-Saharan Africa, major outbreaks of O157:H7 have
been reported in this region. The first outbreak occurred in Swaziland, in 1992, and
involved over 20,000 cases (Eﬄer et al. 2001). The source of EHEC was surface
water contaminated with bovine faeces (Eﬄer et al. 2001). Five years later, another
outbreak, associated with eating smoked meat pie (kanda) of cattle origin, occurred
in the remote rural population of Central Africa Republic (Germani et al. 1997).
Over 290 cases were involved, including four fatalities (Germani et al. 1997). A third
outbreak occurred in Cameroon, involving over 275 cases and 45 deaths (Cunin et al.
1999). The source of infection was not established but STEC-contaminated water
and food were possible sources of the organisms (Cunin et al. 1999). In all cases
cattle were implicated as the source of O157:H7 infection (Germani et al. 1997;
Cunin et al. 1999; Eﬄer et al. 2001). A recent outbreak of severe diarrhoea was
reported in the Democratic Republic of Congo (DRC) in 2003, which involved more
than 463 children (Koyange et al. 2004). Stool sample screened from 32 of them
contained O157:H7 (Koyange et al. 2004).
Sporadic cases have also been reported on the continent; O157:H7 was isolated from
a 2-year old boy with severe diarrhoea in Kenya (Sang et al. 1996). Additionally,
outbreaks have occurred in Cote d’Ivoire (Dadie et al. 2000), South Africa (Galane
and Roux, 2001) and Nigeria (Okeke et al. 2000,2003). This organism has also been
isolated from animal food products (Abdul-Raouf et al. 1996; Benkerroum et al.
2004).
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In contrast to developed nations, STEC outbreaks in Africa have occurred in the
rural communities causing high morbidity and mortality (Germani et al. 1997; Cunin
et al. 1999; Eﬄer et al. 2001). Thus, STEC infection is a potential health problem
to a disease-burdened population (Rutstein, 2000; WHO, 2003; Stein et al. 2004),
particularly when it occurs in association with S. dysenteriae type 1 (Cunin et al.
1999).
1.5.4 Epidemiology of Shiga toxin producing E. coli in
Uganda
Although several studies have identified a variety of bacterial pathogens associated
with childhood diarrhoea (Nasinyama, 1996; Kaddu-Mulindwa et al. 2001; Tumwine
et al. 2002, 2003; Mbonye, 2004), none of the studies has reported STEC. In one
particular study, Kaddu-Mulindwa et al. 2001 investigated STEC in cattle from
a farm in central Uganda, and among diarrhoeal children in the urban district of
Kampala. Of the 159 cattle sampled, STEC was isolated in 43(28%), however, none
of the children had STEC. Since the children and cattle investigated for STEC were
in different locations, it was not possible to correlate STEC infections in cattle and
children. Of special concern, however, are the pastoralist communities that live in
close contact with their cattle, drink raw milk and share drinking water sources
with their cattle, which are risk factors associated with STEC infection (Wilson et
al. 1996; Valcour et al. 2002; Schets et al. 2005).
Generally little is known about the epidemiology of STEC in Uganda, and to the
best of my knowledge, nothing is known about STEC serotypes of human and cat-
tle origin in the pastoralist communities of Kiruhura district, Mbarara sub-region
in southwestern Uganda. Since surveillance of STEC is not done routinely in de-
veloping countries (Park et al. 2002; Tarr et al. 2005; WHO, 2005), its incidence
remains unknown in these countries. Thus, the aims of this study were to investigate
and characterise STEC from cattle, water sources and diarrhoegenic-children in the
pastoral community of Nyabushozi county, Kiruhura district.
28
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
Chapter 2
Isolation and detection of STEC
strains from humans, cattle and
water sources in the pastoral
systems of Nyabushozi county,
Kiruhura district
2.1 Introduction
Numerous studies carried out over the last 25 years have confirmed cattle as primary
reservoirs of STEC for human infections (Thorpe, 2004; Caprioli et al. 2005; Tarr
et al. 2005; Hussein and Sakuma, 2005; Hussein, 2007). These organisms may
be transmitted from healthy, STEC-excreting cattle to humans via the food chain
(Hussein and Sakuma, 2005). In recent times, cases of STEC infection acquired
from direct contact with cattle, or their environment (O’Brien et al. 2001; Crump
et al. 2002; Heinikainen et al. 2007), and the consumption of water contaminated
with bovine faeces (Olsen et al. 2002; Grif et al. 2005) have increased among rural
farming communities (Wilson et al. 1996; Olsen et al. 2002; Valcour et al. 2002).
Notwithstanding numerous worldwide studies on the prevalence of STEC, including
EHEC strains, in cattle (Hornitzky et al. 2002; Pearce et al. 2006; Mora et al. 2007),
there is little information on the presence of these organisms in cattle in Uganda.
This chapter describes the isolation and identification of STEC in children, bovines
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and water in Nyabushozi county, Mbarara subregion in southwestern Uganda.
2.2 Experimental design
2.2.1 Study area and population
The study was carried in Nyabushozi county, Kiruhura district in Mbarara subregion,
which until 2006 was part of Mbarara district. Kiruhura is a remote district which
shares its western border with Mbarara, Ibanda and Isingiro districts, Rakai and
Sembabule districts are on the eastern border, and Kyenjojo district lies on the
North (Figure 2.1).
Figure 2.1: Kiruhura district in Mbarara sub-region.
Valley dams (1-5) are indicated.
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Kiruhura is divided into two administrative units, Nyabushozi and Kazo counties,
that are connected by all-weather gravel roads and seasonal access roads. Govern-
ment health care in Nyabushozi county is provided within the three health clinics of
Kyakabunga, Rushere and Kiruhura in addition to two mobile vaccination centres.
Nyabushozi county with an estimated human and cattle population of 110,000 and
65,000 respectively, is predominantly a cattle keeping area. As the area experiences
severe water shortage, valley dams (Figure 2.1) scattered in the county provide water
for the pastoralists and their livestock.
2.2.2 Period of sample collection
The study was carried out in 2 phases: October 2004 to January 2005 (phase 1)
and October 2005 to January 2006 (phase 2). During the 4 months of phase 1,
faecal samples from cattle and the first group of children were collected. In phase 2,
additional faecal samples were collected from children and also, water samples were
collected from November 2005 to January 2006. The study periods (phase 1 and 2)
coincided with the dry season when people and their livestock inevitably share the
water from and at the valley dams.
2.2.3 Ethical considerations
The study was approved by the Research and Ethics Committee of the Uganda Na-
tional Council for Science and Technology (Appendix A). An informed consent was
sought from each parent or guardian of the sick child after explaining the rationale
of study. Only children from adults who willingly signed the consent forms were
included in the study (Appendix B).
2.2.4 Human study population
The target population was children of 12 years and below experiencing episodes
of diarrhoea and reporting for treatment at any of the three health clinics (Kyak-
abunga, Rushere, Kiruhura) or mobile vaccination centres between October 2004
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and January 2005 or October 2005 to January 2006. This age group was chosen
because a majority of the diarrhoeal cases recorded at the three health clinics prior
to this study belonged to this age category. During these periods, stool samples
were collected Monday to Wednesday of each week from children with diarrhoea.
No duplicate stool samples were included in the study. An episode of diarrhoea was
defined as the passing of three or more loose or watery stools in the 24-h period
(Baqui et al. 1991), prior to presentation at a clinic.
2.2.5 Demographics and clinical information of diarrhoeal
children
Pre-coded questionnaires were completed at the time of recruitment to record demo-
graphic details of the children (Appendix C). A medical worker fluent in Runyankore,
the language used in the community, examined and recorded the physical signs and
clinical histories of the children. In order to ascertain the age of the children their
health cards, baptismal or birth certificates were used. In cases where these records
were absent, the age was derived from recalling previous dates of major local events
such as the last elections of local leaders in the county.
2.2.6 Inclusion and exclusion criteria
For inclusion in the study, children must have resided in the area for at least one
month prior to the study. Additionally, the children’s families were asked whether
they had used the selected valley dams, during the time of the study. A positive
reply was necessary for inclusion. Only children from parents or guardians who
consented to the study were included.
Children suffering from diseases other than diarrhoea, from homesteads not using
the selected valley dams, and those visiting the locality for less than 4 weeks were
excluded. Further, children older than 12 years were excluded.
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2.2.7 Collection of stool samples
A medical worker assisted parents and guardians of children to collect stool samples
or rectal swabs in cases where there was no stool. A total of 256 stool samples were
collected during phase 1 and phase 2 of the study. All stools/rectal swabs were
placed in sterile plastic bottles containing 20ml of Stuart’s transport media (BBLr)
and transported on ice in a cooler box to the Microbiology Laboratory, Faculty of
Veterinary Medicine, Makerere University where they were placed at 4oC.
2.2.8 Selection of cattle and faecal collection
Cattle were purposefully selected based on the homestead of diarrhoeal children
recruited during the study. A guide assisted with the identification of cattle associ-
ated with the homestead of the child. Children were followed to their homesteads
where fresh faecal samples were collected from every nth-cattle where 1/n samples
represented 10% of the sampled cattle in a homestead. A total of 300 cattle from
90 herds (homesteads) were sampled. Diarrhoeal cattle were purposely included in
the study. About 50gm of cattle faeces was collected by a veterinary surgeon (Dr
Samuel Majalija) from the rectum and placed in sterile plastic bottles containing
20ml of Stuart’s transport media (BBLr) and transported as described [2.2.7].
2.2.9 Selection of valley dams
Selection of communal valley dams was determined based on information from local
leaders of shared use of dams by humans and their livestock (Figure 2.2). The 5
selected dams were Nshwereenkye (1), Rugongi (2), Kiruhura (3), Rwabigyemano (4)
and Kyakabunga (5), as indicated in Figure 2.1. The sizes of the dams varied from
about 8m by 15m for the smallest Kiruhura dam to about 20 x 80m for Rugongi
and Rwabigyemano. These provide water for the community and their livestock
all year round. Cattle had direct access to water since the valley dams were not
barrier-protected, and their movements were not restricted to a particular valley
dam.
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Figure 2.2: Rwabigyemano valley dam.
Children and cattle share the same water source.
2.2.10 Water sample collection
From each dam, three sampling sites used by humans as water collection points and
cattle as watering spots were selected. Every month, 300ml water samples were
collected in sterile 500ml polypropylene bottles, from each site, for three consecutive
months. From November 5 2005 to January 6 2006, 45 water samples were collected.
Immediately after collection, water samples were placed on ice in a cooler box and
transported to the microbiology laboratory [2.2.7].
2.2.11 Media and buffers
Media and buffers used in the study are presented in Appendix D.
2.2.12 Bacteriological culture
The isolation, identification and preparation of E. coli glycerol stocks was carried
out by Mr. Lubowa Musiisi, Chief Technician, Veterinary Microbiology Laboratory
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Makerere University. He was similarly responsible for the isolation and identification
of Salmonella and Shigella strains.
Bacterial cultures for the isolation of E. coli were prepared within 24 and 48 hours
of obtaining water and faecal samples, respectively.
Faecal swabs were inoculated on MacConkey (MAC) and sorbitol MacConkey
(SMAC) agar (Oxoid Ltd., Basingstoke, Hampshire, United Kingdom) and in-
cubated at 37oC for 18-24 h. Presumptive E. coli lactose fermenting pink and
non-sorbitol fermenting (SF−) colourless colonies on MAC and SMAC respectively,
were confirmed using standard biochemical methods, including API 20E test strips
(Biomerieux Vitek, Inc., Hazelwood, Mo.) where necessary.
Bacteriological culture and enumeration of E. coli from water samples was carried
out using standard techniques (World Health Organization, 1971). Briefly, the 300ml
water sample was poured through a cellulose ester membrane filter. The filter was
placed on m-FC agar (Difco) and incubated at 44.50C for 24 hours. Blue or partially
blue colonies suggestive of E. coli were individually tested and confirmed by standard
biochemical methods (Ewing, 1986). E. coli count was recorded as number of colony
forming units (cfu) per 100ml of water. Prior to preparation of glycerol stocks, E.
coli were separately sub cultured on MAC.
In order to increase the possibility of isolating STEC strains, glycerol stocks
containing multiple isolates of bovine, humans and water E. coli populations
were prepared. A sweep of 30-40 E. coli colonies from MAC and/or SMAC
agar plates, were each inoculated in 2-YT broth (10ml) and incubated at
37oC for 18-24 h with shaking. Thereafter, glycerol stocks of the cultures
were prepared and stored at −70oC. Bacterial stocks were packed and trans-
ported according to the guidelines for shipping infectious substances category A
(http://www.idph.state.il.us/about/laboratories/manual08/app G.pdf), to the Di-
vision of Medical Microbiology, Faculty of Health Sciences, University of Cape Town,
South Africa where further analyses was carried out. Colonies taken from SMAC
and MAC cultures were used as primary cultures.
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2.2.13 Preparation of genomic DNA
Two methods were used to extract DNA: the boiling method and the cetyltrimethy-
lammonium bromide (CTAB) method (Ausubel et al. 1987; Sambook, 1995). With
respect to the former, a loopful of bacteria, or single colonies of E. coli, was suspended
in 20µl and 5µl ultra-pure water respectively. DNA was released by boiling for 10
minutes. Cellular debris was removed by centrifugation and lysate was transferred
to an Eppendorf tube. In addition, genomic DNA was extracted using the CTAB
method (Sambook, 1995). DNA concentration was determined by spectrophotomet-
ric analysis (UV-Visible Spectrometers Biomate 5, Thermo Electron Corporation,
UK), in which the absorbance at a wavelength of 260nm was measured.
2.2.14 Detection of STEC by polymerase chain reaction
(PCR) amplification
2.2.14.1 Primers and PCR detection of stx
Oligonucleotide primers used for the detection of stx genes (Table 2.1) were syn-
thesized by the DNA synthesis laboratory at the University of Cape Town. Initial
detection of stx-containing E. coli was carried out using DNA extracted by boiling
a sweep of colonies cultured from glycerol stocks [2.2.12].
Table 2.1: Primers and PCR amplification conditions for
the detection of stx genes
Primer Target Primer (5′ → 3′) Product PCR cycle Reference
gene sequence size (bp) conditions*
stx1F stx1 CGCTGAATGTCATTCGCTCTGC 302 94
oC, 60 s; Blanco
stx1R CGTGGTATAGCTACTGTCACC 55oC, 60s; et al.
72oC, 60 s. (2003b)
stx2aF stx2 CTTCGGTATCCTATTCCCGG 516 94
oC, 60 s; Blanco
stx2aR CTGCTGTGACAGTGACAAAACGC 55oC, 60 s; et al.
72oC, 60 s. (2003b)
stx2bF stx2 GATGGCGGTCCATTATC 1493 94
oC, 60 s; Paton
stx2bR A-subunit AACTGACTGAATTGTGA 47oC, 60 s; et al.
72oC, 90 s. (1993)
*Extension at 72 ◦C for 5 min completed the amplification process.
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Multiplex PCR assays were used: primers stx1F/stx1R (Blanco et al. 2003b) were
used for the detection of stx1, while one of 2 sets of primers stx2aF/stx2aR (Blanco et
al. 2003b) and stx2bF/stx2bR (Paton et al. 1993) was used for the detection of stx2
(Table 2.1). Amplification was carried out in a thermocycler (GeneAmp 2720, Perkin
Elmer) in a final volume of 30µl using the conditions presented in Table 2.1. The
reactions contained 50ηg of genomic DNA, 20ρmol of each primer, 200µM of each
dNTP (Fermentas) and 5U Taq DNA polymerase (GoTaq Flexi DNA Polymerase,
Promega) in the buffer supplied. Amplifications proceeded according to parameters
shown in Table 2.1. Extension at 72 ◦C for 5 min completed the amplification.
Assays were repeated 3 times using freshly prepared template DNA from a sweep
of colonies. EHEC O157:H7 was included as a positive control. This was kindly
provided by Mr. Pascal Musoni, Manager Microbiology laboratory Groote Schuur
Hospital, University of Cape Town.
For each of the stx-positive sweeps, the presence of stx genes was determined in 10
individual colonies for each isolate using PCR as described above.
2.2.14.2 Agarose gel electrophoresis
Amplicons obtained were separated by electrophoresis using 0.8-2.5% agarose gel
immersed in 1X TAE buffer. Gels were stained with ethidium bromide (1µg/ml),
visualised under ultraviolet light and photographed with Kodak EDAS 290 Cam-
era. Thereafter, the digital images were captured by Kodak I.D program (Scientific
Imaging System, USA).
2.2.14.3 Purification of PCR products and quantification of DNA
When necessary, PCR products were purified using a QIAquick Gel Extraction Kit
(Qiagen, Southern Cross Biotechnology, Cape Town) according to the manufac-
turer’s manual. To determine the concentration of DNA in the purified PCR prod-
uct; 1µl of DNA was mixed with 1µl gel tracking dye (Bioline, UK) and separated
on 1% agarose. The intensity of the DNA band was visually compared to the inten-
sities of standard bands of molecular weight marker, HyperLadder I (Bioline, UK)
and the corresponding DNA concentration was expressed as ηg/µl.
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2.2.14.4 DNA sequencing and computer analysis of sequencing data
Automated DNA sequencing was carried out at the core sequencing facility, Uni-
versity of Stellenbosch, South Africa, using an ABI 3130 Genetic analyzer. DNA
sequences were analyzed using DNAMAN (version 4.0, Lynnon Biosoft). To
search the Genbank (National Center for Biotechnology Information (NCBI)) for
homologous nucleic acid sequences and to deduce amino acid sequence similar-
ity with existing sequences, the basic local alignment search tool (BLAST) at
http://www.ncbi.nlm.nih.gov/BLAST/Blast.cgi was used.
2.3 Results
2.3.1 Clinical information on children and isolation of E.
coli, Salmonella and Shigella from their faeces
Of the 256 children from whom faecal samples were collected, 90 and 166 were
sampled in phase 1 and 2, respectively. Bloody diarrhoea was observed in 57 of the
256 children (Table 2.2) and predominantly in children aged 2-12 years (54 children).
E. coli was isolated from the stools of 41 of the 57 children (Table 2.2).
Table 2.2: Types of diarrhoea in children and the isola-
tion of E. coli, Salmonella and Shigella
Age group (years)
< 2 2-5 6-12 Isolation of
P1 P2 P1 P2 P1 P2 E.c S Sh S, Sh
Diarrhoea Total
Bloody 0 3 12 18 8 16 57 41 0 0 0
Watery 16 29 26 46 22 38 177 164 4 6 1
Mucoid 3 5 4 6 1 3 22 17 0 0 0
P1, phase 1; P2, phase 2 of the study.
E.c, E. coli; S, Salmonella; Sh, Shigella
The majority of the children (177), representing all the age groups, presented with
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watery diarrhoea (Table 2.2). E. coli was isolated from 164 of the stools obtained
from these children. In addition, Salmonella or Shigella was isolated from 4 and 6 of
these children (aged 2-12 years). One child was infected with both pathogens. The
remaining children (22) had mucoid diarrhoea. E. coli was isolated from 17 of the
stools (Table 2.2).
Based on verbal reports to medical personnel, 22 of the 256 children, had received
antibiotics, usually co-triamoxazole. Some of the children were on treatment at the
time a stool sample was taken.
2.3.2 Age and health status of cattle and isolation of E. coli
A total of 300 rectal faecal samples were obtained from 235 adult bovines, 50 heifers
and 15 calves, representing 90 different herds. E. coli was isolated from 196 of 235
(83%) adult bovines, 10 of 50 (20%) heifers and 10 of 15 (66%) calves. Seven of
these calves had diarrhoea. In total, 216 (72%) of the 300 faecal samples contained
E. coli (Table 2.3).
Table 2.3: Age of cattle and isolation of E. coli
Calves Heifers Adults Total
Age in months 0-6 >6-24 > 24
No. of cattle 15 50 235 300
sampled
Isolation of E. coli 10(66) 10(20) 196(83) 216(72)
No. (percentage)
2.3.3 Information on valley dams
For each of the valley dams, (Figure 2.2) triplicate water samples were collected
for 3 consecutive months (November 2005 to January 2006) from 5 dams. Where
possible, sampling was carried out at water collection points used by inhabitants of
the community and where there was evidence of cattle (cattle pats) using the same
site.
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E. coli was isolated from all the water samples (45) and in numbers greater than
100cfu/100ml of water (Table 2.4). All dams had E. coli counts higher than the
maximum acceptable limit (<10 coliforms per 100ml) for drinking water in rural
water sources (WHO, 1971).
Table 2.4: E. coli counts in water samples from 5 valley
dams
Sampled valley dams
Sample Kyakabunga Kiruhura Rwabigyemano Nshwereenkye Rugongi
period E. coli cfu/100ml of water
Nov’05 A 700 1100 950 600 240
B 450 800 950 525 120
C 180 750 670 465 150
Dec’05 A 380 950 950 535 780
B 180 620 1700 400 610
C 720 450 400 335 145
Jan’06 A 550 700 740 400 400
B 260 800 480 320 215
C 300 700 800 230 200
A, B and C represent 3 sampling sites per valley dam
2.3.4 Detection of stx genes in human, bovine and water
E. coli isolates using PCR and DNA extracted from
a sweep of colonies
PCR assays to detect the presence of stx genes were carried out. E. coli glycerol
stocks from MAC and/or SMAC isolates from children and cattle [2.2.12] collected
during phase 1 of the study [2.2.2] were inoculated on 2-YT agar and incubated at
37oC for 18 hours [2.2.12]. E. coli strains from 62 children were recovered from MAC
stocks and the remainder (from 18 children) were obtained from SMAC preparations.
The bovine isolates were cultured from MAC (190) and SMAC (26) glycerol stocks.
E. coli from one bovine (Bb7) was isolated from both MAC and SMAC stocks.
PCR amplification was carried out using primers (Table 2.1) to detect stx1 and stx2
with DNA released by boiling a sweep of colonies [2.2.13]. Amplification products
of 302 bp and, 512 bp or 1493 bp, representing stx1 and stx2, respectively (Table
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2.1) were obtained with E. coli O157:H7. No PCR product was obtained with the
negative control, E. coli K-12. Appropriately sized amplicons were obtained from 7
of 80 (8.8%) human, and 15 of 216 (6.9%) cattle, faecal E. coli isolates. To confirm
whether the obtained PCR products contained stx genes, amplicons representative
of stx1 and stx2, from 1 human and 2 bovine E. coli isolates were extracted from
agarose, purified [2.2.14.3] and sequenced [2.2.14.4]. Analysis of the sequencing data
confirmed them as portions of stx1 and stx2, respectively.
E. coli from children in phase 2 of the study and from the water samples were
cultured on MAC only. The glycerol stocks were inoculated as described [2.2.12]
and DNA from sweeps of colonies were used in PCR assays to detect stx genes. Of
the 142 human E. coli isolates, products consistent with the presence of stx1 or stx2
were obtained from 11 E. coli. None of the 11 E. coli were obtained from the same
homestead as the bovines in phase 1.
Amplicons were obtained from 3 of 45 E. coli strains from the valley dams. The stx-
positive strains were from Rwabigyemano (November 2005), Kyakabunga (November
2005) and Kiruhura (January 2006).
2.3.5 PCR detection of stx genes in individual E. coli
colonies from humans, bovines and water samples
In order to obtain single STEC colonies for further studies and to determine whether
the stx gene content was uniform in the individual STEC populations, 10 colonies
from each of the STEC-positive sweeps were investigated for the presence of stx
genes as previously described [2.2.14].
2.3.5.1 Detection of stx genes in human isolates
Of the 7 human STEC-positive sweeps representing phase 1 [2.2.2], 10 stx-positive
colonies were identified in 3 isolates from children designated Hh4, Hh5 and Hh6
(Table 2.5). In each of these isolates the stx gene content was uniform. E. coli from
Hh4 contained stx1, whereas stx2 was identified in E. coli from Hh6 (Table 2.5).
Both stx genes were detected in E. coli from Hh5 (Table 2.5). The stx gene content
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from the remaining humans (Hh1, Hh2, Hh3 and Hh7) is shown in Table 2.5 and
Figure 2.3A.
Table 2.5: Types of diarrhoea in children from phase 1
and stx gene content of individual colonies
Types of Isolate stx1 stx2 stx1+2
diarrhoea I.D (No. of colonies)
WD Hh1 - - +(1)
WD Hh2 - - +(2)
WD Hh3 - +(5) +(3)
WD Hh4 +(10) - -
WD Hh6 - +(10) -
WD Hh7 - +(2) -
BD Hh5 - - +(10)
WD, watery diarrhoea; BD, bloody diarrhoea; I.D, identity
+, detected stx gene(s); -, no stx gene was detected
Figure 2.3: Detection of stx gene in E. coli strains from children in phase 1.
Figure A: Detection of stx following PCR using DNA extracted from a sweep of
colonies. The presence of stx1 and stx2 is indicated by the presence of 302 bp
and 516 bp fragments, respectively. E. coli O157:H7 was included as a positive
control. Lane 1, hyperladder IV (Bioline); lane 2, no DNA; lane 3, O157:H7; lane
4, Hh1; lane 5, Hh2; lane 6, Hh3; lane 7, Hh4; lane 8, Hh5; lane 9, Hh6; lane 10, Hh7.
Figure B: Detection of stx in 10 individual E. coli colonies from Hh3. Lane
1, hyperladder IV (Bioline); lane 2, no DNA; lane 3, O157:H7; lanes 4, 10 and 11,
individual colonies containing stx1 and stx2 genes; lanes 5, 6, 8, 12 and 13, individ-
ual colonies containing stx2 gene. Lanes 7 and 9, individual colonies lacking stx gene.
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Only E. coli from Hh3 demonstrated variable stx gene content (Figure 2.3B and
Table 2.5). None of these children were co-infected with Salmonella and/or Shigella
(Table 2.2).
A similar approach was used to study E. coli stx-positive sweeps from children in
the 2nd phase. The results are presented in Table 2.6.
Only the strains from Hh15 (Figure 2.4A and B) and Hh18 contained both stx
genes; for the remaining strains, there was almost an equal split between stx1 and
stx2-containing strains (Table 2.6).
Table 2.6: Types of diarrhoea in children from phase 2
and stx gene content of individual colonies
Types of Isolate stx1 stx2 stx1+2
diarrhoea I.D (No. of colonies)
WD Hh10 - +(1) -
WD Hh12 +(1) - -
WD Hh13 +(8) - -
WD Hh14 +(6) - -
WD Hh15 - - +(6)
WD Hh16 - +(5) -
BD Hh8 +(1) - -
BD Hh9 +(4) - -
BD Hh11 - +(1) -
BD Hh17 - +(2) -
BD Hh18 - - +(3)
WD, watery diarrhoea; BD, bloody diarrhoea; I.D, identity
+, detected stx gene(s); -, no stx gene was detected
As with the humans in phase 1, none of the humans from phase 2 were co-infected
with STEC, Salmonella and/or Shigella.
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Figure 2.4: Detection of stx gene in E. coli strains from children in phase 2.
Figure A: Detection of stx following PCR using DNA extracted from a sweep of
colonies. The presence of stx1 and stx2 is indicated by the presence of 302 bp and
516 bp fragments, respectively. E. coli O157:H7 was included as a positive control.
Lane 1, hyperladder IV (Bioline); lane 2, no DNA; lane 3, O157:H7; lane 4, Hh8;
lane 5, Hh9; lane 6, Hh10; lane 7, Hh11; lane 8, Hh15.
Figure B: Detection of stx in 10 individual colonies of E. coli from Hh15.
Lane 1, hyperladder IV (Bioline); lane 2, no DNA template; lane 3, O157:H7,
positive control; lanes 4-6, 8-10; individual colonies containing stx1 and stx2 genes.
Lanes 7, 11-13, individual colonies lacking stx genes.
In summary, of the 180 colonies screened for stx genes from 18 STEC isolates from
children, 81 (45%) were stx-positive colonies. Thirty of the colonies (37%) contained
stx1 alone, 26 (32.1%) contained stx2 alone and 22 (30.9%) contained both stx genes
(Table 2.5 and 2.6). There was no further attempt to increase the number of stx-
containing colonies and these results cannot be used to extrapolate the extent of
STEC infections.
2.3.5.2 PCR detection of stx genes in individual E. coli colonies from
bovines and water samples
Using E. coli colony sweeps, stx genes were detected in 15 bovines [2.3.4]. The
results of the PCR detection of stx genes in individual E. coli colonies are shown in
Table 2.6.
Two strains (SF+ and SF−) containing both stx genes were identified in Bb7 (Table
2.6). Most E. coli contained stx1 alone or in combination with stx2 genes. stx gene
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variation was detected in strains from 4 bovines (Bb1, Bb6, Bb8 and Bb14).
The distribution of the stx genes among stx-containing colonies from bovine isolates
was as follows; stx1 gene was detected in 29 (28.7%), stx2 gene in 21 (20.8%) and
stx1/ stx2 in 51 (50.5%) of the stx-containing colonies as shown in Table 2.7.
Table 2.7: stx gene content of individual colonies
Isolate stx1 stx2 stx1+2
I.D (No. of colonies)
Bb1 - +(2) +(8)
Bb2 +(10) - -
Bb3 - - +(10)
Bb4 - - +(1)
Bb5 - - +(7)
Bb6 - +(1) +(8)
Bb7a - - +(4)
Bb7b - - +(10)
Bb8 - +(8) +(2)
Bb9 - +(10) -
Bb10 +(3) - -
Bb11 +(1) - -
Bb12 +(3) - -
Bb13 +(1) - -
Bb14 +(9) - +(1)
Bb15 +(2) - -
Bb7a SF−; Bb7b SF+ strains; I.D, identity
+, detected stx gene(s); -, no stx gene was detected
Three water samples containing STEC strains were identified in the preliminary
studies. stx2-positive STEC strains were isolated from Kyakabunga (1 colony) and
Rwabigyemano (3 colonies) valley dams, while a stx1-positive colony was obtained
from Kiruhura [2.3.4].
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2.4 Discussion
Cattle play a central role in the socio-cultural and economic activities of the rural
pastoral communities in the remote cattle keeping areas of Nyabushozi county. Tra-
ditional practices promote close human-cattle contact, which inevitably expose the
community, children in particular, to STEC infection. Children, as young as 4 years
old, have been assigned to tend calves putting themselves at risk of infection with
STEC from cattle and their environment in the kraal.
To facilitate the isolation of STEC, faeces was collected directly from the rectums of
bovines which is usually associated with higher recovery rates of STEC than isolation
from faecal swabs and pats (Lahti et al. 2003). Fifteen (15) of 216 (7.85%) E.coli
carrying cattle carried STEC, lower than the corresponding rate (28.3%) for cattle
from a farm in central Uganda (Kaddu-Mulindwa et al. 2001). The differences in
husbandry practices could explain the variation in the shedding of STEC observed
between the 2 studies. In my study, the cattle were entirely reared on range; they
were free to move and graze in the vast pastureland, minimizing their contact with
STEC contaminated pastures. Such vast grazing land also reduces the possibility of
STEC transmission to other cattle, as cattle sharing the same pastures is remote.
The prevalence of STEC in cattle in my study accords with other prevalence rates
(0.9-15%) recorded in cattle under similar management practices from a number of
countries including India (Khan et al. 2002b), Australia (Cobbold and Desmarche-
lier, 2000) and the USA (Sargeant et al. 2000; Renter et al. 2003; Cobbold et al.
2004; Bollinger et al. 2005).
Apart from husbandry practices and faecal sampling, geographical location and sea-
sonal variation may influence the prevalence of STEC in bovines (Caprioli et al.
2005), as illustrated by the wide variations in prevalence rates of 0.2 to 75% in Eu-
rope (Pradel et al. 2000; Bonardi et al. 1999; Blanco et al. 2003a; Urdahl et al.
2003), 18-48% in Australia (Hornitzky et al. 2002), 46-69% in Japan (Kobayashi et
al. 2001) and 53-82% in Brazil (Cerqueira et al. 1999, Vicente et al. 2005).
Just over half (8 of 15 isolates; 53.3%) of bovine STEC isolates carried stx1, while
only 6.7% contained stx2. Six of 15 isolates, (40%) carried both genes. These data
contrast with the results of an earlier study in Uganda in which the majority of STEC
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possessed both stx genes (Kaddu-Mulindwa et al. 2001). The literature indicates
that, as with STEC prevalence in cattle, a number of factors, including geographical
location (Aktan et al. 2007) and possibly cattle management may influence stx gene
content of STEC (Cobbold et al. 2004). In India and the USA STEC from free-range
managed cattle carried stx1 in combination with stx2 (Wani et al. 2007; Renter et
al. 2003). On the other hand, stx1-containing STEC were prevalent in cattle reared
on pastures in Norway (Urdahl et al. 2003), whereas, cattle reared under extensive
grazing from Brazil, were mostly infected with stx2-containing strains (Farah et al.
2007).
Notwithstanding the poor quality of the water, valley dams have remained the most
reliable source of water for the inhabitants of Nyabushozi and their livestock, espe-
cially during the prolonged dry seasons. On a daily basis, over 600 head of cattle
used each of the 5 dams during the study period. Cattle defaecated directly into the
water and together with the run-off water flowing from the surrounding pastureland,
inevitably, E. coli was discharged into the dams. Therefore, the high E. coli counts
recorded in all the dams was not surprising. In a study by McBride et al. (2000),
E. coli was isolated from 99% of surface water reservoirs (ponds and dams) accessed
by livestock in New Zealand (Ministry of Agriculture and Forestry, NZ, 2004). As
E. coli can survive in the faeces of bovines for several weeks (Wang et al. 1996;
Kudva et al. 1998) after being discharged into water, high E. coli counts in the
valley dams are consistently maintained. Of course, other animals and birds may
also contaminate the surface water in the valley dams (Hagedorn et al. 1999).
Surface water sources prone to faecal contamination in rural cattle farming commu-
nities, are a major source of STEC infection to humans (Jackson et al. 1998; Michel
et al. 1999; Olsen et al. 2002). As expected, all the dams used by the Nyabushozi
community were highly contaminated with E. coli. Three of the 5 dams contained
STEC (3 of 45 water samples; 7.3%), cattle faeces being the likely source of these
organisms. The presence of STEC in the dams can be attributed to the absence of
protective barriers enabling direct access of cattle to the dams. Of 54 water sam-
ples collected from water sources within dairy farms in Brazil 1.9% contained STEC
(Vicente et al. 2005). Similarly, Sargeant et al. (2000) detected STEC in 1.5% (3 of
199 samples) of water sources in range cattle farms in the USA. As the water sources
were fenced, the source of the STEC is assumed to result from the drainage of water
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contaminated with bovine faeces into the dams (Vicente et al. 2005). In another
study from the Netherlands, 2.7% of private drinking water sources for humans and
cattle in the high density cattle farming areas contained STEC (Schets et al. (2005).
Although the water sources were fenced, molecular typing of STEC strains from wa-
ter, implicated cattle as the source of STEC (Schets et al. 2005). Evidence from
different countries including Canada (Jackson et al. 1998), Scotland (Solecki et al.
2007) and Japan (Yatsuyanagi et al. 2002) has shown that consumption of water
contaminated with bovine faeces is associated with STEC infection, particularly in
children.
Although E. coli is part of the main microflora of intestinal tracts of humans (Nataro
and Kaper, 1998), these organisms were not isolated from the stools of 34 of 256
children. One possible explanation for the absence of E. coli is the use of medicinal
herbs in the treatment of diarrhoea, which could have interfered with the prolif-
eration of gut microflora, including E. coli. It is a common practice among rural
poor communities in Africa (Yousif, 2002) to use medicinal plants with antibacterial
properties in the treatment of diarrhoeal diseases (Olukoya et al. 1993; Iwalokun
et al. 2001; Kamanzy et al. 2002; Samie et al. 2005). In addition, self medication
with antibiotics has been previously reported (Byarugaba, 2004; Awad et al. 2007;
Planta et al. 2007) and this could not be not ruled out, despite the fact that most
of the study population had indicated the opposite.
STEC was isolated from 8.1% (18 of 222) of the E.coli carrying diarrhoeal children.
This frequency rate is similar to the corresponding rate (8.4%) of STEC in diarrhoeal
children living in a low-income rural community in Nigeria without access to treated
water (Okeke et al. 2000). Although interaction between cattle and the children was
not mentioned, it was likely that the rural folk kept livestock which was the source
of STEC in the children.
On the other hand, in two earlier studies in Uganda (Nasinyama 1996; Kaddu-
Mulindwa et al. 2001) STEC was not isolated from 87 and 237 diarrhoeal children,
respectively. Similarly, in two previous studies, one from Tanzania in 1997 (Gascon
et al. (2000) and another one from Mozambique in 1998-99 (Rappelli et al. 2005),
none of the 103 and 548 E. coli strains from diarrhoeal children respectively, con-
tained stx genes as determined by PCR (Gascon et al. 2000; Rappelli et al. 2005).
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A notable difference between the groups of children is that unlike the children in
the Nyabushozi pastoralist community, the children from Uganda, Tanzania and
Mozambique (Nasinyama, 1996; Gascon et al. 2000; Kaddu-Mulindwa et al. 2001;
Rappelli et al. 2005), lived close to urban centres and had no contact with cattle.
Significantly, Nyabushozi county supports one of the highest populations of cattle in
Uganda (Uganda Bureau of Statistics, 2007). Previous studies have reported a direct
correlation between cattle density and human infection with STEC in the rural farm-
ing communities of Canada (Wilson et al. 1996; Valcour et al. 2002). Further, unlike
the residents in central Uganda in particular, consumption of locally fermented raw
milk, known as eshabwe and ghee, is a long time tradition among the inhabitants of
Nyabushozi county, including their children. Unequivocally, unpastuerised milk has
been previously linked to STEC infection (Hussein and Sakuma, 2005).
With respect to the clinical isolates, 27.8% (5 of 18) contained stx1, 33.3% (6) stx2
and 38.9% (7) contained both stx genes. Available clinical and epidemiological
data indicate that the clinical outcome of STEC infection varies with the type of
stx content; STEC carrying stx1 or stx1 and stx2 are associated with mild disease
(watery diarrhoea). On the other hand, strains carrying stx2 alone frequently cause
bloody diarrhoea and HUS (Boerlin et al. 1999; Friedrich et al. 2002). That two-
thirds of the STEC carried stx1 or both genes, suggests that most of the strains
from the children are of low virulence (may cause watery diarrhoea). However, no
association between the stx gene content and nature of diarrhoea can be established
from the preliminary results.
STEC infection may occur concurrently with other diarrhoeal pathogens. However,
none of the STEC infected children was co-infected with Salmonella, Shigella or
both of these pathogens. Undeniably, numerous bacterial pathogens cause childhood
diarrhoea in rural communities, nonetheless, these were outside the focus of this
thesis.
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3.1 Introduction
To identify STEC for further characterisation and to gain an understanding of the
ecology of the strains, the genetic profiles of the STEC were determined.
A number of molecular typing tools have been described; however, pulsed field gel
electrophoresis (PFGE) is regarded as the ‘gold standard’ (Tenover et al. 1995; Olive
and Bean, 1999; Rios et al., 1999; Preston et al. 2000; Avery et al. 2002) because of
its high discriminatory power (Bohm and Karch, 1992; CDC, 1995, 2006, Izumiya
et al. 1997) and reproducibility (PulsenetUSA, 1998; Welinder et al. 2002).
3.2 Experimental design
3.2.1 Bacterial strains
A total of 187 STEC strains from children (n=81), bovines (n=101) and water (n=5)
were investigated (Tables 3.1 and 3.2).
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Table 3.1: stx-positive colonies from children
Origin and number of STEC isolates
Child No. of Child No. of Child No. of
colonies colonies colonies
Hh1 1 Hh7 2 Hh13 8
Hh2 2 Hh8 1 Hh14 6
Hh3 8 Hh9 4 Hh15 6
Hh4 10 Hh10 1 Hh16 5
Hh5 10 Hh11 1 Hh17 2
Hh6 10 Hh12 1 Hh18 3
Hh1-Hh7, children in phase 1
Hh8-Hh18, children in phase 2
Table 3.2: stx-positive colonies from bovines and water
Origin and number of STEC isolates
Bovine No. of Bovine No. of Bovine/ No. of
colonies colonies water colonies
Bb1 10 Bb7b 10 Bb13 1
Bb2 10 Bb8 10 Bb14 10
Bb3 10 Bb9 10 Bb15 2
Bb4 1 Bb10 3 Ww1 1
Bb5 7 Bb11 1 Ww2 3
Bb6 9 Bb12 3 Ww3 1
Bb7a 4
Bb and Ww, STEC-positive colonies from bovines and water, respectively
Bb7a, SF−; Bb7b, SF+ strains
3.2.2 Pulsed field gel electrophoresis
3.2.2.1 Preparation of DNA
Previously described PFGE methods (Gautom, 1997 and PulseNet 1998), were mod-
ified. Briefly, bacterial colonies from an overnight culture on 2-YT agar were emul-
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sified in 400µl cell suspension buffer (100mM Tris, 100mM EDTA, pH 8.0) to an
optical density of 1.3-1.4 at 610nm (UV-Visible Spectrometers Biomate 5, Thermo
Electron Corporation, UK). To deproteinate the cells, proteinase-K and lysozyme
were added, each to a final concentration of 1 mg/ml, mixed thoroughly and incu-
bated for 15 min at 37oC. An equal volume (1% low density agarose gel (Seakem
goldr ) and 1% sodium dodecyl sulphate) was added and the mixture dispensed
into non-disposable plastic moulds and allowed to set at 4 ◦C for 5 min.
3.2.2.2 Cell lysis and restriction enzyme digest of genomic DNA
Plugs for each isolate, were immersed separately in 5ml cell lysis buffer (50mM Tris,
50mM EDTA, pH 8.0, 1% sarcocylr 0.5 mg/ml proteinase-K) and incubated with
shaking, at 55oC for 90 min. Subsequently, the plugs were washed twice at 50oC,
for 15 min each time, in 15ml preheated ultrapure water (Milli-Q) (50 ◦C) and then
four times at 50oC, for 15 min each time, in 10ml of preheated (50 ◦C) TE Buffer
(10mM Tris, 1mM EDTA, pH 8.0) with shaking.
Pre-digest incubation was carried out on 2-4mm plugs at 37oC in the supplied enzyme
buffer (Biolab, New England) for 15 min. Restriction digest ensued at 37oC with
50 U of XbaI and bovine serum albumin at a final concentration of 0.1 mg/ml
(Promega) for 16 hours.
3.2.2.3 Electrophoresis conditions
Electrophoresis was carried out with a contour-clamped homogeneous electric field
(CHEF-DR II) apparatus (Bio-Rad, La Jolla, California). Plugs were loaded and
sealed into a 1% agarose gel (SeaKemr Gold Lonza Rockland, Inc. USA) made of
0.5X TBE, prior to submerging the gel in 2.5 litres of 0.5X TBE. Electrophoresis
was carried out at a pulse time of 2.2 to 54.8 sec for 20 hours at 240v, and the
TBE buffer was maintained at 12 ◦C. PFGE lambda ladder marker (New England
Biolabs) and a control strain O157:H7 were included in each gel.
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3.2.2.4 Visualization and photography of the gel
Following electrophoresis, gels were stained in ethidium bromide (1.0µg/ml) for 30
min, followed by 2 washes in ultra-pure water at 30 minutes interval, before exam-
ining them under UV transilluminator. PFGE profiles were captured by Kodak ID
imaging program (Scientific Imaging System, USA) and stored as TIFF files.
3.2.2.5 Analysis of PFGE data and interpretation of results
The resulting images were converted into a digital form, processed and analysed using
GelCompar II software package (version 4.6 Applied Maths BVBA Belgium). Lanes
were assigned to each profile according to the GelCompar II instruction manual.
The TIFF images were normalized in comparison to the control strain, O157:H7.
Calculation of similarity matrix between STEC fingerprints was carried out using
Dice similarity coefficient (Dice, 1945), which was generated by the GelCompar
II software package (version 4.6 Applied Maths BVBA Belgium). DNA fragments
between sizes 48.5 and 582 kb were considered for analysis. To determine the genetic
relatedness of STEC isolates, cluster analysis of PFGE patterns was performed by
the unweighted-pair group arithmetic averaging (UPGMA) method, at a maximum
band position tolerance of 1.0% and an optimisation of 1%. Dendrograms describing
the relationship among PFGE profiles were generated.
STEC strains exhibiting PFGE profiles with 70-99% were considered closely related;
65-69%, distally (possibly) related and less than 65% similarity, unrelated (Welinder-
Olsson et al. 2002). PFGE profiles of STEC isolates within and across sources were
analysed. PFGE patterns with 70% and more similarity were assigned the same
PFGE profile number. Isolates from individual hosts (child, bovine) and water
clustering in the same PFGE pattern (70-99%, similar), but with distinguishable
PFGE banding patterns were assigned the same profile number and different small
letters representing clonal subgroups (Zhang et al. 2000; Renter et al. 2003; Geue
et al. 2002). Strains belonged to the same cluster if their similarity level was 64%
or more (Vaz et al. 2006).
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3.2.2.6 Optimisation of PFGE assays
For the optimisation of PFGE conditions, 5 DNA assays of O157:H7 prepared on
different days within 2 weeks were digested with restriction enzyme XbaI and run
on the same gel. For each of the 5 assays, a consistent number of bands (18) which
migrated similar distances were produced (Figure 3.1).
Figure 3.1: PFGE of XbaI-digested genomic DNA from STEC O157:H7.
Plugs were prepared on different days but digested at the same time. Lane 1,
PFGE lambda ladder marker (New England Biolabs); lane 2, O157:H7-day 1; lane
3, O157:H7-day-3; lane 4, O157:H7-day-7; lane 5, O157:H7-day-10; lane 6, O157:H7-
day-12.
Additionally, to determine inter gel reproducibility, similarity coefficients of PFGE
profiles of O157:H7 obtained from 8 gels were analysed and a dendrogram generated
as shown in Figure 3.2. The similarity among the strains run in 8 gels ranged from
96-100%, showing high degree of intergel reproducibility.
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Figure 3.2: Dendrogram showing the relatedness of STEC O157:H7.
Genomic DNA was digested with XbaI, followed by PFGE using 8 different gels. As
defined at 100% similarity levels, profiles of STEC O157:H7 obtained from gels 1, 2,
4 and 5 were identical and 96% similar to profiles obtained from the other 4 gels (3,
6-8).
3.3 Results
3.3.1 Genetic fingerprints of individual clinical STEC
colonies from phase 1
Following PFGE, profiles were obtained for 43 of 46 colonies from the children (7)
in phase 1. Although DNA assays were repeated 3 times, profiles were not obtained
for 2 colonies and 1 colony for Hh3 and Hh4, respectively (Table 3.3).
The PFGE profile of the single colony from Hh1 was designated 1. Analysis of the
dendrogram of the 2 profiles of STEC from Hh2 showed a coefficient similarity of
94.1% (Table 3.3). The profile was designated 2 with clonal subgroups 2a and 2b.
Hh4 was co-infected with unrelated strains (profiles 4, 5 and 6) (Figure 3.3, Table
3.3). Strains with profile 5 or 6 are possibly related with a similarity of 67.3% (Figure
3.3). To accommodate these differences Hh4 was designated Hh4i, Hh4ii and Hh4iii.
Similar assignations were applied to multiple STEC from the same source.
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Table 3.3: PFGE profiles and clonal subgroups of indi-
vidual STEC colonies from each child in phase 1
Child No. of PFGE Clonal Similarity
colonies profile subgroups coefficient (%)
Hh1 1 1
Hh2 2 2 2a, 2b 94.1
Hh3/1 3 3 3a, 3b, 3c 90.7-97.7
Hh3/2 3 3 3d, 3e, 3f 92.7-97.7
Hh4i 3 4 4a, 4b, 4c 88.2-96.3
Hh4ii 1 5
hh4iii 5 6 6a, 6b, 6c(2*), 6d 88.9-100
Hh5 10 7 7a, 7b, 7c(3*), 7d, 7e(2*), 7f, 7g 91.2-100
Hh6 10 8 8a(2*), 8b, 8c, 8d(2*), 8e(2), 8f, 8g 79.2-100
Hh7 2 9 9a, 9b 97
*Number of identical colonies
Hh3/1, stx2; Hh3/2, stx1 and stx2-containing STEC
Figure 3.3: Dendrogram showing the relatedness of STEC (colonies 1-9) from Hh4.
The strains in profile 4 are closely related with 88.2-91.8 similarity level and 50%
related to strains in profiles 5 and 6. In turn, strains in profile 6 are closely related
with 88.9-100% similarity level and they are 67.3% related to strains in profile 5.
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The profiles and corresponding dendrogram of each of the 10 colonies from Hh5
(Figure 3.4) indicate that they are closely related. This profile was designated 7
(Table 3.3).
Figure 3.4: PFGE profiles and relatedness of 10 STEC colonies from Hh5.
A: PFGE of XbaI-digested genomic DNA. Lane 1, PFGE lambda ladder marker
(New England Biolabs); lanes 2-11, colonies 1-10 from Hh5; lane 12, STEC O157:H7
that was included as a control.
B: Dendrogram showing the relatedness of STEC colonies from Hh5. The
strains are closely related with 91.2-100% similarity level.
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Similarly, the STEC from Hh6 (profile 8) or Hh3 (profile 3) were also related as
shown in Table 3.3. Strains from Hh3 with the same PFGE profile but different stx
gene content were designated Hh3/1 and Hh3/2. These strains showed a similarity
level ranging from 90.7-97.7%. Similar assignation was applied to the bovine STEC.
3.3.2 Genetic fingerprints of individual clinical STEC
colonies from phase 2
Analysis of PFGE profiles of 38 STEC from children in phase 2 was carried out (Table
3.4). Single colonies obtained from 4 children Hh8, Hh10, Hh11 and Hh12 were
designated PFGE profiles 10, 12, 13 and 14, respectively (Table 3.4). PFGE profiles
11, 23 and 24 were assigned to colonies from Hh9, Hh17 and Hh18, respectively
(Table 3.4). Each of 4 children Hh13, Hh14, Hh15 and Hh16 was co-infected with
unrelated strains elaborating 2 profiles each (Table 3.4).
Table 3.4: PFGE profiles and subgroups of individual
STEC colonies from each child in phase 2
Child No. of PFGE Clonal Similarity
colonies profile subgroup coefficient (%)
Hh8 1 10
Hh9 4 11 11a, 11b, 11c, 11d 84.9-86
Hh10 1 12
Hh11 1 13
Hh12 1 14
Hh13i 7 15 15a, 15b, 15c(2*), 15d(2*), 15e 85-100
Hh13ii 1 16
Hh14i 2 17 17a(2*) 100
Hh14ii 4 18 18a, 18b, 18c, 18d 82-100
Hh15i 5 19 19a, 19b(3*), 19c 84-100
Hh15ii 1 20
Hh16i 1 21
Hh16ii 4 22 22a(2), 22b, 22c 73.5-100
Hh17 2 23 23a(2*) 100
Hh18 3 24 24 100
*Number of identical colonies
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3.3.3 Genetic relatedness of clinical STEC strains in phases
1 and 2
The PFGE profiles and dendrogram of the total clinical STEC strains (24) are shown
in Figure 3.5. The strains are genetically diverse, forming 18 clusters with similarity
levels ranging from 32.2-66.8% (Figure 3.5).
Figure 3.5: Dendrogram showing genetic relatedness of clinical STEC strains.
PFGE profiles 1-9, phase 1 STEC; profiles 10-23, phase 2 STEC. 100%, identical
strains; 70-99.9%, closely related; 65-69.9%, distally related; <65%, no genetic rela-
tionship.
As defined at 68.8% similarity level, the similarity between each of 2 pairs of profiles
10 and 14 (Hh8 and Hh12) and 12 and 13 (Hh10 and Hh11) suggests that the strains
from each of the pairs of children may be distally related (Figure 3.5). Only 2 STEC
from the 2 phases are possibly related: strains from Hh5 (profile 7) and Hh14i (profile
17) show 66% similarity (Figure 3.5).
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3.3.4 Determination and analyses of individual bovine
STEC colonies: relatedness to each other and to the
clinical STEC
Eighteen (18) PFGE profiles with a similarity of 39-100% were obtained from 98 of
101 STEC colonies from the 15 bovines (Figure 3.6). Using a similarity level of 64%
or more to define a cluster, no clustering was observed, indicating genetic diversity
of the strains.
Figure 3.6: Dendrogram showing the relatedness of bovine STEC strains.
100%, identical strains; 70-99.9%, closely related; 65-69.9%, distally related; <65%,
no genetic relationship. Cluster, 64% or more similarity level.
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A comparison of these profiles with the corresponding profiles from the clinical iso-
lates indicated that STEC from Bb7 (a and b) and Bb8ii are identical to profile 4
of STEC from child 4 (Figure 3.7; Table 3.5).
Figure 3.7: Dendrogram showing the relatedness of STEC from Bb7, Bb8 and Hh4.
SF− strains, Bb7a.1-Bb7a.4; SF+ strains, Bb7b1-Bb7b10. Eight identical strains
including 3 SF− and 5 SF+ (4e) have a similarity level of 96.8% with 6 identical
strains in 4f, which comprise 2 isolates from Bb8ii. In turn, these are 96% similar to
2 strains from Hh4i, and 90.7 and 88.2% similar to strains in 4g and 4c, respectively.
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Additionally, the respective PFGE profiles of strains from Bb3 and Bb12 are 78.6-80
and 86% similar to profile 2 of STEC from Hh2 (Figure 3.8).
Figure 3.8: Dendrogram showing the relatedness of STEC colonies from Hh2, Bb3
and Bb12.
Strains from Bb3 are closely related (78.6-100%) and are similarly related (80%) to
STEC from Hh2 and Bb12. Strains from Hh2 are 94.1%1 identical and 86% similar
to strains from Bb12.
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Table 3.5: PFGE profiles of multiple STEC colonies in
individual bovines
Bovine No. of PFGE Clonal Similarity
No. colonies profile subgroup coefficient (%)
Bb1i 10 25 25a, 25b, 25c(3*), 25d, 25e, 25f 80.9-100
Bb1ii 26 26a, 26b 97.6
Bb2 10 27 27a(5*), 27b, 27c, 27d, 27e 96.5-100
Bb3† 9 2 2c(4*), 2d, 2e(2*), 2f, 2g 78.6-100
Bb4 1 28 28
Bb5† 6 29 29a(6*) 100
Bb6/1 8 29 29a(2*), 29b(3*), 29c(2*), 29d, 29e 86-100
Bb6/2 1 29 29e
Bb7a 4 4 4d, 4e(3*)
Bb7b 10 4 4e(5*), 4f(4*) 4g 91.7-100
Bb8i 8 29 29a(3*), 29b, 29d(2*), 29f, 29g 92.9-100
Bb8ii 2 4 4f(2*) 100
Bb9† 9 30 30a, 30b, 30c, 30d, 30e, 30f, 30g,
30h, 30i
83.2-97.1
Bb10i 2 31 31 100
Bb10ii 1 32 32
Bb11 1 33 33
Bb12 3 2 2h(2*), 2i 93
Bb13 1 34 34
Bb14i 10 35 35a, 35b 95
Bb14ii 36 36
Bb14iii 37 37a, 37b 90.5
Bb14iv 38 38a, 38b, 38c, 38d, 38e 80.4-91.9
Bb15i 2 39 39
Bb15ii 40 40
*Number of identical colonies
†One colony each was refractory to digestion
Hh6/1, stx1 and stx2; Hh6/2, stx2-containing STEC
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None of the other bovine STEC were related to the clinical isolates (Figure 3.9 and
3.10).
Figure 3.9: Dendrogram showing the relatedness between bovine and clinical STEC
strains from phase 1.
100%, identical strains; 70-99.9%, closely related; 65-69.9%, distally related; <65%,
no genetic relationship.
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Figure 3.10: Dendrogram showing the relatedness between bovine and clinical STEC
strains from phase 2.
100%, identical strains; 70-99.9%, closely related; 65-69.9%, distally related; <65%,
no genetic relationship.
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The remaining strains from 11 bovines were classified into 16 profiles (25-40) (Table
3.5). Of these, related strains (profile 29) were identified from Bb5, Bb6 and Bb8i
(Figure 3.11).
Figure 3.11: PFGE of XbaI-digested genomic DNA STEC strains from Bb5, Bb6
and Bb8.
A: Lane 1, PFGE lambda ladder marker (New England Biolabs); lane 2, O157:H7;
lanes 3-8, colonies 1-7 from Bb5.
B: Lanes 1, 20, PFGE lambda ladder marker (New England Biolabs); lanes 2-10,
Bb6 colonies 1-9; lane 11, O157:H7; lanes 12-19, Bb8 colonies 1-8 representing strain
Bb8i. Strains in A and B are closely related.
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One of the bovines (Bb14) was infected with 4 unrelated strains (profiles 35-39) as
shown in Figure 3.12.
Figure 3.12: Dendrogram showing the genetic relatedness of STEC colonies from
bovine Bb14.
Ten STEC colonies segregated into 4 profiles, 35-38, which have a similarity level of
59.4-65.9%.
3.3.5 Relatedness of STEC strains from water and their re-
latedness to clinical and bovine isolates
The profile of each STEC from water was unique (profiles 41-45); they are not closely
related to each other, nor to any of the clinical or bovine isolates (Figures 3.13 and
3.14). Only STEC from Hh17 and Ww3, with 64% similarity segregated in the same
cluster (Figure 3.13).
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Figure 3.13: Dendrogram showing genetic relatedness between clinical and water
STEC strains.
100%, identical strains; 70-99.9%, closely related; 65-69.9%, distally related; <65%,
no genetic relationship.
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Figure 3.14: Dendrogram showing genetic relatedness between bovine and water
STEC strains.
100%, identical strains; 70-99.9%, closely related; 65-69.9%, distally related; <65%,
no genetic relationship.
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3.4 Discussion
A majority of the bovine STEC (15 of 24) segregated into 15 unrelated PFGE pro-
files. That 14 of the 15 STEC were obtained from different herds of cattle suggests
that these herds were infected with genetically distinct strains of STEC. This obser-
vation agrees with the findings from previous studies which have shown that different
cattle populations are associated with distinct strains of STEC (Cobbold and Des-
marchelier, 2001; Liebana et al. 2003). Although the bovines in my study were
reared on range, animals within a herd commingle in the night enclosures (kraals),
which could explain the infection of Bb5 and Bb6 with related STEC (profile 29).
The 2 animals were from the same herd; cross-transmission of infection, or acquisi-
tion of infection from a common source, probably occurred within the kraal. This is
not uncommon, close contact promoted STEC transmission within a herd of cattle
has been described (Faith et al. 1996; Cobbold and Desmarchelier, 2001; LeJune et
al. 2004). A different explanation must account for the relatedness of STEC from
Bb5/6 and Bb8 or Bb3 and Bb12 which were not herd-related. Inter-farm clonal
similarity of STEC has been previously reported between two unrelated farms over
121 km apart, which could be attributed to transmission by different vehicles includ-
ing humans and birds, among others (Faith et al. 1996; Rice et al. 1999; Wetzel and
LeJeune, 2006). Since the herds in Nyabushozi shared water sources, the bovines
may have been infected through drinking contaminated water as suggested by the
studies of Faith et al. (1996); Shere et al. (1998); LeJune et al. (2004). Alterna-
tively, frequent movement of cattle between herds which occurs during traditional
ceremonies such as marriage, could result in the transmission of STEC to animals in
a different herd. Nevertheless, since the number of herds with STEC excreting cattle
were few, it is not possible to deduce whether transmission of STEC among herds
of cattle reared on range in Nyabushozi was common or not. A study involving a
large number of herds of cattle would be required.
Bb7 was infected with SF+ and SF− closely related (90.7-100% similar) strains. A
majority of the colonies characterised (8 of 14) segregated into clonal subgroup 4e
which is composed of both SF+ and SF− strains. This is not unusual, previous studies
have reported genetic relatedness between fermenting and non-sorbitol-fermenting
strains of EHEC O157:H7 and O157:NM which comprise a clonal complex (Whittam
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et al. 1993; Feng et al. 1998). A stepwise evolutionary model has been proposed
to explain the loss of sorbitol fermenting characteristics in EHEC O157 (Whittam
et al. 1993; Feng et al. 1998; Donnenberg and Whittam, 2001; Wick et al. 2005).
Likewise, the loss of sorbitol fermenting phenotype by STEC in my study could have
occurred via a similar but parallel evolutionary pathway to STEC O157:H7 (Reid et
al. 2000). Hence, both fermenting and non-fermenting strains have remained closely
related.
Previous studies have characterised clonal subgroups of STEC in naturally infected
individual cattle under range (Renter et al. 2003) or different production systems
(Hancock et al. 1994; Shere et al. 1998; Rice et al. 1999) and in experimentally
infected animals (Akiba et al. 2000). Clonal subgroups were observed in multiple
STEC colonies from 11 of 12 bovines. Although the presence of multiple clonal
subgroups in individual bovine STEC was consistent with previous findings obtained
from range cattle (Renter et al. 2003), a larger proportion of animals in my study
(11 of 13) than in a study (57 of the 93) by Renter et al. (2003) were infected
with multiple clonal subgroups of STEC. In part, this might be a reflection of the
difference in the number of colonies characterised in the two studies. The profiles of
up to 10 colonies were obtained in my study, whereas only 3 colonies were analysed by
Renter et al. (2003). Other factors such as different animal and STEC populations as
well as environmental conditions may also be responsible for infection with multiple
clonal subgroups of STEC. The exact mechanism of clonal diversification is unknown,
nonetheless, there is consensus that it results from alterations in the genome through
point mutations, insertions, deletions of DNA or internal re-arrangement events
(Beutin et al. 1997; Akiba et al. 2000; Iguchi et al. 2003; Bielaszewska et al.
2006; Geue et al. 2006). This has been demonstrated in experimentally infected
bovines where changes in the PFGE profiles of STEC were observed from day 1
to 50 days post-inoculation (Akiba et al. 2000). The presence of multiple clonal
subgroups shed by individual bovines has demonstrated the heterogeneous nature
of STEC and absence of a single predominant clonal subgroup. Thus, analysing
PFGE profiles of multiple colonies provides a deeper understanding of the clonal
characteristics of STEC within an individual host.
Several studies seem to suggest that closely related STEC from an individual host
have similar stx gene content (Beutin et al. 1997; Shere et al. 1998; Sanderson
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et al. 2006). Similarly, the stx gene content of closely related STEC from 7 of 8
bovines and 4 of 5 children was uniform. The loss of Stx2 phage is associated with
alteration of the PFGE profiles of STEC (Murase et al. 1999; Bielaszewska et al.
2006), nonetheless, strains in Hh3 and Bb6 with stx2 or both stx genes were closely
related, suggesting that the absence of stx1 did not alter their profiles. Although
genetically related STEC from individual hosts carried uniform stx genes , equally,
uniform stx genes were carried by unrelated STEC among different hosts. Therefore,
the carriage of uniform stx genes in different STEC populations does not indicate
genetic relatedness.
All five STEC strains from the water samples were genetically distinct, and showed
no relatedness to the bovine STEC and all, except one clinical isolate. Isolates
from Ww3 and Hh17 clustered together (64% similarity level), perhaps suggesting
that they emerged from a distant ancestor (Kim et al. 2001; Yang et al. 2004).
Perhaps due to temporal differences in sampling, cattle were not demonstrated as
the source of STEC contaminating the water; nevertheless, they are the most likely
culprits. In Nyabushozi STEC contaminated water may be a means of transmission
or infection of these organisms to the bovines and children, alike. Studies have shown
a genetic diversity of water STEC which might be associated with different sources
of the organisms, such as other animals (domestic and wild) or birds (Hancock et al.
1994; Faith et al. 1996; Shere et al. 1998). Thus, although bovines were the main
suspects, different animals or birds may be responsible for the STEC contaminated
valley dams.
Transmission of STEC from bovines to humans in rural farming communities has
been well documented (Crump et al. 2002; O’Brien et al. 2001; Grif et al. 2005).
In my study PFGE indicated that STEC isolated from each of two children (Hh2
and Hh4) was acquired from bovines, or their environment. In this context, children
could have been infected following consumption of raw milk or fermented milk (es-
habwe), which is frequent in the community. Previous studies have linked human
infection with ingestion of raw milk or cheese made from raw milk (Descheˆnes 1996;
Hussein, 2005; Nielsen et al. 2005). Since children have direct contact with bovines,
their faeces or their kraals, they could have contracted infection from one of these
sources. These observations accord with previous reports on transmission STEC to
humans (Wilson et al. 1996; Crampin et al. 1999; Bielaszewska et al. 2000; Crump
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et al. 2002; Nielsen et al. 2005; Karch et al. 2005). Additionally, profiles of STEC
from Hh13i and Hh14ii (phase 2), were distally related (66.7%) to bovine isolates
Bb14ii and Bb15ii, respectively, despite the difference in sampling time. It may be
that these strains have diverged from a recent common ancestor (Yang et al. 2004).
A majority of clinical isolates (16 of 25) were genetically distinct, implying that the
isolates originated from different ancestors (Kim et al. 2001). Overall, this diversity
of clinical STEC accords with findings from several studies which involve sporadic
STEC infections in a number of countries (Rios et al. (1999; Khan et al. 2002a;
Vaz et al. 2006). For instance, 21 of 23 clinical STEC from Chile were genetically
diverse (Rios et al. (1999); similar diversity was observed in STEC associated with
sporadic cases of diarrhoea in India (Khan et al. 2002a), or both diarrhoea and HUS
in Brazil (Vaz et al. 2006).
STEC strains from 11 of the 13 children in my study exhibited multiple clonal
subgroups and none of the clonal subgroups was dominant. This is not uncommon,
STEC from individual patients showing multiple clonal groups have been reported
in Germany (Liesegang et al. 2000). Probably, the diversity of the clinical isolates
is linked to the diversity STEC in the bovines. From an epidemiological view point,
it may be necessary to determine PFGE profiles of multiple clinical strains in a
sample from the same patient. This is because multiple clones may be involved in
an infection and may have different virulent profiles.
In conclusion, these data have shown high clonal heterogeneity among the bovine,
clinical and water STEC isolates. Molecular typing strongly indicates transmission
of STEC from bovines to 2 children.
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Serogroups and genetic
heterogeneity of STEC
4.1 Introduction
Since its inception in 1947 (Kauffmann, 1947), serotyping has remained an
important epidemiological and reference typing tool for E.coli (Orskov et al.
1977). Presently, more than 470 serogroups of STEC have been identified
(http://www.lugo.usc.es/ecoli); however, only a small number of O antigenic groups
including O26, O103, O111, O113, O145 and O157 have been associated with hu-
man illness (Nataro and Kaper, 1998; Thorpe, 2004; Caprioli et al. 2005). These
strains, classified as enterohaemorrhagic, are frequently associated with more se-
vere outcomes of infection, including HUS (Levine, 1987; Nataro and Kaper, 1998).
Recently, additional serogroups, such as O8 and O76, which have emerged from
among previously non or less pathogenic serogroups also play a role in human dis-
ease (Welinder-Olsson et al. 2002; Manning et al. 2007).
Thus, to obtain a more complete picture of the clinical STEC from Nyabushozi,
the O antigenic serogroup of these organisms were determined. Additionally, to
evaluate the potential health hazard of the bovines and water for the community,
the serogroups of STEC from these sources were ascertained.
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4.2 Experimental design
4.2.1 Bacterial strains
A single isolate of STEC representing each PFGE profile in association with stx
gene content in the human, bovine and water, was investigated. In total 54 STEC
strains were included: 5 water (Table 3.2), 25 human (Tables 3.3 and 3.4) and 24
bovine STEC strains (Table 3.5).
4.2.2 Serotyping
Serotyping for the O antigens was carried at the Enteric Diseases Reference Unit,
National Institute of Communicable Diseases, National Health Laboratory Service,
Sandringham, Johannesburg, South Africa. The tube agglutination test for serotyp-
ing based on an antigen/antibody reaction was used. Strains that did not form
an agglutination with the O antisera were designated as nontypeable (NT). Typing
for the H-antigens was not carried out. The O serogroups of 2 strains were not
established because they were not viable, their serogroup have been recorded as not
known (NK).
4.3 Results
4.3.1 O antigenic serogroups of STEC from the bovines
Twenty four bovine STEC were serotyped into 12 serogroups (Table 4.1). Four
strains expressed non typeable O antigens. Strains expressing O157 were not iso-
lated. Three serogroups accounted for 12 of the 20 typeable strains: O76 (5 strains),
O8 (4 strains) and O113 (3 strains). The remaining 7 serogroups were distributed as
follows; O142 (2 strains) and serogroups O20, O28ac, O107, O111, O158 and Poly9
contain 1 strain each (Table 4.1).
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Table 4.1: Serogroups of bovine STEC
Bovine Serogroup Bovine Serogroup Bovine Serogroup
Bb1i O111 Bb7a O113 Bb12 O76
Bb1ii Poly9 Bb7b O113 Bb13 NT
Bb2 NT Bb8i O8 Bb14i NT
Bb3 O76 Bb8ii O107 Bb14ii O158
Bb4 O28ac Bb9 O113 Bb14iii O76
Bb5 O8 Bb10i NT Bb14iv O142
Bb6/1 O8 Bb10ii O20 Bb15i O76
Bb6/2 O8 Bb11 O142 Bb15ii O76
Bb7.1a (SF+) and Bb7.2b(SF−) strains
4.3.2 Serogroups of STEC from the water
Three of the 5 strains from water (Ww1, Ww2i and Ww2ii) belonged to serogroup
O166. Strain Ww3 expressed a non-typeable O antigen. The serogroup of the fifth
strain (Ww2ii) was not established because the bacteria were not viable.
4.3.3 Serogroups of STEC from the children
Nineteen of the 25 strains expressed O antigens and segregated into 15 O serogroups
(Table 4.2). For 5 strains, the O antigens were non-typeable (NT) (Table 4.2). The
serogroup of an additional strain was not established because the cells were not
viable.
The 10 strains in phase 1 were typed into 7 O serogroups, one additional strain ex-
pressed a nontypeable O antigen (Table 4.2). Serogroups O107 and O113 comprised
2 strains each (Table 4.2). The remaining 5 serogroups O8, O22, O74, O76 and O78
each comprised one strain (Table 4.2).
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Table 4.2: Serogroups of STEC from children in phases
1 and 2
Child Serogroup Child Serogroup
Phase 1 Hh1 O74 Hh4ii O107
Hh2 O76 Hh4iii O107
Hh3/1 O22 Hh5 O78
Hh3/2 O113 Hh6 NT
Hh4i O113 Hh7 O8
Phase 2 Hh8 O149 Hh14ii NT
Hh9 NT Hh15i O142
Hh10 O29 Hh15ii O142
Hh11 O141 Hh16i O176
Hh12 O166 Hh16ii NK
Hh13i NT Hh17 O169
Hh13ii O111 Hh18 O142
Hh14i NT
NK, serogroup not established
Of the 15 strains in phase 2, 10 were typed into 8 O serogroups, the O antigens of
4 strains were untypeable and one strain was not serotyped (Table 4.2). Of the 8
O serogroups, O142 comprised 3 strains. The remaining 7 serogroups: O29, O111,
O141, O149, O166, O169 and O176 were each represented by a single strain (Table
4.2).
4.3.4 Correlation of stx gene content with serogroups con-
taining multiple strains
Six serogroups were common to STEC from both children and the cattle, and one
serogroup was present in STEC from water and a child (Table 4.3). Correlation
of stx-genotype with serogroup showed that the stx content of clinical O antigen
expressing STEC was not always the same as in the corresponding bovines or water
related STEC (Table 4.3).
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Table 4.3: stx content of STEC strains in various
serogroups from different sources
Origin and stx gene content of STEC
Serogroup Bovine/ water stx content Child stx content
O8 Bb5 stx1/stx2 Hh7 stx2
Bb6/1 stx1/stx2
Bb6/2 stx2
Bb8i stx1/stx2
O76 Bb3 stx1/stx2 Hh2 stx1/stx2
Bb12 stx1
Bb14iii stx1/stx2
Bb15i stx1
Bb15ii stx1
O107 Bb8ii stx2 Hh4ii stx1
Hh4iii stx1
O111 Bb1i stx1/stx2 Hh13ii stx1
O113 Bb7a stx1/stx2 Hh3/2 stx1/stx2
Bb7b stx1/stx2 Hh4i stx1
O142 Bb11 stx1 Hh15i stx2
Bb14iv stx1 Hh15ii stx2
Hh18 stx1/stx2
O166 Ww1 stx2 Hh12 stx1
O166 Ww2i stx2
O166 Ww2ii stx2
Bb7.1a (SF+) and Bb7.2b(SF−) strains
4.3.5 Genetic heterogeneity of STEC clones within a
serogroup
The clonal heterogeneity of STEC strains within a serogroup was investigated in 5
serogroups (O8, O76, O113, O142 and O166) containing 4 or more strains. The data
was analysed as described [3.2.2.5] and results are presented in Figure 4.1).
Strains within each of the 5 serogroups belonged to 2 or more clonal subgroups. As
in Figure 4.1A, 3 of the 5 isolates in serogroup O8, are identical (clonal subgroup
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29a) and closely related to a strain in 29f.
Figure 4.1: Dendrograms showing clonal heterogeneity of STEC within a serogroup.
Macrorestriction digest of genomic DNA was carried out with XbaI. Similarity co-
efficient was generated by Dice coefficient using UPGMA with arithmetic averages
at a position tolerance of 1%. The respective clonal subgroups are shown in Tables
3.3 and 3.5.
Strains (6) in serogroup O76 separated into 4 clonal complexes (Figure 4.1B) with
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only clonal subgroups 2a, 2c and 2h being closely related. While 3 of the 5 strains
in serogroup O113 are closely related (4a, 4e and 4f), they are distinct from strains
in clonal subgroups 3d and 30e (Figure 4.1C). All strains in serogroups O166 and
O142, separated into distinct unrelated clonal subgroups (Figure 4.1D and E).
4.4 Discussion
All the serogroups of STEC isolated from the bovines in Nyabushozi have been pre-
viously isolated from cattle in different countries, including Australia (Hornitzky et
al. 2005; Brazil (Irino et al. 2005); Japan (Kobayashi et al. 2003, the USA (Cobbold
et al. 2004) and a number of European countries (Beutin et al. 1997; Pradel et al.
2001; Pearce et al. 2006). Strains of serogroups O76 and O113 were reported in an
earlier study by Kaddu-Mulindwa et al. (2001) in central Uganda, suggesting that
these serogroups are prevalent in cattle from different parts of Uganda.
It is probably difficult to assess infection of bovines with O157:H7 from Uganda,
and on the African continent in general, because of the few available studies. In
one particular study, Kaddu-Mulindwa et al. (2001) investigated the occurrence of
STEC in bovines from Uganda. These investigators did not isolate STEC O157:H7
from 43 STEC shedding bovines. Similarly, none of 15 STEC excreting bovines in
my study shed STEC O157:H7. Corresponding studies from Australia (Hornitzky
et al. 2002) and a number of countries in Europe suggest that cattle from these
countries predominantly shed non-O157:H7 strains (Montenegro et al. 1990; Blanco
et al. 2001). On the other hand, the available literature from North America, Brazil,
United Kingdom and Japan (Izumiya et al. 1997; Slutsker et al. 1997; Michino et
al. 1999; Thorpe, 2004; Vali et al. 2004; Irino et al. 2005) have shown that cattle
predominantly shed O157:H7. From these observations, the shedding of O157:H7
or non-O157:H7 by bovines varies with the geographical location. Since only non-
O157:H7 STEC were isolated from cattle in Nyabushozi, it can be suggested these
strains are more associated with cattle in Uganda. However, these results cannot
be generalised. Future studies involving large numbers of cattle and from different
geographical and husbandry practices would need to be investigated.
It is known that cattle are frequently co-infected with multiple serogroups of STEC
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(Beutin et al. 1997; Pradel et al. 2000; Pearce et al. 2004). Unsurprisingly,
some bovines (Bb1, Bb8, Bb10 and Bb14) excreted two or more serotypes of STEC.
Results from a study in Scotland showed that some cattle shed several serotypes
(O26/O145 or O26/O103/O157) (Pearce et al. 2004), indicating that different
serogroups of STEC can co-exist within the intestinal tract of bovines. Of course,
co-existing serogroups may vary depending on the prevalent serogroups within an
ecological niche.
That STEC serogroups O8, O20, O76, O111 and O113, known to cause bloody di-
arrhoea and HUS in humans (http://www.microbionet.com.au/vtectable.htm) were
shed by cattle in the pastoralist community suggests that humans within the com-
munity are at risk of infection with STEC belonging to pathogenic serogroups.
Clinical isolates belonging to 15 serogroups were isolated indicating the existence of
diverse STEC serogroups from children with diarrhoea in Nyabushozi. Interestingly,
three of these: O29, O149 and O176 have not been previously described in humans.
This shows the capability of diverse serogroups of STEC to colonise the human
intestinal tract. Further, the isolation of novel STEC serogroups accords with the
findings of Beutin et al. (2004), who observed that more human STEC strains remain
to be identified. As the children infected with these serogroups were from phase 2 it
is perhaps not surprising that their equivalents were not obtained from the bovines.
In this context, STEC O176 has been isolated only from water buffaloes in Brazil
(Oliveira et al. 2007); however, there are no water buffaloes in Nyabushozi county.
Nonetheless, cattle remain the likely source of most of the clinical STEC, although
this was not demonstrated.
Eight of the serogroups from children: O8, O74, O76, O78, O107, O111, O113 and
O166 have been implicated as human pathogens (Beutin et al. 1998,2004; Keskima¨ki
et al. 1998; Welinder-Olsson et al. 2002; Bettelheim, 2003; Blanco et al. 2003a;
Ratchtrachenchai et al. 2004; Karch et al. 2005; Tarr et al. 2005; Manning et
al. 2007). Of these, O76 from Hh2 is genetically related to the corresponding
serotype from Bb3 and Bb12, while O113 from Hh4 is similarly related to O113
and O107 strains from Bb7 and Bb8ii, respectively (Figure 3.9 and Figure 4.1).
One group, STEC O166, associated with human infection in Germany (Beutin et
al. 2004), was also isolated from a child and water in Nyabushozi. Although STEC
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O166 had not been isolated previously from water (http://www.lugo.usc.es/ecoli/;
http://www.microbionet.com.au/vtectable.htm), the fact that these STEC can sur-
vive in an aquatic environment indicates the potential health hazard of STEC-
contaminated water. It is noteworthy that, although the STEC strains from the
different sources were not genetically related, water samples and faeces from the
O166 infected child were obtained during the same sampling period. Serogroup
O142 is believed to have emerged recently (Todd et al. 1999; Arthur et al. 2002).
Interestingly, this serogroup was the most frequently identified group in the phase 2
children, suggesting that O142 STEC are able to thrive and proliferate within the
intestinal tracts of children in Nyabushozi. In general, the diversity of serogroups
displayed by the clinical STEC in Nyabushozi is comparable to diverse serotypes
reported in sporadic infections in other countries (Beutin et al. 1998; Eklund et
al. 2001; Blanco et al. 2004a). For example, in Spain, 126 isolates belonged to 41
O serogroups (Blanco et al. 2004a), 56 isolates from Thailand segregated into 20
O serogroups (Eklund et al. 2001) and 89 STEC from Germany belonged to 15 O
serogroups (Beutin et al. 1998).
There is a clear distinction between serogroups of STEC collected 12-15 months
apart, in phases 1 and 2. None of the serogroups isolated from phase 1 were identified
in phase 2 and vice versa. Importantly, none of the children sampled in phase 2
were from the same homestead as both the children in phase 1 and the bovines,
although they were from the same locality. These differences in the serogroups may
be linked to the complex cattle-human-STEC dynamics in the ecosystem. This
probably indicates that different populations of STEC were sampled in phase 1 and
phase 2. Additionally, factors including high cattle population turn-over, changes in
diet (Djordjevic et al. 2004; Pearce et al. 2004; Geue et al. 2006), the host immune
response (Beutin et al. 1998) and seasonal human-cattle migration across the cattle
corridor in Nyabushozi, which disrupt the stability of the ecosystem, would also alter
the STEC population and the serogroups involved.
Simultaneous human infection with multiple serogroups of STEC has previously been
reported in several countries including the USA (Gilmour et al. 2007b), Thailand
(Leelaporn et al. 2003) and India (Khan et al. 2002b). Similarly, each of two children
were co-infected with serogroups O107/O113 or O111/NT. Additionally, two other
children were each co-infected with different strains of the same serogroup. Since
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the serogroup of one of the strains from Hh16 is unknown, it is possible that this
child was infected with strains belonging to more than one serogroup.
STEC within serogroups O8, O76 and O113 were clonally related (Figure 4.1), al-
though within each serogroup one or more clones were distinct. While all clones
within serogroups O142 or O166 were unrelated. These observations were unex-
pected, as previous studies have described unrelated and related clones of STEC
within various serogroups (Geue et al.; Vaz et al. 2006). Recent studies have
described the occurrence of genetically related STEC belonging to different O
serogroups such as O22/O128 and O117/O128 (Urdahl et al. (2003). In agree-
ment with these findings, related STEC of serogroups O22/O113 or O107/O113
were observed in my study, suggesting that these could have emerged from antigenic
shift and switching of their O antigens. Previous studies suggested that antigenic
shift resulted in the emergence of STEC O111 from STEC O26 (Feng et al. 1998;
Whittam et al. 1993; Donnenberg and Whittam, 2001).
In conclusion, STEC from children and bovines in Nyabushozi belong to diverse
serogroups. While a number of cattle excreted serogroups associated with severe
human illnesses, children were infected by both pathogenic serogroups and previously
unknown humans STEC serogroups. Both unrelated and closely related clones of
STEC were isolated from various serogroups.
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Production of Stx, variants of stx2
and eae genes of STEC strains
5.1 Introduction
To gain deeper understanding of the virulence of STEC strains described in Chapter
4, the presence of stx2 variants and eae genes was examined. Clearly, the carriage
of stx genes is fundamental to the pathogenesis of EHEC-associated human disease
(Thorpe, 2004; Kaper et al. 2004). The two major bacteriophage-borne stx1 and
stx2 genes (Karch et al. 2005; Beutin et al. 2004) may be present alone, or in
combination (Karch et al. 2005). STEC that elaborate Stx2 only are more virulent
than STEC that produce Stx1 alone or both toxins (Boerlin et al. 1999); however,
strains elaborating only Stx1 or both Stx are equally virulent (Friedrich et al. 2002).
While Stx1 is more conserved, greater amino acid variation in Stx2 is associated
with proteins of different toxicity profiles in cultured cells or/and animals (Paton
et al. 1995; Melton-Celsa et al. 1996,2002; Pierard et al. 1998). Clinical and
epidemiological studies have implicated stx2−EDL993 and stx2c in most cases of bloody
diarrhoea and HUS, whereas the activatable stx2d genes (stx2d−1 and stx2d−2 are
associated with mild to severe diarrhoea (Friedrich et al. 2002). The different
subtypes of stx2 were described in detail in Chapter 1.
Besides stx, EHEC contain a pathogenicity island LEE (Willshaw et al. 1985;
Schmidt et al. 1994), which supports eae, the gene encoding adhesion to, and effacing
of, the intestinal mucosal surface (Sherman et al. 1988; Jerse et al. 1990). While
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the 3’-end of eae is conserved the 5’-end is heterogenous as a result of recombination
events, involving foreign DNA, in this region (McGraw et al. 1999), also called Int280
(Adu-Bobie et al. 1998b; Frankel et al. 2001; Zhang et al. 2002b; Ramachandran et
al. 2003). To date 18 distinct genes (α1, α2, β1, β2, ξ or β2B, δ(κ,β2O), γ1, γ2(θ),
ε1, ε2(νR), ζ, ι1, ι2(µR), λ, µB, νB, ξB and ρ) have been described (Adu-Bobie et
al. 1998a; Oswald et al. 2000; Tarr and Whittam, 2002; Zhang 2002b; Jenkins et al.
2003a; Ramachandran et al. 2003; Blanco et al. 2004b; Mora et al. 2007; Cookson
et al. 2007).
This chapter describes studies related to the production of Stx in STEC, and the
identification of variants of stx2 and eae genes carried by the strains.
5.2 Experimental design
5.2.1 Bacterial strains
A total of 54 STEC strains which are described in Chapter 4 were investigated.
These included 25, 24 and 5 strains from children, bovines and water, respectively.
STEC O157:H7 and E. coli K-12 were used as control strains, where necessary.
5.2.2 Shiga toxin production
Duopath Verotoxin detection kit (Merck KgaA, Darmstadt, Germany) was used
according to the instruction manual to detect the production of Stx1 and Stx2.
Minimal measurable quantities of Stx in amounts of 25ηg/ml and 62.5 ηg/ml for
Stx1 and Stx2, respectively, were detected.
5.2.3 Detection of virulence genes by PCR amplification
5.2.3.1 PCR amplifications and detection of stx2 variants
Primers designed to detect 8 stx2 variants (Table 5.1) were used to amplify the stx
genes according to the PCR amplification parameters presented in Table 5.1. PCR
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conditions were identical to those for the previous amplification of stx [2.2.14.1],
except for time and temperature (Table 5.1).
Table 5.1: Primers and PCR amplification conditions for
the detection of variants of stx2 gene
Primer stx2 Primer (5
′ → 3′) Product PCR cycle Reference
sequence size (bp) conditions*
stv1F stx2c, TCGAATCCAGTACAACG 1379 94
oC, 60 s; This
stv1R stx2d−1, ACATACCACGAATCAGG 57oC, 60 s; study
stx2d−2, 72oC, 90 s
stx2g,
stx2−O48,
stx2−OX3b,
stx2−EDL993
stv1F stx2−vhc TCGAATCCAGTACAACG 1366 94oC, 60 s; This
stv3R ATCCGGTTATGCCTCAG 55oC, 60 s; study
72oC, 90 s
*Extension at 72 ◦C for 5 min completed the amplification process.
5.2.3.2 PCR amplifications and detection of eae and variants of eae
genes
The presence of eae gene was detected using one of the 3 primers UF/UR (Mora
et al. 2007), lpF/lpR (Cookson et al. 2007) or orfU/escD (Oswald et al. 2000)
and conditions as shown in Table 5.2. While primers UF/UR (Mora et al. 2007)
and lpF/lpR (Cookson et al. 2007) targeted the conserved 3’end of the eae gene,
orfU/escD (Oswald et al. 2000) was used to amplify the entire structural gene.
Six eae subtypes α1, α2, β1, β2B/ξ, γ1 and γ2/θ were amplified using primers
and conditions shown in Table 5.2. All eae amplification reactions included magne-
sium chloride at a concentration of 1.75mM rather than 1.5mM, used in other PCR
reactions.
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Table 5.2: Primers and PCR amplification conditions for
the detection of eae and variants of eae genes
Primer eae Primer (5′ → 3′) Product PCR cycle Reference
gene sequence size (bp) conditions*
UF eaea GGAACGGCAGAGGTTAATCTGCAG346 94oC, 55s; Mora
UR GGCGCTCATCATAGTCTTTC 55oC, 60s; et al.
72oC, 60s. (2007)
lpF eaea GATTCAAAACTGTTAACTCA 1848 94oC, 60s; Cookson
lpR AGCCTTAATCTCAGTAATGCT 55oC, 60s; et al.
72oC, 120s. (2007)
orfU eaeb TATGATGATCTATGGCGTCTGT 3.7 Kb 94oC, 30 s, Oswald
escD TATTTTCAAAAAGAATGATGTC 48 oC, 60s; et al.
72oC, 120s. 2000
α1F α1 AAAACCGCGGAGATGACTTC 820 94oC, 60s; Blanco
α1R CACTCTTCGCATCTTGAGCT 60oC, 60s; et al.
72oC, 60s. (2004c)
α2F α2 AGACCTTAGGTACATTAAGTAAGC 517 94oC, 60s; Blanco
α2R TCCTGAGAAGAGGGTAATC 60oC, 60s; et al.
72oC, 60 s (2004c)
β1F β1 ACTTCGCCACTTAATGCCAGC 730 94oC, 60s; Blanco
β1R TTGCAGCACCCCATGTTGAAT 65oC, 60s; et al.
72oC, 60s. (2004c)
β2F β2B/AAGGGGGGAACCCCTGTGTCA 604 94oC, 60s; Blanco
β2R ξ ATTTATTCGCAGCCCCCCACG 62oC, 60s; et al.
72oC, 60s. (2004c)
γ1F γ1 AAAACCGCGGAGATGACTTC 804 94oC, 60s; Blanco
γ1R AGAACGCTGCTCACTAGATGTC 63oC, 60s; et al.
72oC, 60s. (2004c)
γ2F γ2/ AGAACGTTACTGGTGACTTA 414 94oC, 60s; Blanco
γ2R θ CTGATATTTTATCAGCTTCA 50oC, 60s; et al.
72oC, 60s. (2004c)
*Extension at 72 ◦C for 5 min completed the amplification process.
aPrimers targeted a portion of the conserved 3’-end of the gene
bPrimers targeted the structural gene
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5.2.3.3 Optimisation and identification of eae gene variant for use as a
control
Despite the authors’s best efforts to obtain control strains, none were forthcoming.
Therefore, the eae gene of STEC O157:H7, used in the diagnostic laboratory as
a control for serotyping putative O157:H7 strains, was characterised for use as a
control. PCR eae-related products were not obtained using primers for the detection
of 6 eae subtypes α1, α2, β1, β2B/ξ, γ1 and γ2/θ as shown in (Table 5.2). However,
using PCR-RFLP the eae gene in this strain was identified as eae-γ1 [5.3.4.1].
Since eae is frequently prevalent in EHEC O111, PCR amplifications were carried
from O111 from Bb1i as template. Amplicons were obtained only with γ2F/γ2R
(Blanco et al. 2004c), indicating the presence of eae-γ2/θ. The amplicon was purified
[2.2.14.3] and sequenced [2.2.14.4]. Analysis of the sequencing data confirmed the
PCR product as a portion of eae-γ2/θ. Hereafter, serogroup O111 from Bb1i was
used as positive control strain for the detection of eae-γ2/θ.
5.2.4 PCR-Restriction fragment length polymorphism
(PCR-RFLP)
PCR amplification was carried out using primers lpF/lpR (Cookson et al. 2007)
and amplification conditions shown in Table 5.2. The pair of primers delineated a
fragment of 1848 bp and RFLP analysis of the fragments (Jenkins et al. 2003a;
Cookson et al. 2007) was used to identify the eae types.
Between 200-400 ηg of the PCR product was digested with 5U of HaeIII or HhaI in
separate experiments in the recommended buffer (New England Biolabs, Cape Town
South Africa), at 37oC for 3 hours. Electrophoresis was carried out as previously
described using 2.5% agarose gel [2.2.14.2]. Digital images were captured and stored
[2.2.14.2]. The patterns generated were compared with the sequences of 18 intimin
subtypes obtained from the Genbank (http://www.ncbi.nlm.nih.gov/) and aligned
using DNAMAN (Lynnon Biosoft v4.0.0.1) sequence alignment editor. The HhaI
and HaeIII RFLP patterns for the different eae types were predicted from restriction
fragments of the corresponding 1848bp nucleotide sequences (Jenkins et al. 2003;
Cookson et al. 2007) generated by DNAMAN (Appendix E).
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5.2.5 Southern hybridisation
Where necessary Southern hybridisation was carried out (Southern, 1975). All proto-
cols, buffers, and reagents used were according to the instruction manual (Amersham
International).
DNA probes were prepared by PCR and labeled DNA probes were labeled using
the ECLr direct nucleic acid labeling and detection systems kit (Amersham In-
ternational). Pre-hybridisation was carried out at 42oC for one hour, followed by
hybridisation at 42 ◦C with 50% formamide (14-16 hours) and subsequent washes
at 55oC, according to the instruction manual. Hybridisation was detected using
alkalinephosphatase-labeled anti-digoxigenin monoclonal antibody with the ECLTM
direct nucleic acid labeling and detection systems (Amersham International).
5.3 Results
5.3.1 Production of Stx protein by clinical STEC strains
The production of Stx was investigated using Duopath Verotoxin detection kits
(Merck KgaA, Darmstadt, Germany) [5.2.2]. The minimal detectable quantities for
Stx1 and Stx2 of 25ηg/ml and 62.5ηg/ml, respectively were recorded. Expression of
Stx1 and Stx2 was detected in O157:H7. As expected, no expression was detected
from E. coli K-12.
Of the 25 STEC strains from children, Stx1 or Stx2 or both Stx were produced
in 21 isolates (Table 5.3). In addition, expression of Stx1 was detected in 7 of 10
strains containing only stx1 and in all of the STEC (6 strains) containing this gene in
combination with stx2 (Table 5.3). Stx2 expression was detected in 13 of 15 STEC
strains carrying stx2, including 7 of 8 strains containing this gene alone (Table 5.3).
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Table 5.3: Stx production by clinical STEC strains
Detected Detected
Child Sero stx Stx Child Sero stx Stx
group 1 2 1 2 group 1 2 1 2
Hh1 O74 + + + + Hh11 O141 - + - +
Hh2 O76 + + + + Hh12 O166 + - + -
Hh3/1 O22 - + - + Hh13i NT + - + -
Hh3/2 O113 + + + + Hh13ii O111 + - + -
Hh4i O113 + - - - Hh14i NT + - + -
Hh4ii O107 + - - - Hh14ii NT + - + -
Hh4iii O107 + - - - Hh15i O142 + + + +
Hh5 O78 + + + + Hh15ii O142 + + + +
Hh6 NT - + + Hh16i O176 - + - -
Hh7 O8 - + - + Hh16ii NK - + - +
Hh8 O149 + - + - Hh17 O169 - + - +
Hh9 NT + - + - Hh18 O142 + + + -
Hh10 O29 - + - +
stx, Shiga toxin gene detected by PCR; NK, serogroup unknown
Stx, Shiga toxin detected using Duopath Verotoxin detection kit
5.3.2 Stx production by STEC strains from the bovines and
water
A similar approach [5.3.1] was used to investigate Stx expression in STEC from the
bovines and water. The results are presented in Table 5.4. Nineteen of 24 bovine
STEC produced Stx1 or Stx2 or both toxins (Table 5.4). Expression of Stx1 and
Stx2 was detected in 7 of 9 strains containing both stx genes (Table 5.4). While
expression of the respective toxin was detected in 9 of 12 strains containing stx1 and
in two of the three strains with stx2 (Table 5.4). Similarly, toxin expression was
detected in 2 of the 5 STEC strains from water (Table 5.4).
90
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
Chapter 5 Production of Stx, variants of stx2 and eae genes of STEC strains
Table 5.4: Stx production by STEC strains from the
bovines and water
Detected Detected
Bovine Sero stx Stx Bovine Sero stx Stx
group 1 2 1 2 Bovine group 1 2 1 2
Bb1i O111 + + + + Bb11 O142 + - + -
Bb1ii Poly9 - + - + Bb12 O76 + - + -
Bb2 NT + - + - Bb13 NT + - + -
Bb3 O76 + + + + Bb14i NT + - - -
Bb4 O28ac + + + + Bb14ii O158 + - - -
Bb5 O8 + + + + Bb14iii O76 + + + +
Bb6/1 O8 + + + + Bb14iv O142 + - - -
Bb6/2 O8 - + - + Bb15i O76 + - + -
Bb7a O113 + + + - Bb15ii O76 + - + -
Bb7b O113 + + + +
Bb8i O8 + + - - Ww1 O166 - + - +
Bb8ii O107 - + - - Ww2i O166 - + - -
Bb9 O113 + - + - Ww2ii O166 - + - +
Bb10i NT + - + - Ww2iii NK + - - -
Bb10ii O20 + - + - Ww3 NT + - - -
stx, Shiga toxin gene detected by PCR; NK, serogroup unknown
Stx, Shiga toxin detected using Duopath Verotoxin detection kit
Bb, bovine strains; Ww, water strains; Bb7a, SF−; Bb7b, SF+ strains
5.3.3 Characterisation of stx2 genes
Certain stx2 variants are associated with severe sequelae following infection with
STEC; thus, the identities of the stx2 genes were more precisely determined. PCR
assays were carried out with DNA released by CTAB method [2.2.13]. Amplification
conditions and the primers used are shown in Table 5.1.
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5.3.3.1 stx2 variants in clinical STEC
An amplification product of 1379 bp with primers stv1F/stv1R was obtained from
O157:H7 suggesting one of a number of variants in O157:H7 (Table 5.1). Using
primers stv1F/stv3R a 1366 bp amplicon was obtained from STEC O111, suggestive
of stx2−vhc (Table 5.1). As expected, no PCR product was obtained with E. coli K-
12.
Fifteen clinical strains contained either stx2 alone or in combination with stx1. Ap-
propriately sized amplicons were obtained with primers stv1F/stv3R with 8 STEC
from Hh1, Hh2, Hh3/1, Hh3/2, Hh5, Hh6, Hh7 and Hh11, indicating stx2−vhc in these
strains (Table 5.5). All the amplicons were sequenced and confirmed as stx2−vhc.
Table 5.5: stx1 and variants of stx2 carried by clinical
STEC strains
Detected stx genes Detected stx genes
Child stx2 variant stx1 Child stx2 variant stx1
Hh1 stx2−vhc + Hh11 stx2−vhc -
Hh2 stx2−vhc, stx2d−2 + Hh12 - +
Hh3/1 stx2−vhc - Hh13i - +
Hh3/2 stx2−vhc + Hh13ii - +
Hh4i - + Hh14i - +
Hh4ii - + Hh14ii - +
Hh4iii - + Hh15i stx2−EDL993 +
Hh5 stx2−EDL993, stx2−vhc - Hh15ii stx2c +
Hh6 stx2−vhc - Hh16i stx2d−2 -
Hh7 stx2−EDL993,stx2−vhc - Hh16ii stx2d−2 -
Hh8 - + Hh17 stx2c -
Hh9 - + Hh18 stx2c +
Hh10 stx2−EDL993 -
+, gene detected; -, gene not detected
Products were obtained from 10 STEC using primers stv1F/stv1R. As these primers
are not variant specific it was necessary to sequence the amplicons to ascertain their
identities. Analysis of the sequencing data identified 4 amplicons as stx2−EDL993 and
3 amplicons each as stx2c and stx2−d2 (Table 5.5).
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In summary, stx2−vhc was the commonest variant identified (8 strains) and 3 STEC
from Hh2, Hh5 and Hh7 contained 2 stx2 variants (Table 5.5). Additionally, the
STEC from 6 children (Hh1, Hh2, Hh3, Hh5, Hh15 and Hh18) carried stx1 (Table
5.5).
5.3.3.2 stx2 gene variants in STEC from bovines and water
Using a similar approach [5.3.3], variants of stx2 were determined in the bovine and
water STEC strains.
Twelve of the 24 bovine strains carried stx2 alone or in combination with stx1. Using
primers stv1F/stv1R amplicons of the expected sizes were obtained from 10 bovine
isolates. Sequencing of the amplicons identified them as stx2−d2 (7 amplicons) and
stx2−EDL993 (3 amplicons) as shown (Table 5.6).
Table 5.6: stx1 and variants of stx2 in STEC strains from
the bovines and water
Detected stx genes Detected stx genes
Bovine stx2 variant stx1 Bovine/water stx2 variant stx1
Bb1i stx2−EDL993, stx2−vhc + Bb11 - +
Bb1ii stx2−vhc - Bb12 - +
Bb2 - + Bb13 - +
Bb3 stx2−EDL993, stx2−vhc + Bb14i - +
Bb4 stx2d−2, stx2−vhc + Bb14ii - +
Bb5 stx2d−2, stx2−vhc + Bb14iii stx2d−2 +
Bb6/1 stx2d−2, stx2−vhc + Bb14iv - +
Bb6/2 stx2−EDL993 - Bb15i - +
Bb7a stx2d−2 + Bb15ii - +
Bb7b stx2d−2, stx2−vhc +
Bb8i stx2d−2 + Ww1 stx2−vhc -
Bb8ii stx2−vhc - Ww2i stx2−vhc -
Bb9 - + Ww2ii stx2−vhc -
Bb10i - + Ww2iii stx2−vhc -
Bb10ii - + Ww3 +
Bb, STEC from the bovines; Ww, STEC from water
Bb7a, SF−; Bb7b, SF+ strains; +, gene detected; -, gene not detected
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When primers stv1F/stv3R were included in the reaction, amplicons were obtained
from 8 STEC, indicating the presence of stx2−vhc in these strains, which was con-
firmed by sequencing.
In summary, STEC containing stx2−vhc alone (2 strains) or in combination with other
variants, primarily stx2−d2, were most common in the bovine STEC. Additionally,
all except 3 of the strains, from Bb1ii, Bb6/2 and Bb8ii, contained stx1 (Table 5.6).
With respect to the 4 water STEC isolates: amplicons were obtained only with
primers stv1F/stv3R, indicating the presence of stx2−vhc which was confirmed by
sequencing (Table 5.6).
5.3.4 Detection and characterisation of eae genes
As a first step to understanding the eae gene content of the STEC, PCR assays
[5.2.3.2] were carried out to detect this gene using universal primers UF/UR (Mora et
al. 2007) (Table 5.2). Subsequently, eae types were determined using combinations
of PCR and hybridization studies [5.2.5], and PCR-RFLP investigations [5.2.4].
5.3.4.1 eae genes in clinical STEC
Using universal primers UF/UR (Mora et al. 2007) (Table 5.2) PCR products of
anticipated size (346 bp) were obtained with strains from 6 of 10 children represent-
ing phase 1, and 9 of 15 children from phase 2 (Table 5.7). An appropriately sized
product was obtained with O157:H7, no PCR product was obtained with E. coli
K-12.
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Table 5.7: eae-containing clinical isolates from phases 1
and 2
Phase 1 Phase 2
Child eae gene Child eae gene Child eae gene
Hh1 - Hh8 - Hh15ii +
Hh2 + Hh9 + Hh16i -
Hh3/1 + Hh10 - Hh16ii -
Hh3/2 + Hh11 - Hh17 -
Hh4i + Hh12 + Hh18 +
Hh4ii - Hh13i +
Hh4iii - Hh13ii +
Hh5 + Hh14i +
Hh6 + Hh14ii +
Hh7 - Hh15i +
+, eae gene detected; -, no eae gene detected
To further characterise the eae genes of the 6 STEC from phase 1, PCR assays were
carried out using sets of primers for the detection of variants α1, α2, β1, β2B/ξ, γ1
and γ2/θ (Table 5.2). Products were not obtained with E. coli K-12. As expected,
using γ2F/γ2R (Blanco et al. 2004c), for the detection of γ2/θ, products were
obtained with O111 from Bb1 [5.2.3.2]. These primers (γ2F/γ2R) were extended in
4 of the 6 STEC, indicating eae-γ2/θ in strains from Hh2, Hh3/1, Hh3/2 and Hh6
(Table 5.8).
Table 5.8: eae genes in clinical STEC from phase 1
Child Serogroup eae gene Child Serogroup eae gene
Hh1 O74 - Hh4ii O107 -
Hh2 O76 γ2/θ Hh4iii O107 -
Hh3/1 O22 γ2/θ Hh5 O78 eae*
Hh3/2 O113 γ2/θ Hh6 NT γ2/θ
Hh4i O113 eae* Hh7 O8 -
eae*, unknown eae gene type; -, eae was not detected
To confirm the identification of the products from the clinical isolates hybridisation
studies [5.2.5] were carried out using the PCR product from O111 (Bb1i), which was
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identified as eae-γ2/θ by DNA sequencing, as a probe [5.2.5]. Further, hybridisation
studies were possible because there is only a 65% nucleotide similarity between eae-
γ2/θ and the corresponding regions of the other variants. The probe hybridised to
each of the products from 4 STEC, confirming eae-γ2/θ in these strains (Table 5.8
and Figure 5.1).
Figure 5.1: Identification of eae-γ2/θ in clinical STEC (phase 1).
A: Agarose gel electrophoresis following PCR using primers for the detection of
eae-γ2/θ. The presence of eae-γ2/θ is indicated by the presence of 414bp fragments.
STEC O111 was included as a positive control. Lane 1, O111; lanes 2 and 10,
HyperLadder I (Bioline); lane 3, no DNA; lane 4, Hh2; lane 5, Hh3/1; lane 6,
Hh3/2; lane 7, Hh4i; lane 8, Hh5; lane 9, Hh6.
B: Autoradiograph of DNA shown in A probed with a portion of eae-γ2/θ prepared
from O111. Lane 1, O111; lanes 2, 3, 10, no DNA; lane 4, Hh2; lane 5, Hh3/1; lane
6, Hh3/2; lane 7, Hh4i; lane 8, Hh5; lane 9, Hh6.
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PCR-RFLP was used to characterise the eae genes of the 9 eae-positive clinical
STEC (phase 2) and the corresponding genes from the 2 STEC (phase 1) which
were not identified in the previous experiments. Using primers lpF/lpR (Cookson
et al. 2007)(Table 5.2) products of the expected size (1848 bp) were obtained with
STEC O157:H7.
Figure 5.2: HhaI and HaeIII restriction patterns of 1848 bp PCR product from
O157:H7.
A: Restriction digest with HhaI. Lane 1, HyperLadder IV (Bioline); lane 2, 1848
bp fragment from O157:H7. The DNA fragments 72 168 230 408 429 483 bp are
consistent with eae-γ1.
B: Restriction digest with HaeIII. Lane 1, 1848 bp fragment from O157:H7; lane 2,
HyperLadder I (Bioline). The DNA fragments 23 163 303 1359 bp are consistent
with eae-γ1.
The amplicons were digested with HhaI or HaeIII in separate experiments. The
subsequent restriction patterns were compared with those of known eae-types (Ap-
pendix E). The HhaI and HaeIII patterns of the amplicons from O157:H7 were
consistent with those of eae γ1 (Figure 5.2, Table 5.9).
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Similarly, the HhaI and HaeIII patterns of the amplicons from STEC O111 (B1i)
were consistent with those of eae γ2/θ (Figure 5.3, Table 5.9).
Figure 5.3: HhaI and HaeIII restriction patterns of 1848 bp PCR product from
STEC O111 (Bb1i).
A: Restriction digest with HhaI. Lane 1, HyperLadder IV (Bioline); lane 2, 1848 bp
fragment from STEC O111. The DNA fragments 62 168 205 224 230 476 483 bp
are consistent with eae-γ2/θ.
B: Restriction digest with HaeIII. Lane 1, 1848 bp fragment from O111; lane 2,
HyperLadder I (Bioline). The DNA fragments 23 105 173 188 1359 bp are consistent
with eae-γ2/θ.
Products were obtained with each of the 9 clinical STEC from phase 2, and with the
2 STEC from phase 1. The restriction patterns of the 9 clinical STEC from phase 2
are presented in Figure 5.4, Table 5.9.
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Figure 5.4: RFLP of HhaI and HaeIII digests of PCR products from 9 STEC (phase
2).
1A: HhaI; 1B: HaeIII. Lane 1, HyperLadder IV (Bioline) (1A) or HyperLadder I
(Bioline) (1B); lane 2, Hh13i; lane 3, Hh13ii. RFLPs are consistent with eae-β1.
2A: HhaI; 2B: HaeIII. Lanes 1, 8, HyperLadder IV (Bioline) (2A) or HyperLadder
I (Bioline) (2B); lane 2, Hh12; lane 3, Hh14i; lane 4, Hh14ii; lane 5, Hh15i; lane 6,
Hh15ii; lane 7, Hh18. RFLPs are consistent with eae-κ.
3A: HhaI; 3B: HaeIII. Lane 1, HyperLadder IV (Bioline) (3A) or HyperLadder I
(Bioline) (3B); lane 2, Hh9. RFLPs are consistent with eae-µ.
Table 5.9: HhaI and HaeIII digests of 1848 bp portions
of selected eae genes
eae Accession no. HhaI HaeIII
γ1 AF081185 62 72 168 230 404 429 483 23 163 303 1359
γ2/ AF449420/ 62 168 205 224 230 476 483 23 105 173 188 1359
θ AF025311
β1 AF453441 48 49 62 72 78 205 230 354 357 392 22 30 75 172 361 1187
κ/ AJ308552/ 63 72 168 230 341 429 545 23 83 163 303 399 877
δ AJ875027
µ AJ705049 63 72 168 230 341 429 545 23 83 147 156 163 399 877
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Additionally, the HhaI and HaeIII patterns of the amplicons from 2 STEC (phase
1) identified them as eae-β1.
5.3.4.2 eae genes in STEC from water and bovines
Using the approach [5.3.4.1] to identify eae types in STEC from phase 2 children,
PCR products were obtained in 3 of the 5 STEC from water, with primers UF/UR
(Mora et al. 2007) and with 2 of these STEC using lpF/lpR (Cookson et al. 2007).
The HhaI and HaeIII RFLPs of the lpF/lpR (Cookson et al. 2007) generated 1848
bp product were consistent with those of eae-β1 (Table 5.10).
Using primers orfU and escD (Oswald et al. 2000) that anneal to sequences flanking
eae (Table 5.2), no PCR product was obtained with the remaining eae-positive
strain. The eae in this strain from Ww2iii was recorded as untypeable (Table 5.10).
Table 5.10: Detection of eae in bovine and water STEC
strains
Bovine eae gene Bovine eae gene Bovine/water eae gene
Bb1i γ2/θ Bb8i - Bb14iii γ2/θ
Bb1ii γ2/θ Bb8ii - Bb14iv γ2/θ
Bb2 γ2/θ Bb9 γ2/θ Bb15i β1
Bb3 - Bb10i - Bb15ii γ2/θ
Bb4 γ2/θ Bb10ii -
Bb5 γ2/θ Bb11 - Ww1 β1
Bb6/1 eae Bb12 γ2/θ Ww2i β1
Bb6/2 - Bb13 - Ww2ii -
Bb7a - Bb14i - Ww2iii eae
Bb7b γ2/θ Bb14ii γ2/θ Ww3 -
Bb, bovine; Ww, water; eae, untypeable eae type; -, no eae detected
Bb7.1a (SF+) and Bb7.2b(SF−) strains
Twenty four STEC were isolated from 15 bovines. Primers UF/UR (Table 5.2)
detected eae in 14 strains. Using primers specific for variants α1, α2, β1, β2B/ξ, γ1
and γ2/θ products (414 bp) were obtained from 12 strains, suggesting the presence
of γ2/θ in these strains. As in the previous study [5.3.4.1] the PCR products were
hybridised to a γ2/θ probe prepared from O111 (Bb1i) [5.2.5].
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A signal was obtained with each of the products, confirming the presence of γ2/θ in
the 12 strains (Table 5.10, Figure 5.5).
Figure 5.5: Identification of eae-γ2/θ in bovine STEC.
A: Agarose gel electrophoresis following PCR using primers for detection of eae-
γ2/θ. The presence of eae-γ2/θ is indicated by the presence of 414bp fragments.
STEC O111 was included as positive control strain. Lane 1, STEC O111; lane 2,
blank; lane 3, no DNA; lane 4, Bb1ii; lane 5, Bb2; lane 6, Bb4; lane 7, Bb5; lane 8,
Bb6/1; lane 9, Bb7b; lane 10, Bb9; lane 11, Bb12; lane 12, Bb14ii; lane 13, Bb14iii;
lane 14, Bb14iv; lane 15, Bb15i; lane 16, Bb15ii; lane 17, HyperLadder I (Bioline).
B: Autoradiograph of DNA shown in A probed with a portion of eae-γ2/θ prepared
from O111. Lane 1, Bb1i-O111; lanes 2, 3, 17, no DNA; lane 4, Bb1i; lane 5,
Bb2; lane 6, Bb4; lane 7, Bb5; lane 8, Bb6/1; lane 9, Bb7b; lane 10, Bb9; lane 11,
Bb12; lane 12, Bb14ii; lane 13, 14.3; lane 14, Bb14iv; lane 15, Bb15i; lane 16, Bb15ii.
The eae genes of unknown type from the 2 bovine STEC (Bb6/1 and Bb15i) were
characterised further using PCR-RFLP [5.3.4.1]. A PCR product was obtained with
only one of the 2 STEC with primers lpF/lpR (Table 5.2). Restriction digest of
the 1848 bp with HhaI and HaeIII generated patterns consistent with eae-β1 (Table
5.10).
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Using primers orfU and escD (Table 5.2), no PCR product was obtained with the
remaining eae-positive strain (Bb6/1), which was recorded as untypeable eae (Table
5.10).
5.3.5 Profiles of STEC
The data with respect to virulence markers, expression of Stx and serogroups of
STEC was collated and their profiles are presented in Table 5.11 and Table 5.12.
Table 5.11: Presence and expression of stx genes and
carriage of eae genes by clinical STEC
Detected virulence marker
Child Serogroup stx2 type Stx2 stx1 Stx1 eae
Hh1 O74 stx2−vhc + + + -
Hh2 O76 stx2−vhc, stx2d−2 + + + γ2/θ
Hh3/1 O22 stx2−vhc + - - γ2/θ
Hh3/2 O113 stx2−vhc + + + γ2/θ
Hh4i O113 - - + - β1
Hh4ii O107 - - + - -
Hh4iii O107 - - + - -
Hh5 O78 stx2−EDL993, stx2−vhc + + + β1
Hh6 NT stx2−vhc + - - γ2/θ
Hh7 O8 stx2−EDL993,stx2−vhc + - - -
Hh8 O149 - - + + -
Hh9 NT - - + + µ
Hh10 O29 stx2−EDL993 + - - -
Hh11 O141 stx2−vhc + - - -
Hh12 O166 - - + + κ/δ
Hh13i NT - - + + β1
Hh13ii O111 - - + + β1
Hh14i NT - - + + κ/δ
Hh14ii NT - - + + κ/δ
Hh15i O142 stx2−EDL993 + + + κ/δ
Hh15ii O142 stx2c + + + κ/δ
Hh16i O176 stx2d−2 - - - -
Hh16ii NK stx2d−2 + - - -
Hh17 O169 stx2c + - - -
Hh18 O142 stx2c - + + κ/δ
NK, serogroup not established; Stx1, Shiga toxin 1; Stx2, Shiga toxin 2
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Table 5.12: Presence and expression of stx genes and
carriage of eae genes in bovine and water STEC
Detected virulence marker
Bovine/water Serogroup stx2 type Stx2 stx1 Stx1 eae
Bb1i O111 stx2−EDL993, stx2−vhc + + + γ2/θ
Bb1ii Poly9 stx2−vhc + - - γ2/θ
Bb2 NT - + + γ2/θ
Bb3 O76 stx2−EDL993, stx2−vhc + + + -
Bb4 O28ac stx2d−2, stx2−vhc + + + γ2/θ
Bb5 O8 stx2d−2, stx2−vhc + + + γ2/θ
Bb6/1 O8 stx2d−2, stx2−vhc + + + eae*
Bb6/2 O8 stx2−EDL993 + - - -
Bb7a O113 stx2d−2 - + + -
Bb7b O113 stx2d−2, stx2−vhc + + + γ2/θ
Bb8i O8 stx2d−2 - + - -
Bb8ii O107 stx2−vhc - - - -
Bb9 O113 - - + + γ2/θ
Bb10i NT - - + + -
Bb10ii O20 - - + + -
Bb11 O142 - - + + -
Bb12 O76 - - + + γ2/θ
Bb13 NT - - + + -
Bb14i NT - - + - -
Bb14ii O158 - - + - γ2/θ
Bb14iii O76 stx2d−2 + + + γ2/θ
Bb14iv O142 - - + - γ2/θ
Bb15i O76 - - + + β1
Bb15ii O76 - - + + γ2/θ
Ww1 O166 stx2−vhc + - - β1
Ww2i O166 stx2−vhc - - - β1
Ww2ii O166 stx2−vhc + - - -
Ww2iii NK stx2−vhc - - - eae*
Ww3 NT - - + - -
Bb and Ww, STEC from bovines and water, respectively
Bb7a, SF−; Bb7b, SF+ strains; NK, serogroup not established
eae* ; untypeable eae gene; Stx1, Shiga toxin 1; Stx2, Shiga toxin 2
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5.4 Discussion
Shiga toxins are the major virulence determinants of STEC associated with human
illness, albeit in conjunction with the products of other genes such as eae. Essentially,
Stx are the primary cause of the clinical signs associated with STEC infection. To
induce diarrhoea, Stx may cause direct injury to the intestinal mucosa (O’Loughlin et
al. 2001) or to the underlying intestinal capillaries (Sjogren et al. 1994). A majority
of human and bovine STEC strains in this study expressed Stx, a result which was
similar to findings reported in previous studies (Beutin et al. 2004; Zhang et al.
2005). However, expression was not detected in a few strains including members
of serogroup O107. It is possible that in these strains the stx genes are located
on non-inducible defective phages (Zhang et al. 2005). Alternatively, the genetic
background of the Stx-negative strains does not enhance the expression of stx genes
(Escobar-Paramo et al. 2004).
Systematic analysis of stx genes from the clinical STEC showed that 7 of the 10
strains which carried stx1, expressed this gene (Table 5.11). Interestingly, among
strains carrying stx2, subtype stx2−vhc was the most prevalent, carried by 8 of the 15
strains. This result contrasts the the findings of De Baets et al. (2004), who did not
detect this variant from randomly selected clinical isolates in Belgium. Similarly,
none of the clinical STEC from France contained stx2−vhc (Pradel et al. 2001;2008).
Thus the carriage of different stx2 subtypes may be depend on the geographical
location and STEC population.
STEC from serogroups O29, O149 and O176, not previously described in humans,
contained stx2−EDL993, stx1 and stx2d−2, respectively. While the pathogenicity of
STEC with stx2−EDL993 has been well described (Lindgren et al. 1993; Melton-Celsa
et al. 1996; Friedrich et al. 2002), strains carrying stx2d−2 and possibly stx2−vhc
may be associated with moderate virulence (Friedrich et al. 2002) because both
genes encode amino acid sequences which regulate mucous activation (De Baets et
al. 2004). However, given the high disease burden, malnutrition and naive immunity
among the rural poor children in Nyabushozi (Kikafunda et al. 1998; Mbonye, 2004),
childhood infection with even the mildest form of STEC could present aggravated
clinical signs. Therefore, strains carrying stx2−vhc and stx2d−2 genes may be regarded
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as moderately virulent and of public health importance in poor countries.
That the bovines contained more than a single copy of stx2 was not surprising as a
number of studies have identified more than one copy of this gene in bovine STEC
(Schmitt et al. 1991; Bertin et al. 2001; Bielaszewska et al. 2006; Beutin et al.
2007). What was surprising, however, was that stx2−vhc, rarely identified in cattle
(De Baets et al. 2004), was the most frequent variant identified in the bovine STEC
from a number of serogroups (Table 5.12). Of the variants identified in my study,
stx2−EDL993 was most prevalent in France (Bertin et al. 2001 and Australia (Brett
et al. 2003a) and stx2d−2 was widespread among cattle from different locations
(Bertin et al. 2001; Brett et al. 2003a; Beutin et al. 2007). Taken together these
data probably indicate that different stx2 genes are carried by STEC within specific
ecological niches associated with distinct STEC populations.
A close association between stx2−vhc and stx2d−2 observed among bovine STEC might
indicate that the strains belong to a specific lineage of STEC (Girardeau et al. 2005).
One study has shown that stx2d−2 genes are either not, or poorly expressed in both
basal and induced conditions (de Sablet et al. 2008). Of the total STEC strains
in my study, carrying this variant alone, Stx2 expression was not detected in 3 of
the 5 strains. On the other hand, when stx2−vhc was the sole variant, expression
was detected in 8 of 11 strains. Expression of Stx2 was consistently detected in
strains (5) containing both variants suggesting that the presence of stx2−vhc may
compensate for the poorly expressed stx2d−2 (Table 5.12).
The reasons for some STEC being more virulent than others are not fully understood;
nevertheless, the link between the presence of eae in STEC and its ability to cause
disease in humans has been well documented (Nataro and Kaper, 1998; Paton and
Paton, 1998a; Donnenberg and Whittam, 2001; Karmali et al. 2003; Karch et al.
2005; Girardeau et al. 2005; Pradel et al. 2008). The observed high frequency of
eae-positive isolates from the bovines (58.3%, 14 of 24) was unexpected, as previous
studies have shown a much lower prevalence of eae-positive STEC in healthy cattle
(Hornitzky et al. 2002; Blanco et al. 2004c; Caprioli et al. 2005). eae-γ2/θ was the
predominant subtype identified in the bovine STEC (10 of 14) comprising a variety
of serogroups, indicating that it occurs in diverse serogroups. That this eae type
is common among EHEC O111 strains (Beutin et al. 2004; Blanco et al. 2005)
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suggests that it may confer a higher degree of virulence on serogroups containing
this eae type.
Interestingly, 2 of the 3 members of serogroup O113 from bovines possessed γ2/θ.
Strains belonging to this serogroup are prevalent in cattle from different regions
(Kobayashi et al. 2003; Brett et al. 2003a), however, previously reported STEC
O113 strains are typically eae-negative (Brett et al. 2003a; Kobayashi et al. 2003;
Mellmann et al. 2005). Two of the O113 strains from Bb7a and Bb7b, which are
SF− and SF+ respectively, are closely related but possess different virulence genes.
While, both shared stx1 and stx2d−2, the SF+ STEC contained also stx2−vhc and
eae-γ2/θ. The close genetic relatedness of the 2 strains suggests that they diverged
from a common ancestor and that eae was subsequently acquired by the SF+ variant.
The detection of eae among STEC strains from the children revealed a high preva-
lence of eae-positive strains (60%; 15 of 25), and contrasts with results from other
studies (Friedrich et al. 2002; Karch et al. 2005). It is noteworthy that strains of
serogroups O28ac, O142 and O158 carried eae-γ2/θ. To the best of my knowledge
this is the first report of eae-γ2/θ in these serogroups. Previous studies have shown
an association between severity of disease and the presence of eae in STEC (Boerlin
et al. 1999; Eklund et al. 2002; Jenkins et al. 2003b), suggesting that non-EHEC
strains containing this gene may be virulent.
A comparison of eae-subtypes carried by STEC in phase 1 and 2, showed distinct
differences in eae types. Six of 9 phase 2 eae-positive strains possessed eae-κ/δ,
2 carried eae-β1 and eae-µ was identified in one strain. None of 6 eae-positive
strains in phase 1 carried eae-κ/δ, but eae-γ2/θ and β1 were present in 4 and
2 strains, respectively. The prevalence of eae-κ/δ in the clinical STEC (6 of the
15 strain) contrasts with the findings of a number of studies in which this gene
was rarely isolated from clinical STEC in Europe (Oswald et al. 2000; Zhang et
al. 2002b; Jenkins et al. 2003a). This may signify differences in populations and
lineages of STEC. There is evidence that previously described eae-κ/δ genes have
been associated with virulent O118 and O157:H7 strains (Zhang et al. 2002b),
suggesting that this gene may be a marker of virulence. eae-β1 genes are ubiquitous,
having been identified in STEC from humans, animals and environmental sources
(Oswald et al. 2000; Ramachandran et al. 2003). In this study STEC containing
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this gene type were isolated from a bovine, children and water (Table 5.11 and Table
5.12). Several studies have suggested that eae type may indicate the phylogenetic
origin of STEC (Adu-Bobie et al. 1998a; Mundy et al. 2007). The presence of eae-
γ2/θ among the majority of eae-positive STEC from phase 1 children and bovines
might signal a phylogenetic relationship between the strains. Additionally, eae-γ2/θ
is closely associated with EHEC O111 (Oswald et al. 2000; Vaz et al. 2006) and
has specific tissue tropism (Phillips et al. 2000; Fitzhenry et al. 2002), suggesting
that STEC carrying this gene may have similar tissue tropism. Although previous
studies have reported that eae subtypes show differential tissue tropism and host
specificity (Phillips et al. 2000; Phillips and Frankel, 2000), no single eae type has
been linked with HUS (Schmidt et al. 1999; Oswald et al. 2000).
Although eae-negative strains serogroup O113 are frequently associated with bloody
diarrhoea and HUS in Australia and Germany (Elliott et al. 2001; Beutin et al.
2004), clinical strains carrying eae-γ2/θ or eae-β1 were isolated in my study. It
may be that the eae-positive O113 strains have emerged from a distinct lineage of
eae-carrying ancestor (McGraw et al. 1999; Oswald et al. 2000; Ramachandran et
al. 2003). The eae gene had not been detected in strains of a different serogroup
(O142) (Todd et al. 1999; Arthur et al. 2002); however, eae-positive O142 STEC
were isolated from bovines and children in my study.
Collectively, the presence of eae genes in STEC strains belonging to serogroups
known to cause mild disease was surprising. The spectrum of eae-carrying STEC
serogroups, including O113, O142 and O166, isolated from humans in my study is
wider than identified in other studies (Beutin et al. 1998; Elliott et al. 2001; Vaz
et al. 2006; Pradel et al. 2008). The presence of eae containing STEC suggests
a distinct population and lineage of these organisms which has evolved within the
unique ecological niche in Nyabushozi.
Previous studies have shown that eae-positive strains more frequently carry
stx2−EDL993 (Boerlin et al. 1999; Beutin et al. 2004). A similar association was
not apparent in my study: only 3 of all the STEC carried eae and stx2−EDL993. The
commonest variant identified in all strains was stx2−vhc, either alone or in combi-
nation with stx2d−2; a majority of these STEC contained eae-γ2/θ, suggesting an
association between carriage of stx2−vhc and eae-γ2/θ. That the majority of stx2d−2
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containing STEC were eae-negative was not unexpected and is consistent with the
findings of others (Pradel et al. 2000; Beutin et al. 2004).
In conclusion, a significant proportion of STEC from bovines and water sources
in Nyabushozi contained eae genes and stx2-variants associated with pathogenicity.
Therefore, these STEC may represent a potential public health risk to the commu-
nity, especially children. A majority of STEC isolated from children carried eae, of
which some contained stx2 variants associated with severe infection.
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Chapter 6
The phylogeny of STEC in
association with virulence markers
and seropathotypes
6.1 Introduction
In the previous chapter some of the virulence determinants of STEC were described
in detail. Although the carriage of virulence genes is essential in the pathogenesis of
disease, the importance of the genetic background in the acquisition and expression
of the virulence genes is increasingly recognised (Johnson, 2002; Escobar-Pa´ramo et
al. 2004).
Substantial evidence indicates that combinations of horizontal transfer of exogenous
DNA and mutation have resulted in the emergence of four major phylogenetic groups
(PGs) of E. coli; A, B1, B2 and D (Clermont et al. 2000; Escobar-Pa´ramo, et al.
2004). While extraintestinal E.coli predominantly belong to B2 and D (Donnenberg
and Whittam, 2001; Johnson et al. 2001; Bingen-Bidois et al. 2002), STEC strains
segregate mainly into PGs A, B1 and D (Clermont et al. 2000; Escobar-Pa´ramo et
al. 2004). Phylogenetic group (PG) D STEC frequently contain eae genes and have
been associated with severe human illness (Girardeau et al. 2005), indicating the
public health importance of this group. Some strains in PG B1 are associated with
HUS and often carry eae (Pradel et al. 2008), while strains in PG A are commonly
isolated from asymptomatic carriers and usually lack eae genes (Girardeau et al.
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2005). In bovines, group A and B1 strains tend to predominate (Girardeau et al.
2005; Pradel et al. 2008).
The epidemiological and clinical data based on the incidence and association with
HUS and diarrhoeal outbreaks has been used to classify STEC into five seropatho-
types (SPTs), A to E (Karmali et al. 2003). Accordingly, EHEC O157:H7, the major
cause of epidemic outbreaks of HUS, belongs to seropathotype (SPT) A. Serogroups
O26, O103 and O111 which cause similar outbreaks of HUS but less frequently
belong to SPT B. SPT C is comprised of serogroups such as O8, O113 which spo-
radically cause bloody diarrhoea and HUS (Girardeau et al. 2005). On the other
hand, strains in SPT D are known to cause watery diarrhoea, while strains in SPT
E have not been reported among human pathogens (Karmali et al. 2003; Girardeau
et al. 2005). Intimin, a marker of virulence is more associated with strains in SPTs
A, B and C than SPT D or E (Girardeau et al. 2005; Ziebell et al. 2008).
To gain deeper understanding of the evolutionary origin of STEC, the PGs of strains
from different sources were determined in relation to their virulence markers. Ad-
ditionally, using SPTs the potential human health risk associated with the clinical
STEC was determined.
6.2 Experimental design
6.2.1 Bacterial strains used in the study
Fifty four STEC strains, 25 from children, 24 from cattle and 5 from the water
(Chapter 4) were investigated.
6.2.2 Sorbitol fermenting phenotype
STEC cultures were inoculated on SMAC (Oxoid Ltd., Basingstoke, Hampshire,
United Kingdom) and incubated at 37oC for 18-24 h as described [2.2.12]. SF+ or
SF− colonies were recorded.
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6.2.3 Triplex PCR for phylogenetic grouping
The presence or absence of chuA and yjaA genes and an anonymous DNA fragment,
TspE4.C2 determine the PG (Clermont et al. 2000). Using DNA extracted by CTAB
method [2.2.13], the triplex PCR was used to detect these genes and an anonymous
DNA fragment. Amplification with primers shown in Table 6.1 proceeded with an
initial DNA denaturation at 94oC for 4 minutes, followed by 30 cycles of 5 s DNA
denaturation at 94oC, annealing temperature at 60oC for 10 s and extension for 15
s at 72oC. A final extension at 72oC for 5 min completed the amplification.
Table 6.1: Primers used in triplex PCR for the amplifi-
cation of target genes/ DNA fragment and the expected
sizes of PCR products
Primer Gene/ Primer (5′ → 3′) Product Reference
DNA sequence size (bp)
fragment
ChuA.1 chuA GACGAACCAACGGTCAGGAT 279 Clermont et al.
ChuA.2 TGCCGCCAGTACCAAAGACA (2000)
YjaA.1 yjaA TGAAGTGTCAGGAGACGCTG 211 Clermont et al.
YjaA.2 ATGGAGAATGCGTTCCTCAAC (2000)
Tsp1 TspE4.C2 GAGTAATGTCGGGGCATTCA 152 Clermont et al.
Tsp2 CGCGCCAACAAAGTATTACG (2000)
6.3 Results
6.3.1 Phylogenetic distribution of STEC from children,
bovines and water
A PCR product (279 bp) indicative of chuA and consistent with PG D STEC was
obtained with O157:H7 (Figure 6.1 and Table 6.2). Similarly, an appropriately sized
amplicon (152 bp) consistent with the presence of TspE4.C2 was obtained with
STEC O111, and indicative of group B1. A 211 bp yjaA-related amplicon was
obtained with E. coli K-12 and no PCR product was obtained from a non-STEC
clinical E. coli strain isolated from the faeces of a child. Both of these are consistent
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with PG A strains (Figure 6.1 and Table 6.2). Thereafter, these were used as control
strains in further phylogenetic studies.
Figure 6.1: PCR for the identification of the PGs of the control STEC strains.
Agarose gel electrophoresis following triplex PCR for phylogenetic classification of
STEC. The phylogenetic classification is based on the presence/absence of one or
more fragments (297, 211 or 154 bp). Lane 1, HyperLadder IV (Bioline, UK); lane
2, no DNA; lane 3, E. coli K-12; lane 4, non-STEC clinical E. coli; lane 5, STEC
O111 (Bb1i); lane 6, O157:H7
Table 6.2: Phylogenetic grouping of E. coli using PCR
amplification of the chuA and yjaA genes and DNA frag-
ment TspE4.C2
Phylogenetic groups
Target A B1 B2 D
chuA - - - + + + +
yjaA - + - + + - -
TspE4.C2 - - + - + - +
+, obtained PCR product; -, no PCR product obtained
Adopted from Clermont et al. (2000).
Of the 25 clinical STEC, an equal number of STEC, 10 (40%) segregated into PGs
A or D, and the remaining 5 (20%) strains belonged to B1 group (Figure 6.2). All
strains lacking a PCR product were repeated three times, and consistently none
yielded an amplicon.
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Figure 6.2: PCR for the identification of the PGs of clinical STEC.
A: Agarose gel electrophoresis following triplex PCR for phylogenetic classification
of STEC. The phylogenetic classification is based on the presence/absence of one or
more fragments (297, 211 or 154 bp). Lane 1, HyperLadder IV (Bioline); lane 2, no
DNA; lane 3, E. coli K-12; lane 4, non-STEC clinical E. coli; lane 5, STEC O111
(Bb1i); lane 6, O157:H7; lane 7, Hh1; lane 8, Hh2; lane 9, Hh3/1; lane 10, Hh3/2;
lane 11, Hh4i; lane 12, Hh4ii; lane 13, Hh4iii; lane 14, Hh5; lane 15, Hh6; lane 16,
Hh7.
B: Lanes 1, HyperLadder IV (Bioline); lane 2, no DNA; lane 3, E. coli K-12; lane
4, non-STEC clinical E. coli; lane 5, STEC O111 (Bb1i ); lane 6, O157:H7; lane 7,
Hh8; lane 8, Hh9; lane 9, Hh10; lane 10, Hh11; lane 11, Hh12; lane 12, Hh13i; lane
13, Hh13ii; lane 14, Hh14i; lane 15, Hh14ii; lane 16, Hh15i; lane 17, Hh15ii; lane 18,
Hh16i; lane 19, Hh16ii; lane 20, Hh17; lane 21, Hh18.
Similarly, of the 24 bovines STEC, most strains belonged to B1 group (13 strains,
54.2%), 9 strains (37.5%) belonged to A group and 1 strain to group D. An additional
strain which could not be typed was designated non typeable (NT). The five water
STEC belonged to PG A.
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6.3.2 Phenotypic and genotypic attributes of PG A STEC
from children, bovines and water
Twenty four (24) STEC in PG A comprised 10 clinical, 9 bovine and 5 water STEC.
The strains belonged to 9 serogroups including O176 not previously described in
humans (Table 6.3).
Table 6.3: Phenotypic and genotypic attributes of PG A
STEC from children, bovines and water
Sero Detected virulence marker
PG group Source stx2 type Stx2 stx1 Stx1 eae SF
A O8 Hh7 stx2−EDL993, stx2−vhc + - - - +
A O8 Bb5 stx2d−2, stx2−vhc + + + γ2/θ -
A O74 Hh1 stx2−vhc + + + - +
A O76 Hh2 stx2−vhc, stx2d−2 + + + γ2/θ +
A O76 Bb3 stx2−EDL993, stx2−vhc + + + - +
A O76 Bb15i - - + + β1 +
A O76 Bb15ii - - + + γ2/θ +
A O113 Hh3/2 stx2−vhc + + + γ2/θ +
A O113 Bb7b stx2d−2, stx2−vhc + + + γ2/θ +
A O142 Hh18 stx2c - + + κ/δ +
A O158 Bb14ii - - + - γ2/θ +
A O166 Ww1 stx2−vhc + - - β1 +
A O166 Ww2i stx2−vhc - - - β1 +
A O166 Ww2ii stx2−vhc + - - - +
A O169 Hh17 stx2c + - - - +
A O176 Hh16i stx2d−2 - - - - +
A NT Hh6 stx2−vhc + - - γ2/θ +
A NT Hh13i - - + + β1 -
A NK Hh16ii stx2d−2 + - - - +
A NT Bb2 - - + + γ2/θ +
A NT Bb13 - - + + - +
A NT Bb14i - - + - - +
A NK Ww2iii stx2−vhc - - - eae* +
A NT Ww3 - - + - - +
PG, phylogenetic group; Hh, child; Bb, bovine; Ww; water; eae* ; untypeable eae gene
NK, serogroup not established; Stx1, Shiga toxin 1; Stx2, Shiga toxin 2
SF, ability (+)/inability (-) to ferment sorbitol
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Three of the serogroups O8, O76 and O166 had multiple strains (Table 6.3). Isolates
of serogroups O74, O142 and O169 were from clinical STEC, while O8, O76 and O113
were shared between clinical and bovine isolates. STEC O158 and O166 were from
the bovine and water, respectively (Table 6.3).
Eight of the strains in group A contained stx1 as the only stx gene, while 16 strains
contained stx2 or both stx genes (Table 6.3). Twelve of the 16 strains carrying
stx2, contained stx2−vhc gene alone, or in combination with other genes (Table 6.3).
Variant stx2d−2 was carried alone, or in combination with stx2−vhc in 3 clinical and
2 bovine strains. Variants stx2c was present in 2 clinical strains while stx2−EDL993
was present in a clinical and bovine isolate (Table 6.3).
A majority of group A strains, 14 of 24 (58.3%) contained eae gene. Most strains
(8 of 13) harboured eae-γ2/θ, 4 strains carried eae-β1, while one strain each carried
eae-κ/δ or a nontypeable intimin gene (Table 6.3). The ability to ferment sorbitol
was assessed, and 22 of 24 (91.7%) group A STEC were SF+ strains (Table 6.3).
6.3.3 Phenotypic and genotypic attributes of PG B1 STEC
from children and bovines
Of the 18 STEC in PG B1, a majority (13) were bovines STEC and the remainder
(5) were clinical strains (Table 6.4). Nine of the strains belonged to 3 serogroups
O8, O107 and O113. The remaining strains belonged to different O serogroups.
Serogroups O107 and O113 were shared between clinical and bovine STEC while
O8, O76 and O111 were from the bovines (Table 6.4).
Ten strains contained one or two variants of stx2 alone or in association with stx1
(Table 6.4). stx2−vhc was carried by most strains (7), while stx2d−2 and stx2−EDL993
were carried by 4 and 3 strains, respectively (Table 6.4), showing that different stx2
genes are carriage by STEC in group B1.
Ten of 18 (55.6%) group B1 STEC carried eae gene including eae-κ/δ (6 strains of
different serogroups), eae-β1 in 2 strains and one strain each possessed eae-κ/δ or a
non-typeable eae gene (Table 6.4). In addition, 11 of 18 (61.1%) group B1 strains
fermented sorbitol.
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Table 6.4: Phenotypic and genotypic attributes of PG B1
STEC from children and bovines
Sero Detected virulence marker
PG group Source stx2 type Stx2 stx1 Stx1 eae SF
B1 O8 Bb6/1 stx2d−2, stx2−vhc + + + eae* -
B1 O8 Bb6/2 stx2−EDL993 + - - - -
B1 O8 Bb8i stx2d−2 - + - - -
B1 O20 Bb10ii - - + + - +
B1 O22 Hh3/1 stx2−vhc + - - κ/δ +
B1 O28ac Bb4 stx2d−2, stx2−vhc + + + γ2/θ +
B1 O76 Bb12 - - + + γ2/θ +
B1 O78 Hh5 stx2−EDL993, stx2−vhc + + + β1 -
B1 O107 Hh4ii - - + - - +
B1 O107 Hh4iii - - + - - +
B1 O107 Bb8ii stx2−vhc + - - - -
B1 O111 Bb1i stx2−EDL993, stx2−vhc + + + γ2/θ +
B1 O113 Hh4i - - + - β1 +
B1 O113 Bb7a stx2d−2 - + + - -
B1 O113 Bb9 - - + + γ2/θ -
B1 O142 Bb14iv - - + - γ2/θ +
B1 Poly9 Bb1ii stx2−vhc + - - γ2/θ +
B1 NT Bb10i - - + + - +
PG, phylogenetic group; Hh, child; Bb, bovine; eae* ; untypeable intimin gene
Stx1, Shiga toxin 1; Stx2, Shiga toxin 2
SF, ability (+)/inability (-) to ferment sorbitol
6.3.4 Phenotypic and genotypic attributes of PG D STEC
from children and bovines
Similarly, analyses of STEC in PG D revealed that 8 of the 11 STEC belonged to 7
serogroups including O111. Eight strains are eae-positive and eae-κ/δ was detected
in most strains (5) while one strain each possessed eae-β1, γ2/θ or µ (Table 6.5).
Variants of stx2 carried alone or in combination with stx1 include stx2−EDL993 (2
strains) and one strain each possessed stx2c, stx2−vhc or stx2d−2 (Table 6.5). Nine 9
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of 11 (81.8%) strains were SF+.
Table 6.5: Phenotypic and genotypic attributes of PG D
STEC strains from children and bovines
Sero Detected virulence marker
PG group Source stx2 type Stx2 stx1 Stx1 eae SF
D O29 Hh10 stx2−EDL993 + - - - +
D O76 Bb14iii stx2d−2 + + + γ2/θ +
D O111 Hh13ii - - + + β1 -
D O141 Hh11 stx2−vhc + - - - -
D O142 Hh15i stx2−EDL993 + + + κ/δ -
D O142 Hh15ii stx2c + + + κ/δ -
D O149 Hh8 - + + + - -
D O166 Hh12 - + + + κ/δ -
D NT Hh9 - + + + µ -
D NT Hh14i - + + + κ/δ -
D NT Hh14ii - + + + κ/δ -
Hh, child; Bb, bovine; SF, ability (+)/inability (-) to ferment sorbitol
Stx1, Shiga toxin 1; Stx2, Shiga toxin 2
The PG of a sorbitol fermenting bovine STEC Bb11 (O142) could not be established
and was recorded as untypeable (NT). The strain was eae-negative and carried stx1.
6.3.5 Distribution of clinical STEC in different SPTs
The classification of clinical STEC strains into the various SPTs (A to D) was
adopted from Karmali et al. (2003). Each O serogroup was assigned to an appro-
priate SPT based on the available published data (Karmali et al. 2003; Girardeau
et al. 2005; de Sablet et al. 2008; Ziebell et al. 2008) and internet databases
(http://www.microbionet.com.au/vtec2u.htm, http://www.who.int/emcdocuments
/zoonoses/docs/whocsraph988.html, and http://www.lugo.usc.es/ecoli).
Of the 25 clinical STEC, a majority (20, 80%) separated into SPT D, 4 strains (15%)
into SPT C and 1 strain (5%) into SPT B (Table 6.6).
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Table 6.6: Phenotypic and genotypic attributes of clinical
STEC in different SPTs
Sero Detected virulence marker
SPT group Child stx2 type Stx2 stx1 Stx1 eae Diar SF PG
B O111 Hh13ii - - + + β1 WD - D
C O8 Hh7 stx2−EDL993, stx2−vhc + - - - WD + A
C O76 Hh2 stx2−vhc, stx2d−2 + + + γ2/θ WD + A
C O113 Hh3/2 stx2−vhc + + + γ2/θ WD + A
C O113 Hh4i - - + - β1 WD + B1
D O22 Hh3/1 stx2−vhc + - - γ2/θ WD + B1
D O29 Hh10 stx2−EDL993 + - - - WD + D
D O74 Hh1 stx2−vhc + + + - WD + A
D O78 Hh5 stx2−EDL993, stx2−vhc + + + β1 BD - B1
D O107 Hh4ii - - + - - WD + B1
D O107 Hh4iii - - + - - WD + B1
D O141 Hh11 stx2−vhc + - - - BD - D
D O142 Hh15i stx2−EDL993 + + + κ/δ WD - D
D O142 Hh15ii stx2c + + + κ/δ WD - D
D O142 Hh18 stx2c - + + κ/δ BD + A
D O149 Hh8 - - + + - BD - D
D O166 Hh12 - + + κ/δ WD - D
D O169 Hh17 stx2c + - - - BD + A
D O176 Hh16i stx2d−2 - - - - WD + A
D NT Hh6 stx2−vhc + - - γ2/θ BD + A
D NT Hh9 - + + µ BD - D
D NT Hh13i - - + + β1 WD - A
D NT Hh14i - - + + κ/δ WD - D
D NT Hh14ii - - + + κ/δ WD - D
D NK Hh16ii stx2d−2 + - - - WD + A
SPT, seropathotype; NK, serogroup not established; Diar, type of diarrhoea
PG, phylogenetic group; SF, ability (+)/inability (-) to ferment sorbitol
Stx1, Shiga toxin 1; Stx2, Shiga toxin 2
The eae-β1 containing STEC O111 belonged to SPT B, while serogroups O8, O76
and O113 belonged to SPT C. Three of the eae-positive STEC in SPT C contained
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γ2/θ (O76, O113) or eae-β1 in O113 (Table 6.6).
Twenty STEC in SPT D belong to 11 O serogroups (Table 6.6). Slightly over half
of the strains (11 of 20) carried eae, mostly eae-κ/δ (6 strains), β1 (2 strains) and
one strain each carried γ2/θ or µ (Table 6.6). In addition, the strains contained
different stx genes (Table 6.6). There was an equal split, 10 strains possessed SF+
or SF− phenotype.
6.4 Discussion
Several phylogenetic studies of STEC have been carried out using the triplex PCR
method (Girardeau et al. 2005; Ishii et al. 2007; Pradel et al. 2008), because it is
quick and may not require reference collection of strains (Clermont et al. 2000). An
equal proportion of clinical strains (10 strains, 40%) separated into PGs A or D; a
result which contrasts with findings from studies in France (Girardeau et al. 2005;
Pradel et al. 2008) and Canada (Ziebell et al. 2008), where a majority of clinical
STEC belonged to PG B1. This may be attributed to the differences in the STEC
populations or their clonal descent. In addition, inherent host factors and climatic
conditions may influence the distribution of the various PGs of STEC (Duriez et al.
(2001). Although PG D STEC are frequently associated with HUS (Girardeau et
al. 2005), available evidence suggests that PG B1 STEC could potentially cause a
spectrum of disease from mild diarrhoea to HUS (Girardeau et al. 2005; Ziebell et
al. 2008). That none of PG B2 STEC was identified, was expected because group
B2 E. coli rarely cause diarrhoeal disease (Escobar-Paramo et al. 2004; Girardeau
et al. 2005).
More than half of bovine STEC (13 strains, 54.2%) in this study, belonged to PG B1,
a finding which accords with results of other studies (Girardeau et al. (2005; Ishii
et al. 2007). An additional 9 (37.5%) STEC segregated into PG A while one strain
belonged to PG D. Probably this indicates that STEC in PGs A and B1 are more
adapted to the gastrointestinal tracts of bovines in Nyabushozi than PG D STEC.
PG A STEC from water and bovines represent strains that are probably associated
with mild illness (watery diarrhoea) in humans (Girardeau et al. 2005).
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In the majority of STEC the expression of Stx1, Stx2 or both toxins was detected
among the different PGs. This observation suggests that the expression of Stx in
these strains is not entirely dependent on the genetic background. However, the
genetic background may play a significant role in the differential basal expression of
Stx among STEC strains (de Sablet et al. 2008). This was not verified in the present
study because the Duopath Verotoxin assays determined the qualitative production
of Stx. That certain strains of STEC in PGs A and B1 contained multiple variants
of stx2 was expected, as this has been reported in a previous study (Pradel et al.
2008). In contrast to Pradel et al. (2008), none of the STEC in PG D in this study
possessed more than one variant of stx2, possibly because of the differences in STEC
populations.
A majority of PG A STEC (14 of 24) in this study were eae-positive. This finding
accords with results from a recent study in Canada (Ziebell et al. 2008), suggesting
that PG A eae-positive STEC occur in different geographical locations and/or STEC
populations. However, eae gene types carried by PG A STEC described by Ziebell
et al. (2008) remain unknown because the eae gene types were not characterised.
Nonetheless, STEC in PG A from this study carried various eae gene types; a
majority of strains contained eae-γ2/θ (8 of 14) and 4 strains contained eae-β1,
while eae-κ/δ and an untypeable eae were each carried by one strain (Table 6.3).
The carriage of eae in PG B1 STEC (10 of 18) was not unusual as previous studies
have reported eae-positive STEC in the PG (Pradel et al. 2008; Ziebell et al.
2008). What was unusual, however, was the fact that most of the eae-positive
STEC contained eae-γ2/θ. This result differs from findings of Pradel et al. (2008),
who reported eae-β and ε among the clinical STEC, instead of eae-γ2/θ . This
may be attributed to the difference in STEC populations and/or their geographical
location.
Few phylogenetic studies have characterised eae gene types in STEC (Ishii et al.
2007; Pradel et al. 2008), and to the best of my knowledge this is the first description
of eae-γ2/θ in STEC of different genetic backgrounds. The carriage of eae-γ2/θ
gene in a majority of eae-positive STEC in group B1 as well as group A in this
study, probably indicates that eae-γ2/θ is associated with STEC of different genetic
backgrounds (A and B1). It can be suggested that during evolution, genomes with
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A or B1 genetic background preferentially acquired and retained eae-γ2/θ. This is
supported by previous studies that have shown a close association between the clonal
lineage EHEC-1 such as EHEC O157:H7 and eae-γ1 (Wieler et al. 1997; McGraw
et al. 1999; Donnenberg and Whittam, 2001). On the other hand, the presence of
eae may indicate that eae-γ2/θ is widely distributed among clinical and bovine PG
A and B1 STEC in Nyabushozi. The carriage of eae-β1 by STEC in PGs A and B1
was not surprising as this gene is known to be ubiquitous among STEC (McGraw et
al. 1999; Oswald et al. 2000), and most probably of different genetic backgrounds.
It is noteworthy that eae-positive STEC O113 and specifically carrying eae-γ2/θ in
PGs A and B1 are being reported for the first time. Previous studies have reported
eae-negative STEC O113 with genetic background A or B1 (Girardeau et al. 2005;
Pradel et al. 2008; Ziebell et al. 2008). Therefore, it is reasonable to suggest
that STEC O113 from Nyabushozi emerged from distinct clones of eae-carrying
progenitors within the ecological niche.
Nine of the 11 STEC in PG D (with the exception of O76 and O111) were collected
in phase 2, suggesting that they might have evolved from a common distant ancestor.
This also suggests that their ancestral descent is different from phase 1 clinical or
the bovine STEC. As expected, a majority of strains in PG D (8 of 11) carried eae
genes. This accords with previous studies which have shown a strong correlation
between the D genetic background and the presence of eae (Girardeau et al. 2005;
Ziebell et al. 2008). The carriage of eae in STEC with genetic background D in
this study might indicate virulence, since the virulent strains od EHEC O157:H7 are
predominantly eae-positive and belong to PG D (Bidet et al. 2005; Girardeau et al.
2005; Ziebell et al. 2008).
Besides EHEC O111, the eae-positive STEC in PG D, including STEC O29 and
O149, are non-EHEC strains. This probably indicates that non-O157:H7 STEC with
the D genetic background are wide spread among the clinical STEC in Nyabushozi.
Five of the 7 of these STEC carried eae-κ/δ. To the best of my knowledge, the
carriage of eae-κ/δ by strains in PG D has not been previously reported.
The carriage of stx2d−2 has been previously associated with absence of eae in the
STEC genome (de Sablet et al. 2008); unsurprisingly 4 of 5 STEC containing this
gene as the only stx2 gene in PG A and B1 were eae-negative. However, a strain in
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group D contained stx2d−2 and eae-γ2/θ, suggesting that the D genetic background
played a role in the retention of both eae and stx2d−2 genes within the genome
(Escobar-Paramo et al. 2004).
SPTs provide a basis for molecular risk assessment in order to predict the virulence
potential of STEC (Coombes et al. 2008). A majority of clinical strains (20 of 25)
belonged to SPT D, indicating that they could potentially cause mild illness (watery
diarrhoea). The presence of PG A strains in SPT D (7 of 20) was expected because
genetic background A is associated of low pathogenicity (Girardeau et al. 2005;
Ziebell et al. (2008). On the other hand, 4 and 9 strains in SPT D belonged to
PG B1 and D, respectively. This was probably because triplex PCR was unable to
discriminate sufficiently among the various serotypes of STEC (Ziebell et al. 2008).
In general, SPT was able to segregate clinical STEC in different PGs into SPTs B,
C and D, showing its usefulness as a molecular analysis tool. This observation is
in agreement with the previous study , which suggests that SPTs was more precise
than triplex PCR in predicting the virulence potential of STEC (Coombes et al.
2008).
Since both SF+ and SF− STEC were detected among SPT D strains, it indicates
that this phenotype is a weak marker of virulence. This is supported by previous
studies which have shown that most EHEC strains implicated in severe human illness
ferment sorbitol (March and Ratnam et al. 1986; Bielaszewska and Karch, 2000; Tarr
et al. 2005). It can therefore be suggested that SF+ or SF− phenotype within the
different genetic backgrounds of STEC is an indicator of clonal descent.
In conclusion, STEC of genetic background A are widely distributed in the different
sources (humans, bovine and water). Genetic backgrounds B1 and D were closely
associated with bovine and clinical STEC, respectively. Of note eae-κ was predom-
inantly carried by genetic background D STEC whereas γ2/θ was associated with
background A or B1. Although a majority of clinical STEC were in SPT D, the
isolation of strains in SPTs B and C suggests that clinical STEC from Nyabushozi
are potentially pathogenic; capable of causing human illness ranging from mild to
severe diarrhoea and HUS.
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Cattle play a significant role in the livelihood of the rural pastoral communities
in Nyabushozi; a county which supports one of the highest populations of cattle
in Uganda. Undeniably, a large cattle population, coupled with the close human-
cattle contact are risk factors for STEC infection in the community, especially to
the children.
Using biochemical and molecular methods, STEC was isolated from 18 of 222 (8.1%)
E. coli carrying diarrhoeal children. To the best of my knowledge this is the first
report describing clinical STEC in children from Nyabushozi county and Uganda in
general. This probably suggests that previous STEC infections were misdiagnosed,
or not detected during laboratory testing, since screening for STEC is not mandatory
in public health centres in Uganda. In addition, the lack of technical and human re-
source impedes the detection of STEC in most laboratories. The prevalence of STEC
(8.1%) in my study accords with findings from a similar study in a rural community
of Nigeria (Okeke et al. 2000, whereas similar studies in peri-urban communities
from Uganda (Nasinyama, 1996; Kaddu-Mulindwa et al. 2001), Tanzania (Gascon
et al. 2000) and Mozambique (Rappelli et al. 2005) did not identify STEC. This
suggests that children from rural farming communities are more at risk from STEC
infections than in peri-urban communities, perhaps because of the close contact with
cattle or the farm environment.
The numerous PFGE profiles shown by clinical STEC indicated genetically diverse
STEC. This observation was similar to results of previous studies (Rios et al. 1999;
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Khan et al. 2002a). The genetic diversity accords with previous studies which
reported that non-O157:H7 STEC is a heterogenous group of pathogens from diverse
ancestral clones (Whittam et al. 1993; Feng et al. 1998). Further, the clonal
subgroups of STEC within each host exhibited genetic heterogeneity, which probably
indicates the dynamic nature of STEC genome. The host immune system or the
prevailing external factors may have induced the genomic alteration (Akiba et al.
2000).
The clinical STEC belonged to 15 serogroups including O8, O74, O76, O78, O107,
O111, O113 and O166, previously associated with severe human infections. In ad-
dition, O29, O149 and O176 which have not been previously described in humans
were isolated, suggesting the occurrence of additional unidentified human STEC.
O142 was the most frequent serogroup from the children, suggesting that strains of
STEC O142 are able to thrive and proliferate within the intestinal tracts of children
in Nyabushozi.
There was a clear distinction between clinical serogroups of STEC collected in phases
1 and 2, possibly because phase 2 children were from homesteads different from chil-
dren and bovines in phase 1. This suggests that there are diverse STEC populations
within the ecological niche of Nyabushozi. Probably the high cattle population
turn-over, changes in the bovine diet (Geue et al. 2006) or seasonal human-cattle
migration might have disrupted the ecosystem and altered the population of STEC.
Fifteen of 25 clinical strains contained either stx2 alone or in combination with
stx1. Variant stx2−vhc was the commonest variant, carried alone or in combination
with stx2−EDL993 or stx2d−2c. The predominance of stx2−vhc in clinical STEC from
Nyabushozi contrasts the findings from other studies in Europe (Stephen and Hoel-
zle, 2000; Pradel et al. 2008). This strongly suggests that stx2−vhc is associated with
clinical STEC in Nyabushozi.
Most clinical STEC contained eae gene (15 of 25, 60%); and since STEC carrying
this gene have been associated with severe human illnesses (Boerlin et al. 1999;
Eklund et al. 2002), this probably indicates that eae-positive STEC are potentially
virulent.
A majority of clinical strains in phase 2 contained eae-κ/δ, while phase 1 STEC
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carried either eae-γ2/θ or eae-β1, which might be attributed to the different STEC
populations between the phases. The few serotypes of clinical STEC previously
found to harbour eae-κ/δ are known for their virulence (Zhang et al. 2002b), thus
this gene could be a marker of virulence among the clinical STEC from Nyabushozi.
Phylogenetic analysis classified clinical STEC predominantly into A and D groups.
In the majority of STEC in the various PGs the expression of Stx1, Stx2 or both
toxins was detected. However, further studies are needed to establish the relationship
between PG and the differential basal expression of Stx.
The exclusive carriage of eae-κ/δ in PG D STEC from phase 2, suggests that these
STEC belonged to a distinct lineage and possibly STEC population. Although the
triplex PCR ndoes not sufficiently predict the virulence potential of STEC, strains
carrying LEE are probably more virulent than eae-negative clinical strains.
Rectal faeces containing E. coli from 15 of 216 (7.85%) bovines under range man-
agement in Nyabushozi were positive for STEC. This was the same prevalence as in
bovines from the USA under similar husbandry practice (Renter et al. 2003. How-
ever, this prevalence was much lower than 28.3% for cattle from a farm in central
Uganda (Kaddu-Mulindwa et al. 2001), indicating that shedding of STEC varies
with husbandry practices and the locality.
The analysed PFGE profiles of a majority of bovine STEC revealed that they were
genetically diverse, suggesting that they were derived from different STEC popu-
lations. This is probable because STEC were isolated from different herds, which
are thought to harbour distinct STEC strains. This accords with Cobbold and Des-
marchelier (2001), who identified strains specific to individual farms in Australia.
The intra-herd clonal similarity suggests that transmission of STEC among cattle
within the herd must have occurred, possibly promoted by commingling of cat-
tle within the night enclosures (kraals). On the other hand, the inter-farm clonal
similarity of STEC, suggests that the transmission of STEC among the different
herds may have occurred, possibly via drinking water at the communal valley dams,
through cattle movement between herds during traditional ceremonies or transmis-
sion by humans, birds and other vehicles within the environment in Nyabushozi.
However, the possibility of transmitting STEC from contaminated pastures to other
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cattle was probably minimal because the chances of sharing the same contaminated
pastures are remote.
The genetic relatedness between some bovine and clinical STEC indicates a possible
transmission of STEC from the cattle to children in the community. Infection could
have been acquired through direct contact with cattle, the farm environment or via
ingestion of raw or fermented milk (eshabwe). Contact with cattle or the farming
environment are major risk factors for STEC transmission from bovines to humans
in farming communities (O’Brien et al. 2001; Crump et al. 2002; Grif et al. 2005),
such as the pastoralists in Nyabushozi.
The bovine STEC belonged to previously described serogroups, of which O8, O76,
O111 and O113 were also shed by the children, suggesting that bovines in Nyabushozi
harboured STEC pathogenic for humans. In addition, bovines harboured eae-
positive STEC of serogroups O28ac, O113, O142 and O158. Previously described
STEC in these serogroups lacked eae, suggesting that these strains belong to distinct
clonal descent and STEC populations within the ecological niches of Nyabushozi.
Half of the 24 bovine STEC carried stx2 alone or in combination with stx1. While
STEC containing stx2−vhc alone or in combination with stx2−d2 were most common.
Since stx2d−2 is poorly expressed (de Sablet et al. 2008), STEC carrying this gene
perhaps compensates for the poor expression by carrying stx2−vhc as well. How-
ever, this would need further investigation. Stx2d-2 and Stx-vhc share amino acid
sequences associated with mucous activation, and this would suggest that both pro-
teins have similar virulence profiles and may be associated with mild to moderate
human illness.
The eae gene was prevalent in the bovine STEC, carried by 14 of the 24 strains.
Specifically eae-γ2/θ was carried in 12 of these strains, suggesting that eae-γ2/θ
was a prevalent eae type among the bovine STEC. The carriage of untypeable eae
indicates the presence of additional unknown eae types.
Phylogenetic studies of the bovine STEC classified most of the strains in groups A
and B1. The carriage of eae-γ2/θ gene in a majority of eae-positive STEC in group
B1 as well as group A, probably indicates that eae-γ2/θ is associated with bovine
STEC of different genetic backgrounds in Nyabushozi.
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The valley dams extensively used by humans and their bovines were contaminated
by STEC which belonged to PG A. Most of the strains carried stx2−vhc and eae
gene. STEC O166 was simultaneous isolated from water and a child, indicating the
health risk associated with drinking of the water. Although STEC from the water
was genetically diverse, the valley dams remain an important source of infection to
humans and the bovines.
Since the H-antigen of STEC was not typed, the risk assessment based on the SPT of
the bovine STEC could not be established. Nonetheless, the bovine STEC should be
regarded as potential human pathogens which require further investigation. Clinical
STEC in SPT B and C potentially cause severe illness since they have previously
been associated with epidemic and sporadic outbreaks of HUS (Girardeau et al.
2005). A majority of clinical STEC segregated into SPT D, suggesting that they
could potentially cause watery diarrhoea. However, given the level of childhood mal-
nutrition (Kikafunda et al. 1998) and the disease burden among the rural children
in Uganda, even the mild STEC could cause severe illness. In general, clinical STEC
should be regarded as potentially pathogenic and capable of causing severe illness
in children with naive immunity.
Certain STEC were classified in SPT C basing on their O antigen, however, appro-
priate classification would required typing of their H-antigens. In order to predict
more precisely the virulence potential of eae-positive STEC with the D genetic
background, analysis of the non-LEE pathogenic islands would be required in future
studies.
In conclusion, the genetically diverse STEC from the pastoral system of Nyabushozi,
armed with stx and eae genes within their respective genetic backgrounds have the
potential to cause childhood illnesses ranging from watery to bloody diarrhoea and
HUS.
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Appendix B
Informed consent form
Dear Parent/ Guardian
I am Dr Samuel Majalija, of the Faculty of Veterinary Medicine, Makerere Univer-
sity. I am investigating the human and environmental health impact of farm waste
on the spread of resistant bacteria in Bahima pastoral systems
I will explain to you about my research work: The excess use of animal drugs (an-
tibiotics) are associated with antibiotic resistance among some indicator bacteria,
which also transmitted to humans. The purpose of this research is to identify an-
tibiotic resistant bacteria in children suffering from diarrhoea and cattle from the
same homesteads.
I am inviting you to participate because it is important to test whether your child
is infected by antibiotic resistant bacteria.
If you are willing, I will ask you a few questions and also the nurse will assist you
to collect a stool sample from your child. In addition, I will visit your home within
the next 3 days in order to collect faecal samples from the cattle.
Informed consent
I ....................................................(parent /guardian/ cattle owner),
I have understood the objectives of this research and I agree to participate in the
study on: The human and environmental health impact of farm waste on the spread
of resistant bacteria in Bahima pastoral systems.
I understand that participation involves:
Answering questions regarding the study.
Providing a stool sample from my child
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Allowing the investigator to visit my home where faecal samples will taken from
the cattle.
I understand that participation is completely voluntary and has no financial bearing
whatsoever.
Confidentiality
I understand that my name, the child’s name or a specific cattle identification will
not appear with the results of this research.
I understand that my decision to participate or not to participate in this study will
not alter the health care of my child/ or the cattle.
I understand the results may be communicated to the relevant authorities for future
action.
I understand that in the use of the information generated from this study, my
identity or the identities of my child/ animals will remain anonymous.
I also understand that I am free to withdraw consent at any time during the study.
I understand that for any questions or explanation about the tests or results, I may
contact Dr Samuel Majalija (Tel. Number +256 77 404710).
I understand that by signing in the space below, I indicate that I have understood
the purpose of this study to which I agree to participate.
Signature..................................Parent/Guardian
Age...................................... Date: .........................
Name of investigator: ..........................................
Signature of investigator:.......................................
Date................................................................
Name and signature of witness.........................................
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Appendix C
Questionnaire
Patient biodata
1: Clinical number of patient:
2: Patient identity code:
3: Patient age.................
4: Patient sex..............
5: Name of household head
6: Patient contact address: Local village council (LC1)........................
7: Chairperson of LC1:....................................
8: Name of nearest primary school/ church/ Mosque..................
9: Duration of stay in the village...............................
10: Number of cattle at home......................................
11: Source of drinking water...........................................
12: How often do you drink raw milk or fermented milk (eshabwe) in the
home?................
13: Did this child drink raw milk or fermented milk (eshabwe) in the last 2
weeks?..................
Clinical data
14: Time and date of presentation for care................................
15: Maximum number of loose or liquid motions in any 24-hour period since the
diarrhoea began..................................
16: Duration of diarrhoea....................................
17: Type of diarrhoea.......................................
18: Whether treatment given before reporting to clinic......................
19: Types of antibiotic given at the time of sample collection....................
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Appendix D
Media and buffers
D.1. Media
Caye Broth containing Caye broth supplement
Caye broth 7.95g
Distilled water 200 ml
Autoclave
Cool to 45oC
Add Caye supplement
mTEC Agar (Difco)
Protease Peptone 35.0g
Yeast Extract 3.0g
Lactose 10.0 g
Stuart’s transport medium (BBLTM)
14.1 g of Stuart’s transport medium powder
Dissolve in 1000ml of high grade water.
Dispense in small screw-capped bottles
Autoclave at 121oC for 10 minutes.
2X yeast-Tryptone (YT) broth
Tryptone 16g
Yeast extract 10g
Nacl 5g
Add to 1000ml high grade water and autoclave at 121oC for 10 minutes.
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D.2. Buffers
Cell Lysis Buffer (50 mM Tris:50 mM EDTA, pH 8.0 + 1% Sarcosyl)
25 ml of 1 M Tris, pH 8.0
50 ml of 0.5 M EDTA, pH 8.0 50 ml of 10 % Sarcosyl (N-Lauroylsarcosine, Sodium
salt)
Dilute to 500 ml with sterile Ultrapure (Reagent Grade Type 1) water
Cell Suspension Buffer (100 mM Tris:100 mM EDTA, pH 8.0)
10 ml of 1 M Tris, pH 8.0
20 ml of 0.5 M EDTA, pH 8.0
Dilute to 100 ml with sterile Ultrapure (Reagent Grade Type 1) water
50X TAE Buffer for agarose
Tris (base) 2M (242g)
EDTA (disodium salt)
5M (18.6g)
Adjust to pH 8 with 57ml glacial acetic acid
Make up to 1 litre with distilled water.
Autoclave. For preparing agarose gel and running use 1x TAE, i.e 1ml TAE:49ml
water
0.5X TBE buffer for PFGE
Tris 8.1g
Boric Acid 1.38g
EDTA 0.47g
Dilute to 1000 ml with sterile Ultrapure (Reagent Grade Type 1)
Autoclave
TE Buffer
10 ml of 1 M Tris, pH 8.0
2 ml of 0.5 M EDTA, pH 8.0
Dilute to 1000 ml with sterile Ultrapure (Reagent Grade Type 1) water
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Appendix E
Restriction fragments
E.1. Restriction fragments generated by HhaI digestion of 1848 nu-
cleotide sequences of 18 intimin types from the Genbank
Intimin type Accession
number
DNA fragment generated by re-
striction digest with HaeIII
Alpha (α) 1 AF022236 63, 72, 230, 341, 545, 597
Alpha (α) 2 AJ579368 63, 72, 168, 230, 341, 429, 545
Beta (β) 1 AF453441/ 48, 49, 62, 72, 78, 205, 230, 354, 357,
392
AJ277443
Beta (β) 2/B AJ715407 62, 63, 167, 230, 413, 429, 483
Gamma (γ) 1 AF081185 62, 72, 168, 230, 404, 429, 483
Gamma (γ)2 AF449420 / 62, 168, 205, 224, 230, 476, 483
theta (θ) AF025311
Epsilon () 1 AF116899 62, 72, 78, 205, 230, 392, 404, 405
Epsilon () 2 AF530554/ 62, 72, 168, 205, 224, 230, 404, 483
DQ523614
Zeta (ζ) AF449417 72, 168, 230, 404, 429, 545
Zeta (ζ) AJ298279 72, 168, 205, 224, 230, 404, 545
Eta (η) DQ523604/ 62, 63, 78, 168, 230, 341, 429, 477
AJ308550
Iota (ι) DQ523601/ 72, 168, 230, 404, 429, 545
AJ308551
Iota (ι) 2 AF530553 23, 47, 62, 72, 78, 183, 220, 354, 404,
405
Continued. . .
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Table E.1 – Continued
Intimin type Accession
number
DNA fragment generated by re-
striction digest
Kappa (κ/) AJ308552 63, 72, 168, 230, 341, 429, 545
delta (δ)/ AJ875027
(β2O) U66102
Lambda (λ) AF530557 72, 168, 230, 404, 429, 545
Mu (µ) AJ705049 63, 72, 168, 230, 341, 429, 545
Nu (µ) AJ705050 23, 47, 62, 72, 78, 183, 220, 354, 404,
405
xi (ξ) AJ705051 62, 72, 78, 205, 230, 392, 403, 405
Omicron (o) AJ876648 23, 47, 62, 72, 78, 183, 220, 354, 404,
405
rho (ρ) AJ748084 47, 62, 72, 78, 183, 243, 354, 404, 405
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E.2. Restriction fragments generated byHaeIII digestion of 1848 nu-
cleotide sequences of 18 intimin types from the Genbank
Intimin type Accession
number
DNA fragment generated by re-
striction digest with HaeIII
Alpha (α) 1 AF022236 23, 83, 163, 303, 399, 877
Alpha (α) 2 AJ579368 106, 163, 303, 1276
Beta (β) 1 AF453441/ 22, 30, 75, 172, 361, 1187
AJ277443
Beta (β) 2/B AJ715407 23, 83, 162, 303, 399, 877
Gamma (γ) 1 AF081185 23, 163, 303, 1359
Gamma (γ)2 AF449420 / 23, 105, 173, 188, 1359
theta (θ) AF025311
Epsilon () 1 AF116899 23, 30, 75, 168, 172, 193, 1187
Epsilon () 2 AF530554/ 23, 163, 303, 482, 877
DQ523614
Zeta (ζ) AF449417 23, 147, 156, 163, 482, 877
Zeta (ζ) AJ298279 23, 482, 1343
Eta (η) DQ523604/ 23, 83, 147, 156, 163, 222, 225, 829
AJ308550
Iota (ι) DQ523601/ 23, 163, 303, 482, 877
AJ308551
Iota (ι) 2 AF530553 30, 436, 1382
Kappa (κ/) AJ308552 23, 83, 163, 303, 399, 877
delta (δ)/ AJ875027
(β2O) U66102
Lambda (λ) AF530557 23, 163, 303, 1359
Mu (µ) AJ705049 23, 83, 147, 156, 163, 399, 877
Nu (µ) AJ705050 23, 30, 83, 436, 447, 829
xi (ξ) AJ705051 22, 30, 75, 172, 361, 1187
Omicron (o) AJ876648 12, 18, 106, 436, 447, 829
rho (ρ) AJ748084 12, 18, 23, 436, 1359
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